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Abstract
A brief history of nucleosides and their photophysics provides the background
information for the discussion of synthesis, photophysics and incorporation of fluorescent
nucleotide analogs during enzymatic DNA synthesis. Through the use of nucleoside
starting material, it is possible to synthesize a number of modified nucleotides for use as
fluorescent probes in biochemical research. Synthetic endeavors into the synthesis of
these and related molecules from nucleobase starting materials are also presented. The
synthesis of these molecules involved re-development of the synthetic routes to broaden
substrate scope by overcoming the changed reactivity resulting from the presence of
additional functionality.
While many highly useful fluorescent probes exist today, there remains to be
filled significant gaps in performance. Brighter probes, probes that emit at various
wavelengths while maintaining fluorescence when present in folded biomolecules
(proteins, nucleic acids), and probes that work together as a nucleic acid FRET pairs are
still needed.
In the work described in this thesis, a series of cytidine analogs that are closely
related have been synthesized and investigated to elucidate trends in effects on
photophysical properties by the electronic character and position of substituents. The
location of substitution as well as the surrounding environment has an influence on how
the introduction of new functionality affects the photophysical properties of the
ii

chromophore. Tricyclic cytosine skeletons have been substituted to produce analogs that
are brighter, and more or less sensitive to their environment.
These substitutions affect not only the photophysical properties of the compound
but also the tautomeric equilibrium between cytosine and tyrosine-like hydrogen bonding
patterns. This equilibrium between hydrogen positions controls the base pairing
properties of the compound and how it is treated by cellular machinery during
incorporation in nascent nucleic acids. Incorporation studies reveal that the substitution
affects the incorporation efficiency for templates containing different hydrogen bonding
partners.
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Chapter One: Introduction of Key Concepts
Nucleotides
Scientific interest in nucleotides dates back over 200 years which was long before
the fundamental importance of these molecules was known. Karl Scheele discovered uric
acid in 1776.4 This seminal discovery was followed many years later by identification of
the other nucleobases. Guanine’s discovery in 1845 was followed more quickly by the
precursor to adenine in 1847, thymine in 1893, and finally cytosine (which is important in
the context of the molecules in this work) in 1894. The study of the acid resistant portion
of surgical pus “nuclein” began in 1868 resulting in the term that would lead to the name
used for these compounds today.5 The term nucleic acid (for nucleotides and their
polymers) was suggested in 1889 by Altmann and Levene, and Mandel finally introduced
the term nucleotide in 1905.4 First success in the synthesis of a phosphate containing
nucleotide was achieved by Fischer in 1914. Synthesis without the phosphate groups can
be easier, as will be shown in this work. The first published synthesis of cytosine without
phosphate or ribose, the nucleobase, came from Wheeler and Johnson in 1903 (figure 10-1).1 This was not long after the correct structure proposal of the compound by Kossel
and Stendel in 1902.4, 5
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Figure 1-0-1: Original Cytosine Synthesis1. Nucleobase structure was confirmed through its synthesis by
Wheeler and Johnson in 1903.

Nucleotides have a multitude of roles in the cell and are intricately tied to many
processes.6 They are primarily the building blocks for the holders of genetic information
but they also play a role in metabolism, signaling, and enzyme activity.7 Adenine and
cytidine are weak bases, uridine and thymidine are acids and guanosine is amphoteric.8
Due to the variety of processes involving these molecules, probes that can mimic natural
nucleobase structure are highly useful biophysical tools. Probe development is possible
because these monomers and their corresponding macromolecules can be manipulated
and modified through synthesis or with enzymatic activity. Nucleotides assemble into
nucleic acids by rules that are understood and the geometries of these structures are
predictable. The resulting polymers are capable of binding a wide range of compounds,
and even catalyzing reactions.9 It has been recognized for some time that changes to the
nucleotides will change the absorbance spectra of these compounds.8 Additionally, when
making synthetic modifications to nucleotides it is important to keep in mind that the
bond lengths and the bond angles will be different than the natural nucleotide, orientation
with respect to the glycosidic bond will be affected, and the conformation of the
phosphodiester bond can also change.8 These changes are important because slight
2

variations in structure can have a significant effect on the functionality and recognition
by cellular machinery. The earliest synthetic analogs were those that were modified
versions of adenosine. Intercalating nucleotides have been synthesized, e.g. nucleobases
that are stretched through the expansion of the π system like those in this study. Other
large π systems are seen in ligandosides which are fluorescent bases that can be ligands
for metal detection and are tolerated after incorporation into oligomers.10
The nucleobases act like the functional groups of a molecular assembly which is
the DNA helix. They align perpendicular to the backbone and are in direct π-π van der
Waals contact.11 Base pairing occurs when complimentary nucleobases on the same or
different nucleotide strands bind through hydrogen bonds. Watson-Crick pairs form
through size complementarity as well as a matching hydrogen bond pattern.12 The
hydrogen bond pattern is influenced by the tautomeric state of the nucleotides. The bases
of the nucleotides can exist in several tautomeric forms, the natural occurrence of which
is dictated by the presence of the exocyclic hydroxyl and amino substituents. The diketo
tautomer predominates in uridine (U) and thymidine (T) while the keto-amino is favored
in cytidine (C) and guanosine (G), and the amino form is dominant in adenine (A).8
Loops and bulges in oligonucleotides distort the stacking of the bases and can
change the local environment of a nucleotide. Bulges are formed when one strand is
longer than another in the duplex. Loops occur when there are consecutive mismatches
between the strands or mismatches at the end and can be symmetric or asymmetric.13
RNA has a larger amount of structural diversity than DNA does, and individual unpaired
bases are common in structured RNA. The high occurrence of loops, bulges, and
3

mismatches in RNA are essential for the function of RNA. 14 Contrary to this
preponderance of unstacking in RNA, A form DNA is a nucleic acid with a higher
occurrence of stacking from a large amount of π system overlap. B form DNA appears in
the middle with not as significant stacking as A form DNA but without the high
occurrence of mismatch seen in RNA. These stacking differences have an influence on
the electronic properties of the nucleotides.15
The fraying of base pairs at the terminus of the duplex makes studying this region
more difficult than bases elsewhere in the helix.16 At the terminus, the base pair is open a
significant portion of time and this causes the neighboring base pair to experience a
terminus like environment. This behavior of the terminus causes the second base pair to
be more open and affect the next pair and so on and so forth.17 Robust synthetic
nucleosides will be required to study the differing environments in all areas of the helix.

4

Fluorescence of Nucleotides
Fluorescence preceded the nucleic acid history that was described in the
previous section, and therefore the photophysical properties of nucleic acids and
components have been under investigation almost since discovery.18 Using fluorescence
spectroscopy one can obtain a large sample signal and a low background fluorescence so
this technique is used to study a number of biosystems in which other experimental
background signals could be significnat.10 Fluorescent probes give access to structural
elements of DNA-protein interactions and molecule recognition that would otherwise be
unobtainable because probes substitute for the natural counterpart. Data obtained can give
structural information of DNA on the molecular level.19 A florescent label can yield
information about the structure, but because of the tether attachment to the molecule of
interest it is always some distance away. Typically, organic chromophores reside in their
excited states for less than twenty nanoseconds after the femtosecond long excitation
processes. Collisional as well as other forms of quenching lead to a loss of emission
intensity.6
Non-fluorescent techniques are used in medicine daily, but are expensive and
sometimes suffer from poor resolution. Additionally many of these techniques are
unresponsive to physiological changes.6 The natural nucleobases have exceedingly low
quantum yields (QY) and sub-picosecond fluorescent lifetimes, so modified nucleosides
and other molecules have been synthesized to study these biomolecules with
fluorescence. These short lifetimes are the result of rapid nonradiative decay. This decay
has been attributed to the highly efficient internal conversion of absorbed energy to
5

harmless vibrational energy through nearly barrier-less conical intersections between
vibrational states. Furthermore, participation of “dark states” has been observed. These
non-emissive states feature out-of-plane polarized electronic transitions.20 Relaxations of
these molecules are complex, and the decay is non-exponential. There is a strong
wavelength dependence on the behavior of these compounds, and excess energy could
potentially change the populations and the excited state dynamics.21 Guanosine, like the
other natural bases is a poorly emissive compound. Additionally, it has also been
observed that guanosine results in a decrease of the fluorescence from other
chromophores in close proximity. This nucleobase has HOMO and LUMO orbitals of
energies which make it possible to undergo photo-induced electron transfer.22 It has two
strongly allowed ππ* transitions that are in-plane polarized, but perpendicular to each
other that are believed to be able to participate in electron transfer. Additionally, it has
the highest number of heteroatoms and therefore most sites available for hydrogen
bonding interactions. There is a “dark trap” in the energy landscape of guanine (figure 10-2). Generation of this state is usually rapid following excitation, but it can also be
populated from the lowest energy state. It is likely that this state is the πσ*, which is
stabilized in protic solvents because of the stabilization of the nitrogen hydrogen bond.

6

Figure 1-0-2: Energy landscape for guanine. Illustrates the deactivation processes for this nucleobase.
Reproduced from Cheng, C. C.-W.; Ma, C.; Chan, C. T.-L.; Ho, K. Y.-F.; Kwok, W.-M., The solvent effect
and identification of a weakly emissive state in nonradiative dynamics of guanine nucleosides and
nucleotides - a combined femtosecond broadband time-resolved fluorescence and transient absorption
study. Photochem. Photobiol. Sci. 2013, 12, 1351-1365 with permission of The Royal Society of Chemistry
(RSC) on behalf of the Centre National de la Recherché Scientifique (CNRS) and the RSC.

Charge transfer from the amino in adenine is used to explain the observed red
shifting of its emission.20 Similarly, another explanation for the quenching ability of
guanine could be due to the intramolecular charge transfer from its amino to the
chromophore. 8-oxo-guanine is produced upon oxidative stress, and it is shown to be an
even better quencher than guanine. This not only provides a way to monitor oxidative
stress, it supports the photoinduced electron transfer mechanism proposed. Interestingly,
this damage response, if left unreversed leads to lesions, because the carbonyl oxygen
leads to the presentation of the Hoogsteen face that mimics thymidine.23
Fukuzumi has reported that the thermal electron transfer with one electron
oxidants did not result in oxidation values that are significantly different between guanine
and the other bases to explain why it acts so strongly as a reducing agent. The radical
cation has been shown to be easily deprotonated, and this may be the explanation.24 The
base portion in the nucleic acids are the chromophores, because the sugars and the
phosphate backbone have their transitions at higher energy.25 Extensive π systems are
7

present in the natural nucleobases, and these are extended even further in the tricyclic
systems investigated in this work. These π systems lead to intense ππ* transitions. From
the number of filled and unfilled π orbitals many ππ* transitions are possible and these
are the transitions likely observed in the wavelength range being investigated. The nπ*
transitions of the nonbonding oxygen and nitrogen electrons are typically buried by these
other intense transitions.24 Higher ordered structures of nucleotides have a lower
absorbance than the sum of the individual parts because the stacking interactions produce
some hypochromicity.26 For oligonucleotides this typically results in a decrease of 20 to
40 percent, while a dinucleotide has a decrease of 0-13 percent.27 These electronic
characteristics are useful in understanding fluorescent nucleobase analogs (FBA’s).
Aromatic heterocycles such as nucleobases have been shown in previous work to be
receptive to minimally perturbing substitutions designed to direct the photophysics.6 This
receptiveness is exploited in the use of the compounds synthesized in this work to

Figure 1-0-3: Analog Y. Naturally fluorescent tRNA that was isolated in the 1970s and used to
study tRNA using fluorescence.

determine a substitution pattern which would give desired photophysical characteristics.
There are some naturally occurring modified bases that have fluorescence as a
relaxation process. Analog Y was isolated and characterized in the 1970s (figure 1-0-3).
Not only does this analog undergo fluorescence and phosphorescence relaxation, it
undergoes photochemical decomposition.28 By 2007 there were 107 known naturally
8

occurring modifications of RNA nucleotides.29 A few of these have been shown to be
emissive and their photophysics have aided investigations in tRNA, but most studies have
necessitated use of external labels.18, 28, 30
Dyes that lie outside of the base stack can perturb the duplex and interfere with
the interactions of nucleic acids which are of interest for investigation.31 This has been
countered by the development of analogs that are substitutes for the natural bases while
acting as a fluorescent probe of the nucleic acid. Pyrene has been attached to a
nucleobase to take advantage of its significant fluorescence abilities. There are strong
intramolecular interactions between the fluorophore and the base to which it is attached.
The fluorescence lifetime is decreased for this fluorophore through its attachment as a
label.32 Even with the negative impact on photophysics from the attachment of these
labels to nucleotides, it is possible to have high absorptivities, high quantum yield and
high photostability.33 Carboxy fluorescein for example can be conjugated to
oligonucleotides. Fluorescence of this dye has been used to study the internalization of
nucleic acids and the movement of these molecules within the cell.34 Extending the
linkers of label molecules has been shown to provide intense tunable fluorophores. 35
It has been shown that endonucleases do not always cleave sequences which
contain labeled nucleotides, perhaps from the bulk of the dye being in the way. 9 These
labels are also known to substantially increase the contour height and decrease the
thermal stability of the duplex. In addition, the cumulative effect of multiple substitutions
with these labels changes the solubility of the DNA in the organic phase and slows
diffusion and hybridization action. There have also been some epistatic effects observed
9

with these types of substitutions. Attachment of the label to carbon 5 of the nucleobase
through a short linker can place the dye in the minor groove. This placement was used in
FRET (Forster resonance energy transfer) studies that were accurate out to 80 angstroms,
to determine that Holliday junctions have different structures under different salt
concentrations.36
Using FRET it is possible to monitor the conformation changes and interactions
of the system. For this type of energy transfer exploitation, it is important to consider the
quantum yield of the donor chromophore, the spectral overlap between the fluorophores,
the refractive index of the media, and the geometric factor. The geometric factor has to
do with the similarity between the directions of the transition dipoles for the two
molecules.37
Time resolved Stokes shift spectroscopy was used to study abasic sites. There is a
hypothesis that the increased flexibility present when there is an abasic site encourages
the recognition of the site by cellular repair machinery. Experiments performed revealed
that the DNA is a very polar environment.38 The environment of a chromophore is
important to its performance. Solvation and hydrogen bonding cause a range of solvent
effects on the electronic transitions of the nucleobases. The solvent environment of the
molecule can change the structural arrangements that are accessible, it can change the
energy order of the various bright and dark states, and it can promote other deactivating
processes such as tautomerization and proton transfer. 20
It is possible to perform single molecule studies with fluorescence. Analogs that
are able to be selective in their pairing partner are advantages for these studies.
10

Additional qualities of fluorescent base analogs that will be discussed in the following
section make them more desirable than labels for these studies.39

11

Fluorescent Base Analogs
Fluorescent base analogs make it possible to obtain conformational information
on a picosecond timescale. These structural dynamics can be sequence dependent and
FBAs allow for sequence specific experimentation.40 They are used in many applications
because of their versatility and their close resemblance to the natural system.31 These
analogs must have a minimal influence on the native structure of the DNA or RNA
polymer to make them useful.40 A fixed and known orientation is also necessary, to
understand the photophysical data that is to be collected from these probes.40 FBAs serve
as real time probes of base stacking and base pairing and can be probes for diagnostic
sequencing and molecular recognition.41
A variety of probe options improves the experimental capabilities as well, because
a compound can be selected for properties that are the most useful to the system under
study. 40 The stringent design criteria come from the helical stacking structure of the
DNA. Size, shape, charge, polarity, and hydrogen bonding motif are all important for the
determination of how useful a FBA will be and how much it will affect the natural
structure of the duplex.42 Watson-Crick hydrogen bonds are not necessary for polymerase
replication. The most important factor is that the base can fit into the active site of the
enzyme. Polymerases impart restrictions based on sterics that are much stricter than even
the duplex.11
FBAs have the ability to be firmly stacked, and report on the local structure with
high sensitivity.31 Electrostatics are not as important when it comes to stacking, size and
hydrophobicity are more important.11 Conversely, it is possible for analogs that are
12

present opposite an abasic site to be intrahelical or extrahelical, because they lack the
hydrogen bonding partner to keep them within the stack. Sharp emission decay can be
indicative of a flattening of the chromophore. The combination of emission decay and
duplex stability can give information about the intrahelical or extrahelical location of the
FBA. It is generally observed that FBAs that are found to be opposite these empty sites
have an increase in quantum yield.43 Studying the non-nucleic acid functions of
nucleotides is possible with fluorescent base analogs as well. There are NAD analogs and
cAMP analogs which are used to study the interactions of these signal molecules in the
cell.10, 44
Modification to the pyrimidine at the 5 position has been shown to be a
structurally benign modification, therefore this is the position where a lot of fluorescence
enhancing modifications have been made to form FBAs.45 Substitution at this position on
uridine and cytosine does not change the hydrogen bonding abilities and the substituents
are pushed into the major groove in higher order structures. These analogs do show
problems with polymerization likely due to a clash with the substituent and the active site
of the enzyme. In addition analogs have been made to function as metal ligands, so that
the metal can create the base pair.11
Addition of a benzene ring between the sugar and the purines or in-between the
pyrimidine rings of the natural bases has been shown to impart fluorescence (figure 1-04). Only slight quenching is observed upon hybridization of these compounds, which is
quantitatively less than 15%. Having an A in the complement strand was shown to be
enhancing towards fluorescence for all but the extended A analog. Structural distortion
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that leads to self-quenching has been implicated as the cause of this anomaly. The
thermal stability of a duplex containing these analogs increases, but there is disruption in
the natural structure. This distortion has been explained by possible mutual intercalation,
formation of an alternative duplex form, or the lack of any structure at all.22

Figure 1-0-4: Size expanded bases. Addition of a benzene ring imparts fluorescence that is maintained
within a duplex. "Reprinted (adapted) with permission from Krueger, A. T.; Kool, E. T., Fluorescence of
Size-Expanded DNA Bases: Reporting on DNA Sequence and Structure with an Unnatural Genetic Set. J.
Am. Chem. Soc. 2008, 130, 3989-3999. Copyright (2008) American Chemical Society."

One of the most well-known fluorescent base analogs is 2-amino purine (2AP)
which has the adenine exocyclic amine in the 2 position instead of in the 9 position
(figure 1-0-5). 2AP has a quantum yield of 0.68 with excitation at 292 nm and emission
at 305 nm that is significantly reduced upon incorporation.33, 46 This intensity reduction is
presumably due to collisional quenching.15 It is less efficient in base pairing than
adenosine and can act as a guanine analog as well making it less selective in its hydrogen
bonding partner. Perturbations of the duplex which are discussed below are also observed
upon incorporation of 2AP.33 This analog was used to determine the denaturation
dynamics of structured RNA. Differential denaturation methods were shown to have a
different influence on the lifetime components of the fluorescence of this FBA.14 This
FBA was also used to determine that the formation of the open complex is not the rate
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limiting part of translation.47 The perturbations induced by the presence of this FBA were
investigated. There was shown to be an increase in the rate of exchange with water of the
hydrogen bonding hydrogens in the base pairs of the FBA and neighboring bases. There
was no premelting of the area around the FBA in denaturation so it has not been
implicated in interfering with this mechanism. The decrease in the base pair lifetimes
would influence the binding kinetics of cellular enzymes, interfering with the analysis of
these types of mechanisms.16 This analog was observed to bind A dependent riboswitches
with the same affinity as adenine, making it useful for the study of this cellular genetic
control machinery.48

Figure 1-0-5: Some fluorescent base analogs. These are examples of nucleobase mimics that are more
strongly emissive than the natural bases.

Another adenosine analog is 6MAP; this analog has a fluorescence decrease of 90
percent upon incorporation and an additional decrease by a factor of 2 or 3 following
hybridization (figure 1-0-5). This analog is very sensitive to its surrounding bases and can
provide information about its environment. This FBA was used to study A tracts, which
are known to have helix bending as a result of the long stretch of adenines. Metals were
observed to bind preferentially to these tracts, and the degree of bending of the helix was
greater at high concentrations of ions.49
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3MI is a guanine analog that forms ground state complexes when purines are
present on either side in a single strand and has a similar environmental sensitivity to
6MAP (figure 1-0-5).50 Fluorescent analogs of guanine were used in conjunction with
other dyes to determine the cleavage specificity influenced by cofactors on the cellular
machinery.51 Isoxanthopterin is a G analog with a high quantum yield and sensitivity to
its environment that slightly disturbs the duplex hybridization (figure 1-0-5).52 Pteridines
like Isoxanthopterin are also highly environmentally sensitive, and this sensitivity comes
from a combination of hydrogen bonding, stacking, and neighboring base influence.
Although selective excitation is easy, hydrogen bonding to cytosine is hindered, resulting
in a reduction in oligo stability.33
Pyrrolo-dc is selective for its partner, G, but like many of these analogs it has a
quantum yield that decreases from free nucleoside to single stranded and to double
stranded nucleic acids (figure 1-0-5).33 In a duplex system it has been shown that there is
potentially greater accessibility of the conical intersections between the states. This
allows for an increase in the competitive decay processes which is an explanation for the
common decrease in quantum yield.31 To reach these intersections a great deal of
structural variation is required. Another question that has been asked is whether interbase
proton transfer affects the rate of decay of a base pair.20 A potential use for this is the
detection of mismatch by the increase in quantum yield that results from the decrease in
the rigidity of the probe.31 Some groups have used nonpolar, weakly hydrogen bonding
analogs to probe the stacking interactions for surface area, electrostatics, polarizability
and hydrophobicity to understand the environment mismatched bases experience.53
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There are nonpolar nucleoside isosteres which are close mimics to the natural
bases but that cannot form hydrogen bonds. Benzene was substituted for the natural base
as a non-selective stacking nucleoside, but it turned out to be highly destabilizing.11
Combining a small set of fluorophores like these isosteres can give properties that are not
the same as the individual molecules.11 Exciplexes including those in oligonucleotides are
more sensitive to quenching, because there are multiple available quenching positions.
Non-covalent binding interactions affect these phenomena.54 A combination of probes
where each one is detectable through a different channel is an experimentally useful
tool.55
Taking fluorescent base analogs to the next level are the fluorescent analogs that
mimic the electronic structure of the natural bases. There are stringent design criteria for
an analog to be isomorphic to the natural bases, and the relationship between the structure
and photophysics is difficult to establish.45 It is believed that creating a donor type
substitution that can interplay with the acceptor portion of the base can lead to a red shift
and an increase in environmental sensitivity.45 Isomorphic analogs can be used in
fluorescence sequencing and that makes them applicable to single nucleotide
polymorphism (SNP) detection. Applications in this area make fluorescent base analog
development relevant to human health and personalized medicine. Structure and function
elucidation, microenvironment detection, ligand binding studies, and other miscellaneous
applications are made available through the use of these compounds.6
FBAs have uses outside of biophysical tools to study cellular nucleic acid
processes. Attaching fluorescent sensors to a DNA backbone provides water solubility to
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molecules that previously had none, which increases their utility in the determination of
photon flux.56 A long range charge transport through the π stack has interesting biosensor
applications. Metallo base pairs have been used to expand the electronic and magnetic
function ability of these compounds.57 Some modified nucleobases show anticancer and
antiviral properties.11 Extension of the aromatic portion of the nucleobases was
investigated as a possible stabilizer of triplex formation. Triplex formation could be a
way for antisense mRNA to overcome the lack of target association because of
sequestration in a duplex. The alpha anomers prevented exonuclease activity on the
strands studied. Although there was a preferential action of these bases with duplexes, the
triple helix was not stabilized.58 Triple helices are also seen in the use of size expanded
bases (figure 1-0-4). These bases can be fluorescent from the extension of the π system
which increases the size, but are not generally used as FBAs. Although these bases are
destabilizing following incorporation into a natural helix, an all expanded system shows
more stability by 12-25 oC.59 Interestingly, these are not as destabilizing as having no
nucleobase at all.60 Stability is imparted by the fluorescent base analogs which represent
the scaffold for the nucleosides presented in this investigation. These analogs are shown
to be environmentally less sensitive than other quenchable analogs. Environmental
insensitivity generally comes from a high QY as well as a single fluorescence lifetime.
High control of orientation and position is also common in environmentally insensitive
fluorophores.33
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Tricyclic Cytosine Analogs
Some analogs have a problem with base pairing and thus are more likely than the
natural counterparts to be flipped out of the base stack. Conversely, tricyclic cytosine (tC)
appears to be pulled closer to the stack of bases than cytidine (figure 1-0-6). The
hydrogen bonds between tC and guanosine are as stable as those between cytidine and
guanosine. The one drawback of this tight interaction is that binding events that naturally
occur in the major groove may be potentially affected by the presence of the tricyclic
FBA.39 Following incorporation of tC there is minimal change to the local DNA structure
and the overall form remains B-DNA.39 Tricycle to tricycle stacking has been shown to
be dramatically stabilizing.3 Thiol tC has a quantum yield that is insensitive to location of
the FBA within single strand or double strand oligonucleotides. Variations in the
sequence surrounding the FBA also do not affect the QY. The oxygen analog of this
compound is similar to previously discussed FBAs which show some surrounding
sequence dependence, sometimes significantly, on photophysical properties. Oxygen
tricyclic cytosine (tCo) shows a strong distance dependent quenching by guanine to the 5’
side. Both tC and tCo show a single fluorescence lifetime even after incorporation which
is different from other analogs whose number of lifetimes increases upon incorporation
due to various degrees of interactions in the helix. This conformational rigidity combined
with the parallel emission and absorbance dipoles make a combination of tricyclic
cytosine analogs a likely FRET pair.42
Oxygen tricyclic cytosine is predicted to be flexible but planar, while the
switching of oxygen for sulfur creates a bend along the SN axis.61 The ability of the
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additional benzene ring of tricyclic cytosine to invert about this axis is believed to be
unaffected by the placement in the major groove.62
In addition to these two parent compounds; tCnitro, which as the name would
imply, has a nitro group at the 7 position of the nucleobase, all base pair with guanosine.
The selectivity is not the same selectivity as the natural cytosine because there is some
misincorporation opposite adenine in studies performed.63 Misincorporation has been
attributed to the hydrogen bonding face displayed by the analog, as will be further
discussed in Chapter 5 regarding biological behavior of nucleotide analogs.64
Misincorporation rates in RNA and DNA are different because of discrimination
differences by the cellular enzymes.65

Figure 1-0-6: Tricyclic cytidines. The molecular skeleton on which substitutions were made to probe
photophysical properties. X is a carbon, oxygen or sulfur atom. R is usually hydrogen, R1 can be hydrogen
or hydroxyl. R2 and R3 are variable.

Photophysics have been investigated on the parent compounds in many
environments, as will be discussed in Chapter 4 regarding the characteristics of the novel
nucleotides. In general, high quantum yields are maintained following incorporation and
hybridization. Upon incorporation there is a slowing of the nonradiative decay processes,
which allow for an increase in QY. Sulfur analog tC has a decay that is dominated by
temperature dependent processes while the tCo decay is composed of almost an equal mix
of temperature dependent and independent processes that sum to be equal to the decay of
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tC.66 Beginning in single stranded structure, decay of tCo becomes biexponential because
of these multiple processes.33 Although fast decay is not ideal when it comes to the
brightness of a fluorophore, it is believed to increase the photostability.66 The lowest
energy absorption of tC is likely from a single transition polarized at an angle 35 degrees
to the long axis of the chromophore.67
Because tCo shows an increase in cellular permeability, it inspired the synthesis of
a tetracyclic analog that would potentially enhance hybridization.68 Another extension of
the tCo frame work is the g-clamp analog. G-clamp forms an additional hydrogen bond
with the oxygen 6 of the complementary G located on the Hoogsteen face. 69 These
molecules have inspired others and they inspired the work presented in this dissertation.
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Goals
The work presented here builds upon the above knowledge of nucleosides and
their fluorescence. Creating a small library of related molecules that would establish a
potential pattern between substituent and photophysical properties was the goal of this
work. This pattern could then be used to direct further synthesis of fluorescent nucleoside
analogs for specific applications. Selecting a framework that provided the beneficial
characteristics presented in the previous section, tricyclic cytidines were the compounds
selected to be the basis of this family. Knowing that the tC and tCo analogs maintain their
fluorescence upon incorporation and hybridization,42 this investigation aimed to improve
upon this chromophore by determining substituents that would cause an increased
brightness and or a shift in emission to longer wavelengths. A great enough increase
would make these compounds potential tools for single molecule studies. Changes in
HOMO LUMO energy gaps that result in the absorbance of one analog overlapping with
the emission of another would result in a potential FRET pair. These were important
goals of the investigation. Substitutions that would cause the chromophore to signal a
change in environment through a photophysical change would also be useful. Being such
close mimics to the natural structure, these compounds would provide dynamic
information for specific bases in a nucleic acid.
Developing a nucleobase directed synthesis for the tCo compounds would be
exciting for reasons that will be discussed in the chapter regarding that synthesis.
Modifications to the established synthetic routes for these compounds to increase
tolerance towards a variety of substitutions that inherently decrease reactivity are another
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synthetic highlight of this work. Synthetic manipulations of the substituent to further
manipulate the functionality of the chromophore were aims of both the library
establishment and elaboration. As an alternative, nucleoside directed synthesis was also
investigated to determine the best route to the production of novel florescent nucleosides.
With the knowledge that the tricyclic skeleton is compatible with cellular
machinery, but with greater error rates, and the hypothesis that this may be a result of
tautomeric equilibria, substitutions were made to investigate this property as well.64
Establishing a relationship between the substituent and the incorporation of the
nucleotide opposite natural bases would help to prove this long studied mechanism. A
substitution that disturbs the tautomeric ratio enough could allow for detection of the
normally minor form.
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Chapter Two: Nucleobase Directed Synthesis
Introduction
Derivatives of the tricyclic cytidines are potentially accessible by two approaches:
synthesis of the modified nucleobase followed by (deoxy)ribosylation, or synthetic
elaboration of a nucleoside precursor. Both approaches were investigated in this work
because of their distinct merits. The former has the advantages of scalability because in
inexpensive starting materials, whereas the later avoids the need to make the sometimes
challenging glycosidic bond that links the nucleobase to (deoxy)ribose. This chapter
presents the nucleobase directed synthetic approach (the former) to three tricyclic
cytosine analog groups (figure 2-0-1). Parent compound tC which has sulfur in the center
ring, tCo which has oxygen in this position and tCc where the atom in question is a carbon
are the three parent compounds. Not only are the unsubstituted analogs desirable, but
substitutions to the framework that would influence fluorescence are installed
synthetically on these molecules. Some of these substitutions are synthetic handles for the
installation of additional functionality. Alkyl amines are common in fluorescent dye
molecules, and were a desired functionality to install on these synthetic nucleosides.
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Figure 2-0-1: tC skeleton. X illustrates the position the variable atom between the three parent structures, it can
be sulfur, oxygen or carbon.

A nucleobase directed synthesis is a reasonable method by which to create novel
nucleoside analogs.2, 70, 71 It has benefits over a nucleoside directed synthesis because one
does not have to worry about severing the glycosidic bond during the synthetic
elaboration process. Additionally, a sugar does not have to be preselected prior to
synthesis of the chromophore; it can be later attached to whatever moiety the experiment
in question requires. Ribose, deoxyribose or some synthetically developed mimic thereof
are all possible to append.
Having the nucleobase itself can make it easier to investigate the fluorescence
properties as well. Because the sugar group has been shown to have little influence on the
spectroscopic properties of these molecules, photophysical data can be acquired earlier in
the synthesis to give an idea as to which analogs are the most promising.25 It is not all
positives. As with many endeavors there are some drawbacks to a nucleobase directed
synthesis as well. A protecting group strategy is necessary when dealing with the
nucleobase starting materials because of the reactivity of the N1 nitrogen that would be
attached to the sugar in a nucleoside directed synthesis. When the nucleobase is formed,
and it is time to glycosylate, there is often a loss of material because glycosylation lacks
anomeric selectivity (typically a problem for 2’-deoxyribose, but less so for ribose).
Although some methods exist to isomerize these less desirable anomers to the ones
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desired, these methods typically lack broad applicability.53 Reactions developed for
nucleosides are often not applicable to the synthesis of the nucleobases, as they may rely
on the presence of the functionality in the ribose for other assistance besides the
protection of the N1 nitrogen (this will be seen in the following chapter).
Through the method development for synthesis discussed in this chapter, many of
these pluses and minuses of a nucleobase directed synthesis are illustrated. The synthesis
of many intermediates on the route to these synthetic nucleosides is simplified through
the use of a nucleobase directed approach. Unfortunately, the final synthetic steps for the
completion of the tCo chromophore become a major issue in the absence of ribose.
Benzyl protecting group was robust under the conditions for formation of the modified
nucleobase, but were difficult to remove when the time eventually comes for
glycosylation. For the sulfur compounds (tC), a nucleobase directed approach is a method
that is shown to be effective for derivative synthesis in this work. Further derivatives may
be accessible my similar methods.
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Tricyclic Cytosine Analogs
Tricyclic cytosine tC is synthesized as the nucleobase first and then glycosylated
to form the nucleoside. The step by step synthesis of the unsubstituted compound is
found in the literature, and it is by this method that the compound was synthesized for the
fluorescence investigations done by the author.2 2-Aminothiophenol is coupled to 5bromouracil with the assistance of sodium carbonate in refluxing ethylene glycol (figure
2-0-2). The basic environment allows the deprotonation of the sulfur which acts as a
nucleophile for substitution at the bromine on the C5 carbon of 5-bromouracil. Closure of
the second ring through the formation of the secondary amine is accomplished at 75
degrees with hydrochloric acid in ethanol. Acid catalysis encourages the substitution of
the nitrogen of the 2-aminothiophenol at the C4 carbonyl of the uracil in ring closure. The
nucleobase is fluorescent so it is easy to distinguish the product from other reaction
components during analysis and purification.

Figure 2-0-2: Synthesis of tricyclic cytosine nucleobase (tC). 2 Nucleobase synthesis
resulted in improved yields from the previous nucleoside route.
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Figure 2-0-3: Synthesis of tC deoxyribonucleoside. Glycosylation with and deprotection of the nucleobase
synthesized as presented in 2-0-2 to form the deoxyribonucleoside

The glycosylation of this chromophore was improved over the literature methods
in the laboratory. The N1 of the nucleobase is activated for substitution through the use of
bis(trimethylsilyl)acetamide and then the p-tolyl protected chlorine substituted 2deoxyribose is added with tin tetrachloride (figure 2-0-3). The oxygen of the C14
carbonyl attacks the silyl group of the BSA and the lone pair of electrons from the N1
nitrogen are pulled into a double bond with the C14 carbon. Reformation of the carbon
oxygen double bond allows the nitrogen to act as a nucleophile to attack the cation
generated at the 1’ position on the deoxyribose from chlorine elimination. This chemistry
traditionally used for the synthesis of ribonucleosides was useful for both
deoxyribonucleosides and ribonucleosides with the ribonucleoside synthesis resulting in
higher yields.72
The ribonucleoside synthesis was accomplished through the use of a tetra acetyl
ester ribose with trimethylsilyltriflate as the Lewis acid (figure 2-0-4). The presence of
the acetyl oxygen on the 2 position of ribose can coordinate the intermediate cation and
direct the substitution which leads to an increased yield of the desired anomer. Removal
of the protecting groups, whether acetyl or tolyl for the ribonucleosides and
deoxyribonucleosides respectively was accomplished using Zemplen deacetylation.73
These conditions utilize sodium methoxide in methanol. The sodium methoxide acts as a
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nucleophile to substitute at the protecting group for the sugar oxygens and quenching of
the reaction with acetic acid replaces the protecting groups with hydrogens.

Figure 2-0-4: tC ribosylation. Glycosylation with and deprotection of the nucleobase synthesized as presented
in 2-0-2 to form the ribonucleoside

A related synthetic method was used for the synthesis of the tC analogs which
contain additional functionality at the 7 or the 8 position. The synthetic method
development of these molecules is the material of the thesis of Nada El-Sharif and it will
not be discussed here.74 The synthetic route to these substituted tricyclic cytosine analogs
is presented here for reference; these methods were used to produce the molecules that
were used in the fluorescence investigation in this work Chapter 4 (figure 2-0-5).
Substituted benzothiazole is opened to the corresponding 2-aminothiophenol through the
use of refluxing hydrazine hydrate. The hydrazine nitrogen attacks the C2 carbon of the
benzothiazole and the N3 nitrogen C2 carbon double bond takes the hydrogen from the
positively charged hydrazine nitrogen. This process repeats itself to sever the resulting
carbon nitrogen single bond generating the free amine at N3 and an imine between C2
and the hydrazine nitrogen. Attack at the C2 carbon by water breaks the imine and the
double bond abstracts a proton from the incoming water molecule. Deprotonation of the
resulting hydroxyl by the thiazole sulfur leads to the generation of acethydrazine and the
substituted aminothiophenol. This aminothiophenol is unstable, and so it is oxidized with
hydrogen peroxide to form the more stable disulfide intermediate.75 The sulfur of the 229

aminothiopenol attacks the oxygen of the hydrogen peroxide releasing a hydroxide ion
which can deprotonate the sulfur to form the sulfenic acid. This sulfenic acid sulfur is
attacked by sulfur on another aminothiophenol to form the disulfide and releasing a
hydroxide ion.
When ready to couple this 2-aminothiophenol to 5-bromouracil, it can be reduced
back to the sulfide through the use of triethylphosphine with water in diglyme. The
phosphorous of triethylphosphine attacks one of the sulfurs of the disulfide bond and
releases the other as the sulfur anion. The oxygen of water attacks the phosphorous to
begin the generation of triethylphosphine oxide. The sulfur anions remove the protons
from the water oxygen.76 Coupling to 5-bromouracil and ring closure happen in the same
fashion as that described for the parent compound above to afford the substituted tC
nucleobases. These nucleobases are glycosylated to form the deoxyribonucleoside and
deprotected under the same conditions as the unsubstituted compound.

Figure 2-0-5: Synthesis of substituted tC deoxyribonucleosides. Changes to synthetic method from that of the
unsubstituted compound were necessary because of starting material availability and stability.

Using the newly installed substituent on the nucleobase as a synthetic handle for the
installation of new functionality is a possible route to new and interesting compounds.
Given the absence of a sensitive glycosidic bond, first attempts at modification of this
position were made prior to the attachment of the ribose. The methoxy substituted tC
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nucleobase which had the ether substituent in the 8 position of the nucleobase was easier
to synthesize and the starting material was less expensive, so the 8-OMe-tC was the
nucleobase upon which synthetic elaboration was attempted (figure 2-0-6). Reaction with
boron tribromide in dichloromethane afforded the hydroxyl substituted nucleobase
through the cleavage of the ether.77 Oxygen of the methoxy ether attacks the boron of the
boron tribromide and one of the bromines from the intermediate attacks the carbon of the
ether resulting in cleavage of the ether bond. Aqueous workup leads to water displacing
the boron from what was the ether oxygen and protonating this oxygen as well as the
bromine anions that result from the boric acid formation. It was possible to glycosylate
this hydroxyl substituted tricyclic cytosine nucleobase through the usual method. Yields
for glycosylation of the OH-tC were lower than those for the methoxy analog.

Figure 2-0-6: Synthesis of triflate tC nucleobase. Conversion of the methoxy nucleobase to an intermediate
more reactive to substitution

Activation of this hydroxyl group to substitution by new functionality is possible
through the installation of a triflic group on the oxygen.78 Trifluoromethanesulfonic
anhydride was reacted with the hydroxyl tC nucleobase in dichloromethane with
triethylamine and this resulted in the complete conversion of the starting material. The
oxygen of the alcohol is deprotonated by triethylamine and the anion attacks the sulfonic
sulfur resulting in cleavage of the anhydride following sulfur oxygen double bond
reformation. The NMR signals of the nucleobase hydrogens were difficult to identify
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even after purification, and the fluorine signals observed for the crude mixture were
absent from the compound that was recovered from purification. To check the utility of
these triflating conditions, the same conditions were used to install the triflate group on
phenol on small scale in deuterated solvent and investigated by NMR. There was
evidence of a reaction by fluorine NMR. Repetition of the reaction of hydroxyl tC
nucleobase under these conditions was made with multiple additions of triethylamine and
triflic anhydride. This reaction resulted in recovery of the product, as was confirmed by
mass spectroscopy. The material was not recovered in an amount that facilitated the

Figure 2-0-7: Buchwald Hartwig amination. Testing conditions for the conversion of chlorine substituted
nucleobases to alkyl amine substituted nucleobases.

glycosylation or the substitution of this triflic tC nucleobase.
An alternative approach to the installation of new functionality, especially amine
functionality, would be using Buchwald-Hartwig amination and a chlorine substituted
nucleobase (figure 2-0-7).79 Chlorine tCo nucleobases were targets of the synthesis of
oxygen tricyclic cytosine as will be discussed in the following section. To test potentially
suitable reaction conditions, allyl[1,3-bis(2,6-diisopropylphenyl)-imidazol-2ylidene]palladium (II) chloride was combined with potassium tert-butoxide, diethylamine
and chlorobenzene in dimethoxyethane.80 The oxyanion on the tert-butoxide attacks the
double bond of the aryl palladium ligand and the electrons from the metal ligand bond are
left on the metal while the chlorine leaves as an anion resulting in the palladium (0) for
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catalysis, potassium chloride and aryl ether. Alternatively, the catalyst could be activated
resulting in the same products through the oxidative addition of the oxyanion of the tertbutoxide following the loss of the chlorine anion. The oxygen of the tert-butoxide then
attacks the aryl ligand and the metal ligand bond electrons are left on the palladium as the
ether is eliminated. Oxidative addition of the chlorobenzene to the palladium catalyst
begins the cycle. The tert-butoxide substitutes at palladium for the chlorine forming
potassium chloride. The amine substitutes for the tert-butoxide and the oxygen anion can
deprotonate the amine to bring it to neutrality. Reductive elimination results in the
installment of the diethylamine functionality at the position on the benzene that was
previously held by the chlorine. The volatile nature of the chlorobenzene starting material
made this a difficult test reaction to monitor. 1-Chloronaphthalene, being less volatile,
was easier to react under the above conditions and this starting material resulted in the
expected diethylamine product. The yield was not high enough from this reaction to
appear a promising course of action for the substitution of chloro-nucleobases to
diethylamine nucleobases.

Figure 2-0-8: Synthesis of diethylamine benzothiazole starting material. Two methods to conversion of amine
starting material to diethyl amine substituted nucleobase precursor.

Installation of the diethylamino functionality directly into the nucleobase starting
material was another route that was attempted, acknowledging that substitutions greatly
complicate the synthesis of these nucleobases. Benzothiazole is commercially available
with an amine substituent in the 5 or the 6 position. Following the synthetic route for
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substituted tricyclic cytosines found above (figure 2-0-5) these positions correspond to
the 7 or the 8 position of the resulting nucleobase product. The amine was converted to
the diethyl amine through alkylation with bromoethane and potassium carbonate in
dimethyl sulfoxide (figure 2-0-8).81 The substitution of the bromine on the ethyl group by
the amine on the benzothiazole is assisted by the basic environment. Carbonate can
deprotonate the aminal nitrogen after it substitutes for the bromine on the alkane.
Repetition of substitution leads to the diethyl product. This reaction afforded the desired
product but in a mixture of both the di and the monoethyl amines which was difficult to
purify. Alternatively, the amine synthesis was approached through a reductive amination
approach (figure 2-0-8).82 Acetaldehyde, sodium cyanoborohydride, and acetic acid were
combined with the starting material in acetonitrile. The acetic acid protonates the
carbonyl oxygen of acetaldehyde which increases the electrophilicity of this compound.
Nucleophilic attack by the aminal nitrogen of the benzothiazole occurs on the carbonyl
carbon of the protonated acetaldehdye. Proton transfer from the nitrogen of the amine to
the oxygen of the aldehyde creates a good leaving group which the nitrogen lone pair
pushes off. Formation of the double bond between nitrogen and carbon leaves the
nitrogen positively charged. Deprotonation of this amine provides the imine intermediate.
Reduced of this imine intermediate by the cyanoborohydride is the final step, and this
entire process repeats itself to form the diethylamine. The desired product can be isolated
from this reaction in modest yield even upon scale up. 6-Diethylamino-benzothiazole
(compound A figure 2-0-8) was subjected to the cleavage conditions used in the
substituted tricyclic cytosine synthesis discussed above (figure 2-0-5). Refluxing with
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hydrazine gives the desired 5-diethylamino-2-aminothiophenol as evidenced by thin layer
chromatography.83 Upon oxidation of the 5-diethylamine-2-aminothiophenol the desired
disulfide product was not obtained. The possibility for over oxidation led to the attempted
by pass of the oxidation and reduction of the aminothiophenol. In situ coupling to 5bromouracil of the cleavage reaction mixture was attempted. The results of this reaction
were inconclusive.
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Tricyclic Cytosine Analogs Experimental:

3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one tC. 5-bromouracil (3.15 g,
16.6 mmol) was combined with sodium carbonate (1.76 g, 16.6 mmol) and 2aminothiophenol (2.4 mL, 22.3 mmol) under N2 and dissolved in ethylene glycol (10
mL). Under reflux the reaction was stirred for 1 hour. Dilution with water, followed by
neutralization with acetic acid and filtration of the product with water, ethanol and diethyl
ether washes resulted in the intermediate. Sodium hydroxide (0.67 g, 16.7 mmol) in water
(33mL) was heated to 50 °C and the solid intermediate was added in portions.
Neutralization with acetic acid followed by filtration with water, ethanol and diethyl ether
washes resulted in intermediate. Hydrochloric acid (2.4mL 37%) was dissolved in
ethanol (24 mL) and the above intermediate was added and refluxed for 24 hours. After
filtration, the solid product was added to a solution of sodium hydroxide (50 mL 5%) and
stirred for 5 minutes at 50 °C, filtered and dried to yield (418 mg, 1.9 mmol) product
12% yield. 1HNMR ((CD3)2SO) δ 10.97 (s, 1H), 10.22 (s, 1H), 7.41 (s, 1H), 7.08-7.01
(m, 2H), 6.93-6.87 (m, 2H).
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tC 3′,5′-di-O-(p-toluoyl)-2′-deoxy-β-D-ribonucleoside. 3H-pyrimido[5,4b][1,4]benzothiazin-2(10H)-one (100 mg, 0.46 mmol) was suspended in dry acetonitrile
(2.5 mL) in a Schlenk tube under nitrogen. Bis(trimethylsilyl)acetamide (130 μL, 0.53
mmol) was added and the reaction mixture allowed to stir at 50 °C for 1 h. The reaction
mixture was allowed to cool to room temperature and 3′,5′-di-O-(p-toluoyl)-2′-deoxy-αD-ribofuranosyl chloride (198 mg, 0.51 mmol) was added with stirring. The reaction
mixture was cooled to 0 °C and tin(IV) chloride (11 μL, 0.092 mmol) was added
dropwise. The reaction mixture was stirred at 0 °C, then allowed to warm to room
temperature, and the progress was tracked by thin layer chromatography. The reaction
was complete in 90 min. At this time, the mixture was diluted with ethyl acetate (15 mL),
washed with a saturated sodium bicarbonate solution, and dried. Rotary evaporation
followed by purification using flash chromatography (EtOAc in cyclohexane) yielded the
pure β anomer of the product as a yellow solid. (114 mg, 0.221 mmol) in 48 % yield.
1

HNMR (CDCl3) δ 7.97-7.87 (m, 4H), 7.43 (s, 1H), 7.32-7.26 (m, 2H), 7.23-7.17 (m,

2H), 7.07 (ddd, J=8.0, 7.0, 1.9 Hz, 1H), 6.98-6.89 (m, 2H), 6.80 (dd, J=7.9, 1.2 Hz, 1H),
6.37 (dd, J=8.2, 5.5 Hz, 1H), 5.59 (dt, J=6.6, 1.7 Hz, 1H), 4.78 (dd, J=12.3, 3.0 Hz, 1H),
4.67 (dd, J=12.3, 3.2 Hz, 1H), 4.59 (q, J=2.8 Hz, 1H), 2.95 (ddd, J=14.5, 5.6, 1.6 Hz,
1H), 2.43 (s, 3H), 2.36 (s, 3H), 2.21 (ddd, J=14.6, 8.3, 6.4 Hz, 1H).
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tC 2′-deoxy-β-D-ribonucleoside. tC 3′,5′-di-O-(p-toluoyl)-2′-deoxy-β-Dribonucleoside (100 mg, 0.175 mmol) was dissolved in methanol (5 mL) and a solution of
30 % NaOMe in methanol (96 μL, 0.517 mmol) was added dropwise. The reaction
progress was followed by thin layer chromatography and found to be complete in 30 min.
The reaction was quenched by the addition of acetic acid (50 μL, 0.872 mmol) and the
solvent was removed by rotary evaporation. Purification by flash chromatography
(CH3OH in CH2Cl2) yielded the product as a yellow solid (53.0 mg, 0.157 mmol) in 90 %
yield.1HNMR ((CD3)2SO) δ 10.45 (s, 1H), 7.88 (s, 1H), 7.12-7.05 (m, 2H), 6.97-6.91 (m,
2H), 6.10 (t, J=6.4 Hz, 1H), 5.27 (s, 1H), 5.14 (s, 1H), 4.23 (dt, J=6.3, 3.7 Hz, 1H), 3.80
(q, J=3.5 Hz, 1H), 3.64 (d, J=12.0 Hz, 1H), 3.57 (d, J=12.3 Hz, 1H), 2.16 (ddd, J=13.2,
6.1, 3.8 Hz, 1H), 2.03 (dt, J=13.1, 6.5 Hz, 1H). AMM (ESI) calcd. for C15H15N3O4S
333.08, found 356.07 (MNa+).

tC 2′, 3′,5′-tri-O-(acetyl)-β-D-ribonucleoside. 3H-pyrimido[5,4b][1,4]benzothiazin-2(10H)-one (200 mg, 0.92 mmol) was dissolved in dry acetonitrile
(10 mL) under N2 . Bis(trimethylsilyl)acetamide (350 μL, 1.43 mmol) was added and the
reaction mixture was heated to 78 °C. After 20 minutes at 78 °C the reaction was cooled
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to room temperature and 1,2,3,5-tetra-acetyl-β-D-ribofuranose (300 mg, 0.94 mmol) was
added followed by Trimethylsilyltrifluoromethanesulfonate (210 μL, 1.16 mmol) and the
reaction was returned to 78 °C for 2.5 hours. The reaction mixture was poured into
sodium bicarbonate solution (100mL, 5%), extracted with dichloromethane (2X 100mL)
and evaporated. Purification via flash chromatography (EtOAc in cyclohexane) resulted
in the desired product (380 mg, 0.80 mmol) 87% yield. 1HNMR (CDCN) δ 10.20 (s, 1H),
7.26 (s, 1H), 7.18 (dd, J=7.9,1.1 Hz, 1H), 6.95 (ddd, J=8.0, 6.6, 2.2 Hz, 1H), 6.80 (qd,
J=7.7, 1.7 Hz, 2H), 6.05 (d, J=4.4 Hz, 1H), 5.34 (dd, J=5.7, 4.4 Hz, 1H), 5.26 (t, J=5.5
Hz, 1H), 4.01 (q, J=7.2 Hz, 1H), 2.11 (s, 3H), 2.00 (d, J=5.8 Hz, 6H), 1.15 (t, J=5.5 Hz,
1H), 4.01 (q, J=7.2 Hz, 1H), 2.11 (s, 3H), 2.00 (d, J=5.8 Hz, 6H), 1.15 (t, J=7.2 Hz, 2H).

tC-β-D-ribonucleoside. tC 2′, 3′,5′-tri-O-(acetyl)-β-D-ribonucleoside (340 mg,
0.715 mmol) was dissolved in methanol (3 mL) and a solution of 30 % sodium methoxide
in methanol (20.3 μL, 0.109 mmol) was added and stirred at room temperature 18 hrs.
The product was suspended in water (5mL) and filtered to yield (142 mg, 0.406 mmol)
57% yield. 1HNMR ((CD3)2SO) δ 10.43 (s, 1H), 7.96 (s, 1H), 7.07 (ddt, J=7.6, 3.2, 1.5
Hz, 2H), 6.96-6.88 (m, 2H), 5.72 (d, J=3.1Hz, 1H), 5.39 (d, J=4.5 Hz, 1H), 5.21 (t, J=5.0
Hz, 1H), 5.03 (d, J=4.9 Hz, 1H), 3.95 (q, J=3.9, 3.1 Hz, 2H), 3.83 (dt, J=5.6, 2.9 Hz, 1H),
3.70 (ddd, J=12.1, 5.0, 2.9 Hz, 1H), 3.56 (ddd, J=12.2, 5.0, 2.8 Hz, 1H).
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2-[(2-amino-4-methoxyphenyl)disulfanyl]-4-methoxyaniline. 5-Methoxy-2methylbenzothiazole (3.61 g, 20.1 mmol) was placed in a dried 100 mL round-bottomed
flask under N2. Hydrazine hydrate (15 mL) was added and the reaction mixture was
heated at 100 °C for 20 hours with stirring. The mixture was allowed to cool to room
temperature, diluted with 70 mL H2O, and the product sulfide was oxidized by the
addition of 30% H2O2 (20 mL). This aqueous mixture was extracted with ethyl acetate (3
× 50 mL) and the resulting organic phase dried. Removal of the solvent by rotary
evaporation yielded the product disulfide as a pure, yellow oil (3.1 g, 20 mmol) in > 98%
yield. 1HNMR (CDCl3) δ 7.07 (d, J=8.5 Hz, 1H), 6.27 (d, J=2.6 Hz, 1H), 6.20 (dd, J=8.5,
2.6 Hz, 1H), 4.39 (s, 2H), 3.79 (s, 3H). 13CNMR ((CD3)2SO) δ 162.16, 151.49, 137.61,
108.48, 103.19, 98.79, 54.83. AMM (ESI) calcd. for C14H16N2O2S2 308.06, found 309.07
(MH+).

5-[(2-amino-4-methoxyphenyl)sulfanyl]pyrimidine-2,4(1H,3H)-dione. 2-[(2amino-4-methoxyphenyl)disulfanyl]-4-methoxyaniline (3.1 g, 10.1 mmol) was placed in
a dried 100 mL round-bottomed flask under N2. Anhydrous diglyme (20 mL) was added
with stirring, followed by the addition of water (90 μL, 5 mmol) and triethylphosphine
(5.0 mL of a 1 M solution in THF). The reaction was allowed to stir for 30 minutes at
room temperature to complete the reduction of the disulfide. Next, 5-bromouracil (3.85 g,
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20.2 mmol) and anhydrous sodium carbonate (2.14 g, 20.2 mmol) were added and the
reaction mixture was heated with stirring at 120 °C for 1 hour. The reaction mixture was
allowed to cool to room temperature and the product, which was present as a white
precipitate, was collected by filtration, washed with diglyme and then water, and then
dried. NMR measurements showed it to be of high purity (2.3 g, 8.68 mmol) in 86%
yield. 1HNMR ((CD3)2SO) δ 11.20 (s, 2H), 7.40 (s, 1H), 7.28 (d, J=8.5, 1H), 6.28 (d,
J=2.7 Hz, 1H), 6.13 (dd, J=8.5, 2.7 Hz, 1H), 5.63(s, 2H), 3.68 (s, 3H). 13CNMR
((CD3)2SO) δ 163.12, 161.47, 151.46, 151.46, 151.11, 143.11, 137.73, 107.15, 105.45,
103.32, 99.06, 54.84. AMM(ESI) calcd. for C11H11N3O3S 265.02, found 266.06 (MH+).

8-methoxy-3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one. 5-[(2-amino-4methoxyphenyl)sulfanyl]pyrimidine-2,4(1H,3H)-dione (2.07 g, 7.8 mmol) was suspended
in 1-butanol (40 mL) under nitrogen and 37 % hydrochloric acid (8 mL) was added. The
reaction mixture was heated at 120 °C for 3 days with stirring. The reaction mixture was
then allowed to cool to 4 °C in a refrigerator, resulting in the precipitation of the product,
which was collected by filtration. This crude product was added to a 5% aqueous solution
of ammonium hydroxide at 50 °C and stirred, resulting in recrystallization that produced
the product as a yellow precipitate. The product was collected by filtration, washed with
water, and allowed to dry resulting in (1.66 g, 6.7mmol) 86% yield. 1HNMR ((CD3)2SO)
δ 10.18 (s, 1H), 7.43 (s, 1H), 6.98 (d, J=8.5, 1H), 6.60 (d, J=2.6 Hz, 1H), 6.55 (dd, J=8.6,
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2.7 Hz, 1H), 3.70 (s, 3H). AMM (ESI) calcd. for C11H9N3O2S 247.04, found 495.09
(2MH+).

8-methoxy-tC 3′,5′-di-O-(p-toluoyl)-2′-deoxy-β-D-ribonucleoside. 8-methoxy3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one (400 mg, 1.60 mmol) was suspended
in dry acetonitrile (8 mL) in a Schlenk tube under N2. Bis(trimethylsilyl)acetamide (449
μL, 1.84 mmol) was added and the reaction mixture allowed to stir at 50 °C for 1 hour
until the starting material had completely dissolved. The reaction mixture was allowed to
cool to room temperature and 3′,5′-di-O-(p-toluoyl)-2′-deoxy-α-D-ribofuranosyl chloride
(684 mg, 1.76 mmol) was added with stirring. The reaction mixture was cooled to 0 °C
and tin(IV) chloride (37 μL, 0.32 mmol) was added dropwise. The reaction mixture was
stirred at 0 °C, then allowed to warm to room temperature, and the progress was tracked
by thin layer chromatography. The reaction was complete in 45 minutes. At this time, the
mixture was diluted with ethyl acetate (40 mL), washed with a sodium bicarbonate, and
dried. Rotary evaporation followed by purification using flash chromatography (EtOAc
in cyclohexane) yielded the pure β anomer of the product as a yellow solid. (355 mg,
0.656 mmol) 41 % yield. 1HNMR (CDCl3) δ 8.52 (s, 1H), 7.99-7.81 (m, 4H), 7.44 (s,
1H), 7.29-7.26 (m, 2H), 7.23-7.17 (m, 2H), 6.81 (d, J=8.5, 1H), 6.64 (d, J=2.5 Hz, 1H),
6.52 (dd, J=8.6, 2.6 Hz, 1H), 6.36 (dd, J=8.2,5.5 Hz, 1H), 5.59 (dt, J=6.5, 1.8 Hz, 1H),
4.77 (dd, J=12.3, 3.0 Hz, 1H), 4.68 (dd, J=12.3, 3.2 Hz, 1H), 4.60-4.55 (m, 1H), 3.77 (s,
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3H), 2.92 (ddd, J=14.5, 5.6, 1.6 Hz, 1H), 2.43 (s, 3H), 2.37 (s, 3H), 2.22 (ddd, J=14.6,
8.2, 6.4 Hz, 1H). 13CNMR (CDCl3) δ 166.11, 166.03, 161.00, 159.48, 154.47, 144.44
144.32, 136.75, 132.92, 129.78, 129.54, 129.41, 129.23, 126.52, 126.42, 126.36, 110.88,
106.92, 104.26, 97.83, 87.00, 83.45, 75.19, 64.08, 55.64, 39.21, 21.70.

8-methoxy-tC 2′-deoxy-β-D-ribonucleoside. 8-methoxy-tC 3′,5′-di-O-(ptoluoyl)-2′-deoxy-β-D-ribonucleoside (103 mg, 0.172 mmol) was dissolved in methanol
(5 mL) and a solution of 30% sodium methoxide in methanol (96 μL, 0.517 mmol) was
added dropwise. The reaction progress was followed by thin layer chromatography and
found to be complete in 30 min. The reaction was quenched by the addition of acetic acid
(50 μL, 0.872 mmol), and the solvent was removed by rotary evaporation. Purification by
flash chromatography (CH3OH in CH2Cl2) yielded the product as a yellow solid (60 mg,
0.165 mmol) in 96 % yield.1HNMR ((CD3)2SO) δ 10.38 (s, 1H), 7.89 (s, 1H), 7.01 (d,
J=8.5, 1H), 6.61 (d, J=2.6 Hz, 1H), 6.57 (dd, J=8.6, 2.7 Hz, 1H), 6.10 (t, J=6.4 Hz, 1H),
5.26 (s, 1H), 5.12 (s, 1H), 4.23 (dt, J=6.5, 3.6 Hz, 1H), 3.80 (q, J=3.5 Hz, 1H), 3.70 (s,
3H), 3.63 (dd, J=11.9, 3.6 Hz, 1H), 3.57 (dd, J=12.0, 3.6, 1H) 2.16 (ddd, J=13.2, 6.1, 3.7
Hz, 1H), 2.03 (dt, J=13.1, 6.5 Hz, 1H). 13CNMR ((CD3)2SO) δ 159.63, 158.80, 153.75,
137.51, 135.42, 126.79, 109.32, 106.53, 103.37, 94.70, 87.46, 85.39, 69.82, 60.83, 55.23,
48.59. AMM(ESI) calcd. for C16H17N3O5S 363.09, found 727.19 (2MH+).
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2-[(2-amino-5-methoxyphenyl)disulfanyl]-5-methoxyaniline. 6-Methoxy-2methylbenzothiazole (1.07 g, 6.0 mmol) was placed in a dried 50 mL side-armed flask
under N2. Hydrazine hydrate (5 mL) was added and the reaction mixture was heated at
100 °C for 17 hours with stirring. The mixture was allowed to cool to room temperature,
diluted with water (25 mL), and the product sulfide was oxidized by the addition of 30%
H2O2 (7 mL). This aqueous mixture was extracted with ethyl acetate (3 × 50 mL) and the
resulting organic phase dried. Removal of the solvent by rotary evaporation yielded the
product disulfide product as a yellow oil (0.55 g, 3.6 mmol) in 60 % yield. 1HNMR
((CD3)2SO) δ 6.80 (dd, J=8.8, 2.9 Hz, 1H), 6.73 (d, J=8.8 Hz, 1H), 6.62 (d, J=2.9, 2.6 Hz,
1H), 3.55 (s, 3H).

5-[(2-amino-5-methoxyphenyl)sulfanyl]pyrimidine-2,4(1H,3H)-dione. 2-[(2amino-5-methoxyphenyl)disulfanyl]-5-methoxyaniline (semi-crude from oxidative
degradation, ~ 1.7 mmol) was placed in a dried 50 mL round-bottomed flask under N2.
Anhydrous diglyme (4 mL) was added with stirring, followed by the addition of water
(22 μL, 1.2 mmol) and triethylphosphine (1.2 mL of a 1 M solution in THF). The reaction
was allowed to stir for 30 minutes at room temperature to complete the reduction of the
disulfide. Next, 5-bromouracil (0.83 g, 4.3 mmol) and anhydrous sodium carbonate (0.46
g, 4.3 mmol) were added and the reaction mixture was heated with stirring at 120 °C for
1.5 hours. Purification via silica gel flash chromatography (CH3OH in CH2Cl2) resulted
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in product as a dark-colored semi-crude solid. (~ 0.83 mmol), approximately 24 % yield.
1

HNMR ((CD3)2SO) δ 11.38 (s, 2H), 7.61 (s, 1H), 6.91 (d, J=2.9, 1H), 6.74 (dd, J=8.8,

2.9 Hz, 1H), 6.67 (d, J=8.8 Hz, 1H), 5.07(s, 2H), 3.64 (s, 3H).

7-methoxy-3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one. 5-[(2-amino-5methoxyphenyl)sulfanyl]pyrimidine-2,4(1H,3H)-dione (~ 0.83 mmol), semi-crude from
prior step) was suspended in 1-butanol (10 mL) under N2 and 37 % hydrochloric acid (1
mL) was added. The reaction mixture was heated at 120 °C under nitrogen with stirring
for 1 day. The solvent and acid were then removed by rotary evaporation, and the product
was purified by flash chromatography (CH3OH in CH2Cl2) to yield a yellow solid (55
mg, 0.22 mmol) 27 % yield. 1HNMR ((CD3)2SO) δ 11.86-11.36 (m, 1H), 7.57 (s, 1H),
6.91 (d, J=8.6, 1H), 6.75 (d, J=2.6 Hz, 1H), 6.71 (dd, J=8.6, 2.8 Hz, 1H), 3.71 (s, 3H).
AMM (ESI) calcd. for C11H9N3O2S 247.04, found 495.09 (2MH+).

7-methoxy-tC 3′,5′-di-O-(p-toluoyl)-2′-deoxy-β-D-ribonucleoside. 7-methoxy3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one (35 mg, 0.14 mmol) was suspended in
dry acetonitrile (1 mL) in a Schlenk tube under N2. Bis(trimethylsilyl)acetamide (40 μL,
0.163 mmol) was added and the reaction mixture allowed to stir at 50 °C for 1 h. The
reaction mixture was allowed to cool to room temperature and 3′,5′-di-O-(p-toluoyl)-2′45

deoxy-α-D-ribofuranosyl chloride (61 mg, 0.156 mmol) was added with stirring. The
reaction mixture was cooled to 0 °C and tin(IV) chloride (3.3 μL, 0.028 mmol) was added
dropwise. The reaction mixture was stirred at 0 °C, then allowed to warm to room
temperature, and the progress was tracked by thin layer chromatography. The reaction
was complete in 90 min. At this time, the mixture was diluted with ethyl acetate (15 mL),
washed with a sodium bicarbonate, and dried. Rotary evaporation followed by
purification using flash chromatography (EtOAc in cyclohexane) yielded the pure β
anomer of the product as a yellow solid. (10 mg, 0.017 mmol) 12 % yield. 1HNMR
(CDCl3) δ 9.02 (s, 1H), 7.98-7.88 (m, 4H), 7.37 (s, 1H), 7.27 (t, J=1.3 Hz, 2H), 7.24-7.20
(m, 2H), 7.00 (d, J=8.8, 1H), 6.62 (dd, J=8.8, 2.8 Hz, 1H), 6.45 (d, J=2.7 Hz, 1H), 6.38
(dd, J=8.3, 5.5 Hz, 1H), 5.59 (dt, J=6.6, 1.7 Hz, 1H), 4.77 (dd, J=12.3, 3.0 Hz, 1H), 4.67
(dd, J=12.3, 3.3 Hz, 1H), 4.58 (q, J=2.8 Hz, 1H), 3.74 (s, 3H), 2.92 (ddd, J=14.5, 5.6, 1.6
Hz, 1H), 2.43 (s, 3H), 2.37 (s, 3H), 2.25-2.18 (m, 1H). 13CNMR (CDCl3) δ 166.39,
166.36, 156.88, 154.64, 144.72, 144.64, 132.98, 130.09, 129.81, 129.69, 129.50, 129.06,
126.70, 126.59, 118.91, 118.08, 112.80, 111.89, 97.18, 87.23, 83.74, 75.54, 64.43, 55.86,
39.43, 29.94, 21.98.

7-methoxy-tC 2′-deoxy-β-D-ribonucleoside. 7-methoxy-tC 3′,5′-di-O-(p-toluoyl)2′-deoxy-β-D-ribonucleoside (8.1 mg, 0.014 mmol) was dissolved in methanol (0.5 mL)
and a solution of 30 % sodium methoxide in methanol (8.4 μL, 0.045 mmol) was added
46

dropwise. The reaction progress was followed by thin layer chromatography and found to
be complete in 30 min. The reaction was quenched by the addition of acetic acid (10 μL,
0.17 mmol) and the solvent was removed by rotary evaporation. Purification by flash
chromatography (CH3OH in CH2Cl2) yielded the product as a yellow solid (3.4 mg,
0.0097 mmol) 69 % yield. 1HNMR (CD3OD) δ 7.91 (s, 1H), 6.85-6.80 (m, 1H), 6.68 (dd,
J=8.8, 2.7 Hz, 1H), 6.63 (d, J= 2.7 Hz, 1H), 6.21 (t, J=6.4 Hz, 1H), 4.39 (dt, J=6.4, 3.9
Hz, 1H), 3.95 (q, J=3.5 Hz, 1H), 3.87-3.77 (m, 2H), 3.72 (s, 3H), 2.38 (ddd, J=13.6, 6.2,
4.0 Hz, 1H), 2.17 (dt, J=13.3, 6.5 Hz, 1H) 13CNMR ((CD3)2SO) δ 158.27, 157.45,
145.59, 135.79, 130.38, 119.14, 118.96, 113.83, 112.46, 98.31, 88.98, 87.78, 71.71,
62.48, 56.07, 42.17. AMM (ESI) calcd. for C16H17N3O5S 363.09, found 727.18 (2MH+).

8-hydroxy-3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one. 8-methoxy-3Hpyrimido[5,4-b][1,4]benzothiazin-2(10H)-one (20 mg, 0.081 mmol) was dissolved in dry
dichloromethane (1.3 mL) under N2 and cooled in a dry ice acetone bath. Boron
tribromide 1M in dichloromethane (243 μL, 0.243 mmol) was added dropwise to the
reaction and stirred at -78 °C 5.25 hours and then kept at -20 °C for 11 hours. Dilution
with ethyl acetate and evaporation followed by purification via silica gel flash
chromatography (CH3OH in CHCl3) led to desired product (8.3 mg, 0.035 mmol) in 51%
yield. 1HNMR (CD3OD) δ 7.25 (s, 1H), 6.80 (d, J=8.3 Hz, 1H), 6.45-6.39 (m, 2H).
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8-hydroxy-tC 3′,5′-di-O-(p-toluoyl)-2′-deoxy-β-D-ribonucleoside. 8-hydroxy3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one (19 mg, 0.031 mmol) was dissolved in
dry acetonitrile (0.5 mL) under N2 . Bis(trimethylsilyl)acetamide (30 μL, 0.0125 mmol)
was added and the reaction mixture was stirred at room temperature. After 55 minutes
3′,5′-di-O-(p-toluoyl)-2′-deoxy-α-D-ribofuranosyl chloride (44 mg, 0.113 mmol) was
added and the reaction cooled to 0 °C. Tin (IV) chloride (drops) in acetonitrile (350 μL)
was added to the reaction and stirred at 0. Additional bis(trimethylsilyl)acetamide (30 μL,
0.0125 mmol) was added two times and the reaction moved between 0 °C and -20 °C
over 4 days. Dilution with ethyl acetate (10mL), washing with sodium bicarbonate and
brine. drying and evaporation were performed. Purification via flash chromatography
(CH3OH in CHCl3) resulted in the desired product (6.6 mg, .012 mmol) 15% yield.

8-hydroxy-tC-2′-deoxy-β-D-ribonucleoside. 8-hydroxy-tC 3′,5′-di-O-(p-toluoyl)2′-deoxy-β-D-ribonucleoside (6.6 mg, 0.012 mmol) was dissolved in methanol (0.6 mL)
under N2. Sodium methoxide 30% solution in methanol (10 μL, 0.050 mmol) was added
and the reaction stirred overnight in the dark. Additional sodium methoxide 30% solution
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in methanol (10 μL, 0.050 mmol) was added to the reaction and when no starting material
remained via thin layer chromatography, acetic acid (6 μL, 0.10 mmol) was added to the
reaction and it was evaporated. Purification via flash chromatography (CH3OH in
CH2Cl2) resulted in product (3.5 mg, 0.010 mmol) 80% yield.

8-trifluromethanesulfonate-3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one.
8-hydroxy-3H-pyrimido[5,4-b][1,4]benzothiazin-2(10H)-one (9 mg, 0.039 mmol) was
dissolved in dry dichloromethane (1mL) under N2 and cooled to 0 °C. Triethylamine (6.5
μL, 0.047mmol) followed by trifluoromethanesulfonic anhydride (7.2 μL, 0.043 mmol)
were added dropwise to the reaction and the mixture was allowed to warm to room
temperature. After 2 hours, the reaction was cooled back to 0 °C and 2M hydrochloric
acid (40 μL, 0.078 mmol) was added and the reaction was allowed to warm to room
temperature.

1-diethylaminonapthalene. Potassium tert-butoxide (308 mg, 2.75 mmol) was
dissolved in dry tetrahydrofuran (1mL) under N2. Diethylamine ( 60 μL, 0.55 mmol) was
added followed by 1-chloronapthalene (70 μL, 0.5 mmol) and allyl[1,3-bis(2,6diisopropylphenyl)-imidazol-2-ylidene]palladium (II) chloride (15 mg, 0.026 mmol) and
stirred at room temperature. Water was added to the reaction and the organics were
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extracted with diethyl ether, dried, filtered and evaporated. Purification via flash
chromatography (CH2Cl2 in Cyclohexanes) resulted in product (0.4 mg, 0.0021 mmol)
0.4% yield.

2-methyl-1,3-benzothiazol-6-diethylamine. Acetaldehyde (562 μL, 10 mmol) was
dissolved in acetonitrile (10 mL) under N2. 2-methyl-1,3-benzothiazol-6-amine (164 mg,
1 mmol) was combined with sodium cyanoborohydride (94 mg, 1.5 mmol) in acetonitrile
(10 mL) and added to the above reaction followed by acetic acid (1 mL). After 30
minutes at room temperature the reaction was diluted with methanol and evaporated. The
residue was suspended between ethyl acetate and water, dried and evaporated.
Purification using flash silica gel chromatography (Ethyl Acetate in Hexanes) resulted in
the product (151 mg, 0.69 mmol) 69% yield. 1HNMR (CDCl3) δ 7.70 (dd, J=9.0, 0.4 Hz,
1H), 6.95 (d, J=2.4 Hz, 1H), 6.80 (dd, J=9.0, 2.6 Hz, 1H), 2.68 (s, 3H), 1.19 (t, J=7.2 Hz,
4H), 1.12 (t, J=7.1 Hz, 6H).

5-[(2-amino-5-diethylaminophenyl)sulfanyl]pyrimidine-2,4(1H,3H)-dione. 2methyl-1,3-benzothiazol-6-diethylamine (220 mg, 1 mmol) was dissolved in hydrazine
(2.2 mL) under N2. This was refluxed 18 hours and then 5-bromouracil (142 mg, 0. 75
mmol) and sodium carbonate (79 mg, 0.75 mmol) were added and the reaction refluxed
for 30 minutes. Additional 5-bromouracil (142 mg, 0. 75 mmol) and sodium carbonate
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(79 mg, 0.75 mmol) were added and the reaction continued to reflux. Dilution with water
and then evaporation. Purification via flash silica gel chromatography (CH3OH in
CH2Cl2) led to the possible product.
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Oxygen Tricyclic Cytosine Analogs

Figure 2-0-9: Synthesis of tCo. Application of the synthetic routes used to synthesize nucleosides to the synthesis
of nucleobases in which case R is a hydrogen instead of ribose.3 For reaction success and failure see Table 1.

A first attempt to synthesize the nucleobase of tCo under the same conditions as

the nucleoside was synthesized in the literature in the lab, lead to the creation of a new
compound (figure 2-0-9).3 In the unsubstituted nucleoside synthesis, mesitylsulfonylation
occurs at O4. This mesitylsulfonyl ester is poised for substitution at the C4 carbon by the
amine nitrogen of the aminophenol under basic conditions. Crystallization of the resulting
unknown compound was achieved using slow evaporation and solving the crystal
structure revealed that the 2-mesitylenesulfonyl chloride had reacted with the N1 of the
5-bromouracil instead of the C4 carbonyl (figure 2-0-10). This N-Mes-bromouracil was
re-subjected to the above reaction conditions as the N1 was now protected from reaction
and reactivity remained possible for the O4 oxygen. The compound did not appear to
react with the aminophenol in this case either.
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Figure 2-0-10: 5-Bromouracil. Illustration of the numbering convention for the nucleobase starting material

The evidenced greater reactivity of the N1 position on 5-bromouracil was harnessed
through the use of a boc protecting group (figure 2-0-11). It has been previously shown
that it was possible to place this group at the N1 position without also protecting the N3
nitrogen.84, 85 The resonance form of DMAP which has a negative charge on the
pyrimidinal nitrogen utilizes these electrons to attack the carbonyl carbon of boc
anhydride.84 Upon reformation of the carbon oxygen double bond carbonate is released
which can pick up hydrogen from N1. 5-Bromouracil then replaces the DMAP at the
carbonyl carbon of the BOC group via nucleophilic attack by the N1 nitrogen.

Figure 2-0-11: Boc protection of 5-bromouracil. Conditions presented for the installation of a protecting group
at N1 to prevent undesirable side reactions of the nitrogen when 5-bromouracil is reacted under the synthetic
conditions in 2-0-9.

This boc protected 5-bromouracil was reacted under the same standard tCo
synthesis conditions previously described (figure 2-0-2).3 This reaction did not result in
the desired formation of the secondary amine at the C4 carbon of 5-bromouracil. There
was NMR evidence that the boc protecting group was removed during the course of the
reaction, which likely resulted in the undesirable side reaction of the 253

mesitylenesulfonyl chloride with the N1 nitrogen as was seen in the reaction of the
unprotected compound.86 After the Appel chemistry for activation of carbonyls had been
used successfully to synthesize tCo nucleoside secondary amines in the laboratory, as will
be discussed in Chapter 3 Section 1, these conditions were tried to form the amine bond
between 5-bromouracil and aminophenol en route to the tCo nucleobase (figure 2-0-12).87
This chemistry had been successful in the synthesis of nucleoside analogs related to the
oxygen tricyclic cytosine parent.88 Triphenyl phosphine activation was also seen by the
authors who synthesized the parent compound.89 The phosphorous of triphenyl phosphine
uses its lone pair of electrons to extract chlorine from carbon tetrachloride creating the
trichloride carbanion. These anionic electrons deprotonate N3 and this nitrogen can form
a double bond with the C4 carbonyl forcing the double bond electrons onto the oxygen
and causing an oxyanion. The oxyanion attacks the positively charged phosphorous and
releases the chlorine anion. This chlorine can then substitute for the oxygen at the C4
carbon of 5-bromouracil. Upon addition of the aminophenol with DBU, the amine
substitutes for this chlorine at C4 resulting in the desired product. This reaction resulted
in trace amounts of the desired secondary amine formation with concomitant removal of
the boc protecting group as detectable by mass spectroscopy.
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Figure 2-0-12: Appel synthesis of tCo secondary amines. These alternative conditions for the formation of
secondary amine intermediates have R as an H or a protecting group. The most robust protecting group and
greatest product formation is when R is a benzyl group.

Repeating this reaction lead to confirmation of the product by NMR but isolation
was difficult. Following multiple chromatographic attempts to remove the
triphenylphosphine oxide product, it was only possible to recover trace amounts of the
secondary amine. Following optimization of chromatography conditions for the removal
of this impurity the deprotected secondary amine of the tCo nucleobase was recoverable
in an isolated yield of 27% from these reaction conditions.
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Figure 2-0-13: Ethyl carbomate protection of 5-bromouracil. Alternative conditions presented for the
installation of a protecting group at N1 to prevent undesirable side reactions of the nitrogen when 5Figure
2-0-14:
5-bromouracil.
Alternative
bromouracil
is Benzyl
reactedprotection
under the of
synthetic
conditions
in 2-0-9. conditions presented for the installation of a
protecting group at N1 to prevent undesirable side reactions of the nitrogen when 5-bromouracil is reacted
under the synthetic conditions in 2-0-9.

An ethyl carbomate protecting group was installed at the N1 position in place of
the boc protecting group to test the liability of this group under the reaction conditions.70
This reaction occurs with ethyl chloroformate in dichloromethane with assistance from
potassium carbonate (figure 2-0-13). As in the reaction with the boc anhydride, the
deprotonated N1 nitrogen can attack the carbonyl carbon, this time of the acyl chloride
and upon reformation of the carbon oxygen double bond a chlorine anion is expelled.
This ethyl carbomate protecting group installed at the N1 position of 5-bromouracil is
also labile to the Appel reaction conditions (figure 2-0-5). Secondary amine tCo
nucleobase is evidenced in the NMR when aminophenol is reacted with ethyl carbomate
protected 5-bromouracil under these conditions, but was difficult to effectively isolate

from the triphenyl phosphine oxide.
A benzyl protecting group can be alternatively installed at the N1 position through
a combination of hexamethyldisilazane and trimethylsilyl-chloride in dichloroethane
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followed by benzyl bromide and iodine (figure 2-0-14).90 Without the presence of
carbonyl functionality this protecting group may have been less reactive under the
secondary amine formation conditions. The HMDS and TMSCl mixture silylated the C2
carbonyl oxygen with the assistance of the lone pair of electrons on the N1 nitrogen.
Upon addition of the iodine, the silyl group is removed and the assisting electrons of the
N1 are free to substitute for the bromine on the benzyl bromide. This protecting group
remained intact under the reaction conditions and allowed for recovery of the benzyl
protected secondary amine of the parent tCo nucleobase in decent yields. Below is
presented a table (Table 1) of reaction conditions for synthesis of this unsubstituted and
the substituted nucleobase secondary amines.
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Benzyl
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MS

Table 1: Synthesis of nucleobase secondary amines. Analog is the name of the substituted product referring to
figure 2-0-19. Some yields are approximations based on NMR and in the event that no yield is given isolated
product was not obtained. Some isolated reactions or those for purely production purposes are excluded from
this table.
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Table 1continued: Synthesis of nucleobase secondary amines. Analog is the name of the substituted product
referring to figure 2-0-19. Some yields are approximations based on NMR and in the event that no yield is given
isolated product was not obtained. Some isolated reactions or those for purely production purposes are excluded
from this table.
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Table 1 continued: Synthesis of nucleobase secondary amines. Analog is the name of the substituted product
referring to figure 2-0-19. Some yields are approximations based on NMR and in the event that no yield is given
isolated product was not obtained. Some isolated reactions or those for purely production purposes are excluded
from this table.
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Figure 2-0-15: Vilsmeier synthesis of tCo secondary amines. These alternative conditions for the formation of
secondary amine intermediates have R as an H or a protecting group. Reaction was unsuccessful.

Some additional conditions were attempted to activate the C4 carbonyl for attack
by the amine on the aminophenol. Reacting protected 5-bromouracil with phosphorous
oxychloride and n-methyl imidazole in acetonitrile creates the same aryl chloride
intermediate as the Appel conditions (figure 2-0-15).91 These conditions had been
successful in the synthesis of some related compounds.92, 93 NMI functions as a
nucleophile to activate phosphorous oxychloride through the formation of a
dioxophosphonium complex.93 This complex accepts the oxygen electrons from the 5bromouracil carbonyl oxygen at C4 as well as provides the base for the deprotonation of
N3. The chlorine anion can substitute at C4 and results in an intermediate that can be
substituted by the aminophenol. While these conditions are designed to give the same
intermediate, the desired substitution product was not obtained when attempted with the
boc protected 5-bromouracil. Deprotection of the starting material likely resulted in lack
of formation or lack of reactivity of the aryl chloride.
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Figure 2-0-16: Triazole intermediate synthesis. This highly reactive intermediate was desirable for the formation
of nucleobase secondary amines. R is an H or a protecting group. Reaction was unsuccessful.

Forming an intermediate in which a triazole was attached at C4 was another
pathway to the tCo secondary amine nucleobase that was attempted (figure 2-0-16).70
Similarly to the conditions described above a dioxophosphonium complex is formed as a
result of the triazole reaction with phosphorous oxychloride. This complex did not react
with the benzyl protected 5-bromouracil. Initial reaction was tried in acetonitrile at room
temperature and no reaction was seen. A solvent was selected with which the starting
material was more soluble, but in DMF no reaction was observed even when the reaction
was heated to 40 degrees.
Attempts to react the unprotected 5-bromouracil under the Appel conditions did
not result in the recovery of any desired product. This prompted an NMR investigation of
the reaction conditions. In this experiment it was revealed that there was little reaction
with the aminophenol. Lack of substitution reactivity was attributed to a lack of
activation and therefore assumed to be the result of little reaction between the starting
material and the triphenylphosphine. A second NMR investigation of the reaction
between the 5-bromouracil and the activated triphenylphosphine showed reaction to only
a small extent resulting in mostly starting material.
Using the benzyl protected tCo secondary amine that had been synthesized,
nucleophilic aromatic substitution to form the fluorescent nucleobase was attempted. This
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reaction was performed using potassium fluoride in refluxing ethanol for days (figure 20-17).3 The alcohol attached to C1’ is in the position for nucleophilic aromatic
substitution at C5 with the bromine as the leaving group. Under these conditions it was
possible to isolate a small amount of fluorescent product and by NMR this chromophore
appeared to be the desired tricyclic nucleobase which had been debenzylated during the
course of the reaction. The tCo secondary amine that had lost its protecting group during
the previous synthetic step was placed in a higher boiling solvent with a more
dissociative fluorine source to encourage the reaction.71 After heating at 120 oC degrees
for 4 hours in NMP with cesium fluoride the deprotected tCo secondary amine remained
unreacted. This lack of reactivity may have been due to the contamination of secondary
amine with triphenyl phosphine oxide. This triphenyl phosphine oxide may have been
involved in undesirable side reactions

Figure 2-0-17: Nucleobase ring closure. Synthetic conditions presented for the formation of the ether and closure
of the nucleobase to the desired tricyclic structure. For reaction success and failure see Table 2.
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Figure 2-0-18: tCo nucleobase. This is an illustration of the numbering convention for tricyclic cytosine analogs.

8 F-tCo was the first substituted nucleobase analog upon which synthesis began
using 4-fluoroaminophenol in the place of aminophenol in the reaction conditions (figure
2-0-18). Boc protected 5-bromouracil was reacted under the phosphorous oxychloride
conditions and the reaction mixture was purified chromatographically with chlorinated
solvents in attempts to isolate the secondary amine product (figure 2-0-15, 2-0-19). There
was evidence that the nucleobase was deprotected under these conditions, and no desired
product was recovered. Benzyl protected 5-bromouracil was reacted with the MesCl
conditions and this resulted in a 25% yield of the desired product on a 50mg scale
(figures 2-0-2, 2-0-19). Unfortunately scaling up of this reaction to the 500mg or the 2g
scale resulted in decreased yields and increased difficulty in the isolation of the desired
product from the side products. Side reactions likely were the result of debenzylation of
the nucleobase starting material.
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Figure 2-0-19: Secondary amine intermediates of nucleobases. R is an H or a protecting group and the
numbering is based upon the numbering of the final nucleobase product. The most robust protecting group and
greatest product formation is when R is a benzyl group.

Ring closure of the isolated benzyl protected 8-F-tCo nucleobase was achieved by
refluxing in ethanol for 2 days with cesium fluoride (figure 2-0-17). It took scaling up of
the reaction to isolate a mixture which contained enough product to be confirmed by
mass spectroscopy. Side products from the debenzylation of the starting material were
again the major source of contamination. This reaction took only one day, which is the
same reaction time that was needed to observe product formation if the solvent is
switched to butanol and the temperature increased to 101 oC. The yield of product from
these higher temperature conditions was greater, which may also be attributable to the
greater scale.
4-methoxy-2-aminophenol was reacted with ethyl carbomate protected 5bromouracil under the POCl3 conditions in initial attempts to synthesize the 8-OMe-tCo
nucleobase secondary amine (figures 2-0-15, 2-0-18, 2-0-19). Deprotection of the
nucleobase starting material was the only activity that could be confirmed in the reaction,
and none of the desired product was recovered. Using the Appel chemistry conditions to
couple the 4-methoxy-amnophenol to the benzyl protected 5-bromouracil it was possible
to observe NMR evidence of the formation of the desired product, but the secondary
amine was not recoverable (figures 2-0-12, 2-0-19). Doubling the scale of the reaction to
200mg led to production of the desired product in roughly 50% yield. However
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performing the reaction on a gram scale made it prohibitively difficult to isolate the
desired secondary amine product from the triphenyl phosphine oxide. Reaction was
attempted under the MesCl conditions to eliminate the potential for triphenylphosphine
oxide contamination, and this resulted in a comparable yield on the 50mg scale (figure 20-2, 2-0-19). Scaling up by 10 times however resulted in a 50% decrease in the isolable
yield of the desired product due to the difficulty in separation from the unreacted starting
materials.
Benzyl protected 8-OMe-tCo nucleobase was synthesized in trace amounts as
detected by NMR upon heating the secondary amine produced under the above
conditions to 101 oC in butanol for one day with cesium fluoride (figure 2-0-17). These
higher temperature conditions with an alternative fluorine source were more successful
than refluxing 3 days in ethanol with potassium fluoride. Those literature conditions
resulted in the recovery of the remnants of the products of debenzylation of the starting
material. A small scale reaction with cesium fluoride and refluxing in ethanol did not
result in the desired nucleophilic aromatic substitution either.
Under Appel conditions, the 8-Cl-tCo secondary amine was synthesized in 18%
yield on a one gram scale from benzyl protected 5-bromouracil and 4-chloroaminophenol (figure 2-0-5, 2-0-19). Yet, on a 5 gram scale only 1.8% yield of isolable
product was possible from a mixture with large amounts of triphenyl phosphine oxide. In
a follow-up smaller scale reaction, the desired product was also inseparable from
triphenylphosphine oxide, so the MesCl conditions were revisited. It was possible to
obtain the desired secondary amine from the mesitylene intermediate in 22% yield on a
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50mg scale (figure 2-0-2, 2-0-19). Changing the temperature of the carbonyl activation
step from 40 degrees to room temperature resulted in double the yield of the desired
product. This could possibly be attributed to the increase in scale of this reaction but an
increase in reaction scale is ordinarily shown to have the opposite effect. Further
increases in scale resulted in an increase in the debenzylation of the desired product and
the debenzylated secondary amine was unable to be isolated.
Attempting to improve on the activation of the carbonyl carbon to substitution
while avoiding the production of triphenylphosphine oxide, TIBSCl was substituted for
MesCl. These conditions resulted in the formation of a small amount of the deprotected
product (figure 2-0-20). In a similar manner to the 2-mesitylenesulfonyl chloride
conditions, the oxygen of the C4 carbonyl attacks the silicon displacing the chlorine and
priming the oxygen to be a better leaving group for when the aminophenol comes to
substitute.

Figure 2-0-20: TIBS activation of 5-bromouracil for amine formation. A related molecule was tried as an
alternative to MesCl in the synthesis of secondary amines. Reaction was unsuccessful in generating product
where R is a protecting group but did make some product where R is hydrogen.

Refluxing in ethanol for four days with potassium fluoride led to NMR evidence
of the benzyl protected 8-Cl-tCo nucleobase in 15% yield (figure 2-0-17). A combination
of calcium carbonate to increase the nucleophilicity of the 1’ oxygen for substitution and
the more dissociative cesium fluoride in ethanol at 85 ºC did not result in the same
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product. Instead aminophenol was the main recovered material suggesting that these
conditions were encouraging deamination of the starting material.93 A small scale
reaction with just cesium fluoride in ethanol resulted in the recovery of the product of
debenzylation after 2 days. On a larger scale, these conditions resulted in the desired
product which was recovered in comparable yield to the reaction where potassium was
the counter ion. Using butanol as the solvent allowed reactions to be subjected to 101 oC,
under these conditions it was again deamination that appeared to be the major reaction
undergone by the starting material.
Starting material with the chlorine in a position para to the nitrogen was much
more amenable to the formation of secondary amine 7-Cl-tCo (figure 2-0-18, 2-0-19).
Under triphenyl phosphine activation conditions, 1 gram of benzyl protected 5bromouracil led to the desired product, which could not be isolated from the triphenyl
phosphine oxide (figure 2-0-11). When using instead the 2-mesitylenesulfonyl chloride
activator at 40 degrees, a small amount of the product was obtained (figure 2-0-2). In
attempting to generate enough of the intermediate for the following synthetic methods to
be carried out, the scale of the reaction was increased ten times, and this resulted in
enough of the product to confirm its identity using mass spectrometry. There was
difficulty in removing the side product from debenzylation of the starting material. 7-CltCo was best obtained through activation at room temperature instead of at 40 degrees,
and when these conditions were repeated on a 2 gram scale, it was possible to isolate the
product with 51% yield.
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Benzyl protected 7-Cl-tCo secondary amine was refluxed in ethanol for three days
with cesium fluoride and this may have resulted in some trace amounts of the nucleobase
product as evidenced by NMR spectroscopy, but the major isolated product was that from
the debenzylation of the starting material (figure 2-0-17). Using butanol as the solvent
instead and heating at 120 oC led again to NMR evidence of possible product formation
but this was not isolable from the starting material with which it was contaminated. 18crown-6 was showing some utility in the laboratory for increasing the dissociation of the
potassium fluoride through potassium sequestration (seen in Chapter 3 section 1). This
combination of reactants was utilized in diglyme to attempt to ring close the 7-Cl-tCo
secondary amine at 120 degrees. The major result of this reaction turned out to be the
deamination of the starting material
Due to the difficulties in encouraging nucleophilic aromatic substitution with
these substituted tricyclic cytosine nucleobase precursors, some alternative conditions
were visited. One alternative ring closure method that was tried utilizes silver
tetrafluoroborate instead of fluorine. Silver bonds to the bromine to aid it as a leaving
group and weakly coordinating tetrafluoroborate anion might have been useful in the
substitution at this position by the 1’ oxygen. This alternative reagent would likely have
better solubility as well. 7-Cl-tCo secondary amine was reacted with this reagent in
refluxing ethanol, but these conditions led to no reaction of the starting material.
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Figure 2-0-21: Copper iodine ring closure. Iodine was used as a substitute for fluorine in the ring closure step of
tricyclic nucleobase synthesis. . Reaction was unsuccessful.

Copper iodide with 2-picolinic acid and potassium phosphate in DMSO at 90 oC

was another ring closure procedure that was tried. The picolinic acid chelates the copper
to free the iodine, Iodine anions can take the place of the fluorine anions in the original
conditions to coordinate at the C5 position and assist in the leaving of the bromine.
Potassium phosphate creates a basic environment which could assist in increasing the
nucleophilicity of the phenolic oxygen through deprotonation, assisting the closure of the
center ring of this tricycle through the formation of the oxygen (O1’) carbon (C5) bond.
Benzyl protected 8-Cl-tCo secondary amine was subjected to these conditions, but from
purification all that was isolated were the remnants of starting material deamination
(figure 2-0-21).
Ethyl carbomate protected 5-bromouracil was reacted with aminonaphthol under
the alternative conditions using phosphorous oxychloride in attempting to synthesize
tetCo nucleobase secondary amine. These reaction conditions resulted in the removal of
the ester protecting group from 5-bromouracil (figure 2-0-15). Benzyl protected 5bromouracil was reacted under the Appel conditions with aminonaphthol resulting in
NMR evidence of the secondary amine tetCo product. The majority of the compound
recovered was contaminated by triphenyl phosphine oxide (figure 2-0-12). On a smaller
scale it was possible to isolate the desired secondary amine product in 31% yield.
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Figure 2-0-22: Bop activation for tCo secondary amine synthesis. A peptide coupling reagent used as an
alternative in secondary amine intermediate synthesis.

Some alternative conditions were investigated to form the secondary amine of
tetCo without triphenylphosphine oxide, including activation with BOP in acetonitrile.
DBU deprotonates the N3 nitrogen and this resonates to form a double bond with the C4
carbon forming the oxyanion. The oxyanion attacks the phosphorous of BOP, and the
BOP oxygen substitutes for this 5-bromouracil oxyanion at C4 resulting in the formation
of HMPA. The benzothiazole can assist with deprotonation of the aminophenolic
nitrogen which needs deprotonation following substitution at C4 which displaced the
benzotriazolyoxy group. Under these conditions, a compound was obtained in 60% yield
which was possibly the desired secondary amine product (figure 2-0-22). The benzyl
protected tetCo secondary amine products isolated from different conditions all give
NMR evidence of potential product formation, but the spectral data for the products vary
between these different conditions.
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Figure 2-0-23: PYBOB activation for tCo secondary amine synthesis. An alternative peptide coupling
reagent that does not generate HMPA was substituted in secondary amine formation synthesis. . Reaction
was unsuccessful.

PyBOP is preferential to BOP because it does not result in the formation of
HMPA so this activator was tested as an alternative. PyBOP behaves in the same way as
BOP described above, the only difference being that PyBOP has three pyrrolidines
instead of three dimethyl amines attached to the phosphorous and thus does not product
HMPA. Substituting this reagent did not result in the appearance of any of the desired
product, even when using THF as the solvent and heating to 60 oC (figure 2-0-23). Using
the MesCl conditions on a small scale it was possible to isolate the desired tetCo
secondary amine product in high yield (figure 2-0-2). Scaling up these promising
conditions unfortunately resulted in a decrease in the yield of the product and a large
amount of unreacted 5-bromouracil was difficult to remove from the desired product.
Triethylphosphine was tried as a substitute for triphenylphosphine and this
resulted in a production of the deprotected product but in much worse yields than had
been seen for the phenyl version. The following table (Table 2) displays the reaction
conditions for the ring closure to form the oxygen tricyclic cytosine nucleobases.
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KF diglyme
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CsF
CsF Butanol

8-F

8-F

KF
CsF
CsF
CsF

tCo

tCo

Tet

Tet

CsF Butanol

8-Ome

EtOH

EtOH

NMP

EtOH

EtOH

CsF

8-Ome

EtOH

KF

8-Ome

EtOH

CsF

8-F

EtOH

EtOH

EtOH

EtOH

EtOH

CsF Butanol

7-Cl

EtOH

CsF

7-Cl

Time

1day

1day

days

4hrs

Days

1day

Benzyl 3days

Benzyl

None

Benzyl

Benzyl

Benzyl

Benzyl 3days

Benzyl

Benzyl

Benzyl 2days

Benzyl

Benzyl 3days

Benzyl 2days

Benzyl

Benzyl 4days

Benzyl

Benzyl

Benzyl 3days

Analog Fluoride Solvent Protecting

CaCO3

CaCO3

None

None

None

None

None

None

None

None

None

None

None

CaCO3

None

18crown6

None

None

10mg/mL

10mg/mL

25mg/ml

10mg/ml

44mg/ml

10mg/ml

19mg/ml

51mg/ml

10mg/mL

10mg/mL

50mg/ml

50mg/ml

5mg/ml

10mg/mL

20mg/ml

40mg/ml

50mg/ml

50mg/ml

Scale

NA

NA

.4mg

1.3mg

NA

NA

24%

15%

27%

NA

NA

NA

14.7mg

15%

NA

NA

NA

Yield

85 185mg debenzylated

85 78mg

120 10mg

85 15mg

101 133mg

85 20mg

85 130mg

101 405mg

85 130mg

85 17mg

120 300mg

85 300mg

85 17mg

85 20mg

85 200mg

120 100mg

120 500mg

85 200mg

Additive Concentration Temperature

Y

Table 2: Ring closure of nucleobases. Analog is the name of the substituted product. Some yields are
approximations based on NMR and in the event that no yield is given isolated product was not obtained. Some
isolated reactions or those for purely production purposes are excluded from this table.

0.8mg
101 164mg
41mg/ml
None
CsF Butanol
Tet

Benzyl

SM
85 10mg
10mg/mL
None
Benzyl 2days
KF
Tet

EtOH

NA
85 10mg
10mg/mL
None
Benzyl 2days
EtOH
CsF
Tet

Analog Fluoride Solvent Protecting

Time

Additive Concentration Temperature

Scale

Yield

Table 2 Continued: Ring closure of nucleobases Analog is the name of the substituted product. Some yields are
approximations based on NMR and in the event that no yield is given isolated product was not obtained. Some
isolated reactions or those for purely production purposes are excluded from this table.
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In one set of conditions tested calcium carbonate was combined with cesium
fluoride and the benzyl protected tetCo secondary amine synthesized as described above.
This mixture was refluxed in ethanol for days to synthesize the tricyclic nucleobase
(figure 2-0-17). The outcome of this reaction was the debenzylation of the starting
material and no nucleophilic aromatic substitution product was recovered. To ensure that
the product was not just going undetected, the reaction was scaled up, but this resulted
again in only detectable debenzylation. In the absence of the cesium carbonate, the
reaction conditions resulted in evidence of trace amounts of a new compound by NMR
along with a large amount of unreacted starting material. This product was not
recoverable following chromatography. Similar NMR evidence of possible product
formation was seen if the reaction was performed in butanol to allow heating to 101 oC.
Under these higher temperature conditions there was also evidence of starting material
debenzylation. Using the originally reported fluorine source of potassium fluoride in
ethanol did not result in any reaction of the tetCo secondary amine starting material.
The small amounts of tricyclic nucleobase that were synthesized were subjected
to deprotection conditions to remove the benzyl group so that the nucleobases could be
glycosylated. Refluxing benzyl protected 8-Cl-tCo nucleobase in either a 1:1 mixture of
benzene and toluene or xylenes, with boron tribromide afforded small amounts of the free
nucleobase (figure 2-0-24). The oxygen of the C2 carbonyl nucleophilically attacks the
boron releasing one of the bromines as an anion. This anion attacks the benzyl CH2
carbon, displacing the N1 nitrogen. The electrons from this nitrogen resonate to form a
double bond with the C2 carbon and alleviate the positive charge of the oxygen. Upon
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workup, the boron is removed, reforming the carbon oxygen double bond and pushing the
electrons back on to the nitrogen. N1 becomes protonated to give the free nucleobase
product. Under the same conditions, the 8-F-tCo nucleobase retained its benzyl
protecting group. To understand the different outcomes, the benzyl protected 7-Cl-tCo
secondary amine was reacted under these conditions. This resulted in a small amount of
debenzylated secondary amine product being recovered from the reaction (figure 2-0-24).

Figure 2-0-24: Debenzylation. Removal of the benzyl protecting group to make N1 nitrogen available to
glycosylation at the ring closed and secondary amine intermediates. Reaction on left was successful with
some R groups, reaction on right was unsuccessful.

The lack of the lability of the benzyl protecting group was further investigated
with some alternative debenzylation conditions. Standard conditions for the removal of
the benzyl group by hydrogenation of the protected 7-Cl-tCo secondary amine with
palladium on charcoal in methanol did not result in the debenzylation of this compound
(figure 2-0-25). The palladium undergoes oxidative addition inserting itself in the
nitrogen benzyl carbon bond. Hydrogen is coordinated by the palladium and the electrons
of the bond between the nitrogen and the palladium take the hydronium while the hydride
is transferred to the palladium. This releases the deprotected nucleobase and toluene is
released during the reductive elimination to return the palladium to the catalytic cycle.
Using ammonium formate as the hydrogen source in debenzylation of this
secondary amine did show evidence of reaction through the appearance of a new
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compound by thin layer chromatography. Unfortunately, no product was isolated from
purification.

Figure 2-0-25: Alternative debenzylation. Other synthetic conditions applied to the removal of benzyl
protecting group from secondary amine intermediates. Reactions were unsuccessful.

Debenzylation was also attempted using aluminum trichloride in benzene as
opposed to borontribromide. The protected 7-Cl-tCo secondary amine showed no reaction
in this case and this may have been due to a lack of solubility of the starting material
(figure 2-0-25).
Difficulties in debenzylation led to a re-examination of protecting group choice
for 5-bromouracil. An Fmoc protecting group might have been a protecting group that
would be labile enough to be removed following ring closure but not so reactive to the
secondary amine formation conditions as some of the other esters.94 For protection, nmethyl morpholidate deprotonates the N1 nitrogen so it can attack the carbonyl carbon of
the Fmoc-Cl and upon reformation of the carbon oxygen double bond the chlorine anion
is expelled (figure 2-0-26).95 Although thin layer chromatography of the reaction showed
a complex mixture of products, following multiple rounds of purification it was only 5bromouracil with free N1 nitrogen that was recovered.
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Figure 2-0-26: Fmoc protection of 5-bromouracil. Synthetic conditions presented for the installation of an
alternative protecting group at N1 nitrogen of 5-bromouracil. This group would be easier to remove following
secondary amine formation. Reaction was unsuccessful.
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Oxygen Tricyclic Cytosine Analogs Experimental:

1-tert-butoxycarbonyl-5-bromouracil. 5-bromouracil (1.53 g, 8.0 mmol) was
dissolved in acetonitrile (50 mL) under N2. Dimethylaminopyridine (10.3 mg, 0.084
mmol) was added followed by di-tert-butyl dicarbonate (1.73 g, 7.95 mmol) and stirred at
room temperature until no starting material was detectable by thin layer chromatography.
Evaporation and purification via flash silica gel chromatography (CH3OH in CH2Cl2)
resulted in desired product (1.17 g, 4.0 mmol) 50% yield. 1HNMR (CD3OD) δ 8.28 (s,
1H), 1.60 (s, 9H).

1-ethoxycarbonyl-5-bromouracil. 5-bromouracil (191 mg, 1 mmol) was
dissolved in dichloromethane (25 mL) under N2. Ethyl chloroformate (95 μL, 1 mmol)
was added followed by potassium carbonate (226 mg, 1.63 mmol) and this was stirred at
room temperature for 14 hours. An hour of heating to 40 degrees resulted in the reaction
of all of the starting material, and the mixture was quenched with saturated ammonium
chloride (10 mL). After attempted extraction with ethyl acetate and dichloromethane
aqueous and organics were evaporated. Purification via flash silica gel chromatography
(Ethyl acetate in Cyclohexanes) resulted in desired product (82.6 mg, 0.31 mmol) 31%
yield. 1HNMR ((CD3)2SO) δ 11.52 (s, 0H), 7.90 (s, 1H).
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1-benzyl-5-bromoracil. 5-bromouracil (15 g, 78 mmol) was dissolved in
dichloroethane (75 mL) under N2. Hexamethyldisilazane (22 mL, 104 mmol) was added
followed by chloro-trimethylsilane (990 μL, 7.8 mmol) and heated to 85 oC. After 9.5
hours the solvent was removed. At room temperature the reaction was dissolved in
dichloroethane (75 mL), iodine (208 mg, 819 mmol) was added followed by benzyl
bromide (11 mL, 93.3 mmol) and the reaction returned to 85 oC. After 18 hours the
reaction was quenched with water (120 mL). The desired product was filtered, washed
with water and dichloromethane to give (16.3g, 58 mmol) 74 % yield. 1HNMR
((CD3)2SO) δ 8.35 (s, 1H), 7.31 (dt, J = 7.7, 1.3 Hz, 5H), 4.87 (s, 2H).

1-benzyl-5-bromo-N4-(2-hydroxyphenyl)-cytosine. Triphenylphosphine (93 mg,
0.36 mmol) was dissolved in dry dichloromethane (2 mL) with carbon tetrachloride
(2mL) under N2. After 15 minutes at room temperature 1-benzyl-5-bromourail (50 mg,
0.18 mmol) was added and the reaction heated to 44 oC. The reaction was cooled to
room temperature after 5 hours and then to 0 oC. Aminophenol (20 mg, 0.18 mmol) with
1,8-Diazabicyclo[5.4.0]undec-7-ene (27 μL, 0.18 mmol) in dry dichloromethane (0.5 mL)
was added to the reaction and stirred at 0 oC until starting material was no longer
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detectable by thin layer chromatography. Dilution with methanol, evaporation and
purification via silica gel flash chromatography followed by recrystallization from
ethanol gave desired product (21 mg, 0.056 mmol) 32% yield. 1HNMR (CD3OD) δ 8.43
(dd, J=8.1, 1.6 Hz, 1H), 8.14 (s, 1H), 7.69 – 7.60 (m, 1H), 7.60 – 7.52 (m, 1H), 7.42 –
7.27 (m, 5H), 6.99 (ddd, J=8.1, 7.3, 1.6 Hz, 1H), 6.91 – 6.82 (m, 2H), 5.03 (s, 2H).

1,3-diaza-1-benzyl-2-oxophenoxazine. 1-benzyl-5-bromo-N4-(2-hydroxyphenyl)cytosine
(15 mg, 0.040 mmol) was combined with potassium fluoride (23 mg, 0.40 mmol) under
N2 and dissolved in ethanol (1.5 mL). After refluxing 2 days, evaporation and purification
via silica gel flash chromatography followed by recrystallization from ethanol gave
product (0.4 mg, 0.0014 mmol) 3% yield. 1HNMR (CD3OD) δ 7.40 – 7.26 (m, 5H), 6.90
– 6.83 (m, 2H), 6.77 (s, 2H), 4.93 (d, J=3.5 Hz, 2H).
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1-benzyl-5-bromo-N4-(2-hydroxy-5-fluorophenyl)-cytosine. 1-benzyl-5bromoracil (2.0 g, 7.1 mmol) was combined with 2-mesitylenesulfonyl chloride (1.5 g,
7.1 mmol) and dimethylaminopyridine (46 mg, 0.38 mmol) under N2 and dissolved in dry
dichloromethane (80 mL). Triethylamine (11 mL, 80 mmol) was added and stirred at
room temperature 13 hours. 4-fluoro-2-aminophenol (1.2 g, 8.5 mmol) was combined
with 1,8-Diazabicyclo[5.4.0]undec-7-ene (1 mL, 7.1 mmol) in dry dichloromethane to
dissolve and added to the reaction above. Dilution with ethyl acetate, washing with
saturated sodium bicarbonate, filtration and evaporation were followed by purification
via silica gel flash chromatography (Ethyl acetate in Cyclohexanes) to give desired
product (405mg, 1.0 mmol) 14% yield. 1HNMR (CD3OD) δ 8.48 (dd, J=10.8, 3.1 Hz,
1H), 8.03 (s, 1H), 7.73 (s, 0H), 7.40 –7.24 (m, 5H), 6.80 (dd, J=8.8, 5.1 Hz, 1H), 6.66
(ddd, J=8.8, 8.1, 3.1 Hz, 1H), 5.03 (s, 2H).
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8-fluoro-1,3-diaza-1-benzyl-2-oxophenoxazine. 1-benzyl-5-bromo-N4-(2hydroxy-5-fluorophenyl)cytosine (405 mg, 1.0 mmol) was combined with cesium
fluoride (1.6 g, 10.4 mmol) under N2 and dissolved in butanol (8 mL). After heating at
101 oC for 24 hours the reaction was evaporated and purification via flash silica gel
chromatography (CH3OH in CH2Cl2) gave crude product. 1HNMR ((CD3)2SO) δ 11.85
(s, 6H), 8.38 (s, 10H), 7.40 – 7.26 (m, 64H), 6.79 (s, 1H), 6.65(td, J=8.6, 3.0 Hz, 1H),
6.58 (dd, J=9.3, 3.0 Hz, 1H), 4.78 (s, 2H).

1-benzyl-5-bromo-N4-(2-hydroxy-5-methoxyphenyl)-cytosine. 1-benzyl-5bromoracil (501 mg, 1.8 mmol) was combined with 2-mesitylenesulfonyl chloride (389
mg, 1.8 mmol) and dimethylaminopyridine (11 mg, 0.089 mmol) under N2 and dissolved
in dry dichloromethane (20 mL). Triethylamine (2.8 mL, 20 mmol) was added and stirred
at room temperature 18 hours. 4-methoxy-2-aminophenol (300 mg, 2.2 mmol) was
combined with 1,8-Diazabicyclo[5.4.0]undec-7-ene (265 μL, 1.8 mmol) in dry
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dichloromethane to dissolve and added to the reaction above. Dilution with ethyl acetate,
washing with saturated sodium bicarbonate, filtration and evaporation were followed by
purification via silica gel flash chromatography (Ethyl acetate in Cyclohexanes) to give
desired product (133mg, 0.33 mmol) 18% yield. 1HNMR ((CD3)2SO) δ 9.83 (s, 0H), 8.46
(s, 1H), 8.26 (s, 0H), 7.97 (s, 1H), 7.66 – 7.52 (m,1H), 7.39 – 7.26 (m, 5H), 6.82 (d, J=8.8
Hz, 1H), 6.58 (dd, J=8.8, 3.1 Hz, 1H), 4.94 (s, 2H), 3.67 (s,3H).

8-methoxy-1,3-diaza-1-benzyl-2-oxophenoxazine. 1-benzyl-5-bromo-N4-(2hydroxy-5-methoxyphenyl)cytosine (133 mg, 0.33 mmol) was combined with cesium
fluoride (502 mg, 3.3 mmol) under N2 and dissolved in butanol (3 mL). After heating at
101 oC for 24 hours the reaction was evaporated and purification via flash silica gel
chromatography (CH3OH in CH2Cl2) gave crude product (1.3 mg, 0.0036 mmol).

1-benzyl-5-bromo-N4-(2-hydroxy-5-chlorophenyl)-cytosine. 1-benzyl-5bromoracil (2.0 g, 7.1 mmol) was combined with 2-mesitylenesulfonyl chloride (1.5 g,
7.1 mmol) and dimethylaminopyridine (47 mg, 0.38 mmol) under N2 and dissolved in dry
dichloromethane (80 mL). Triethylamine (11 mL, 80 mmol) was added and stirred at
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room temperature 18 hours. 4-Chloro-2-aminophenol (1.2 g, 8.5 mmol) was combined
with 1,8-Diazabicyclo[5.4.0]undec-7-ene (1 mL, 7.1 mmol) in dry dichloromethane to
dissolve and added to the reaction above. Dilution with ethyl acetate, washing with
saturated sodium bicarbonate, filtration and evaporation were followed by purification
via silica gel flash chromatography to give desired product (900mg, 2.1 mmol) 30%
yield. 1HNMR ((CD3)2SO) δ 10.68 (s, 1H), 8.50 (s, 1H), 8.37 (d, J=2.6 Hz, 1H), 8.26 (s,
1H), 7.40– 7.29 (m, 5H), 7.03 (dd, J=8.6, 2.6 Hz, 1H), 6.92 (d, J=8.6 Hz, 1H), 4.95 (s,
2H).

8-chloro-1,3-diaza-1-benzyl-2-oxophenoxazine. 1-benzyl-5-bromo-N4-(2hydroxy-5-chlorophenyl)cytosine (300 mg, 0.70 mmol) was combined with cesium
fluoride (1.1 g, 7.0 mmol) under N2 and dissolved in ethanol (6 mL). After refluxing for
three days the reaction was diluted with methanol and evaporated. Purification via flash
silica gel chromatography (CH3OH in CH2Cl2) gave product (38 mg, 0.12 mmol) 17%
yield. 1HNMR ((CD3)2SO) δ 7.39 – 7.25 (m, 6H), 6.86 (dd, J=8.6, 2.5 Hz, 1H), 6.81 –
6.74 (m, 2H), 4.78 (s, 2H).
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1-benzyl-5-bromo-N4-(2-hydroxy-4-chlorophenyl)-cytosine. 1-benzyl-5bromoracil (2.0 g, 7.1 mmol) was combined with 2-mesitylenesulfonyl chloride (1.5 g,
7.1 mmol) and dimethylaminopyridine (47 mg, 0.38 mmol) under N2 and dissolved in dry
dichloromethane (80 mL). Triethylamine (11 mL, 80 mmol) was added and stirred at
room temperature 18 hours. 4-Chloro-2-aminophenol (1.2 g, 8.5 mmol) was combined
with 1,8-Diazabicyclo[5.4.0]undec-7-ene (1 mL, 7.1 mmol) in dry dichloromethane to
dissolve and added to the reaction above. Dilution with ethyl acetate, washing with
saturated sodium bicarbonate, filtration and evaporation were followed by purification
via silica gel flash chromatography to give desired product (1.5 g, 3.5 mmol) 49% yield.
1

HNMR ((CD3)2SO) δ 11.86 (s, 1H), 9.48 (s, 0H), 8.38 (s, 1H), 7.40 – 7.30 (m, 5H), 6.63

(t,J=1.2 Hz, 1H), 6.55 (d, J=1.7 Hz, 2H), 4.88 (s, 2H).

7-chloro-1,3-diaza-1-benzyl-2-oxophenoxazine. 1-benzyl-5-bromo-N4-(2hydroxy-4-chlorophenyl)cytosine (200 mg, 0.47 mmol) was combined with cesium
fluoride (710 mg, 4.7 mmol) under N2 and dissolved in ethanol (4 mL). After refluxing
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for three days the reaction was diluted with methanol and evaporated. Purification via
flash silica gel chromatography (CH3OH in CH2Cl2) gave crude product.

1-benzyl-5-bromo-N4-(2-hydroxynaphthol)-cytosine. 1-benzyl-5-bromoracil
(500 mg, 1.8 mmol) was combined with 2-mesitylenesulfonyl chloride (388 mg, 1.8
mmol) and dimethylaminopyridine (12 mg, 0.089 mmol) under N2 and dissolved in dry
dichloromethane (20 mL). Triethylamine (2.7 mL, 20 mmol) was added and stirred at
room temperature 18 hours. Aminonaphthol (338 mg, 2.2 mmol) was combined with
1,8-Diazabicyclo[5.4.0]undec-7-ene (265 μL, 1.8 mmol) in dry dichloromethane to
dissolve and added to the reaction above. Dilution with ethyl acetate, washing with
saturated sodium bicarbonate, filtration and evaporation were followed by purification
via silica gel flash chromatography (Ethyl acetate in Cyclohexanes) to give desired
product (164mg, 0.39 mmol) 21% yield. 1HNMR (CD3OD) δ 9.22 (s, 1H), 8.08 (s, 1H),
7.99 (s, 0H), 7.81 (ddd, J=7.9, 1.5, 0.7Hz, 1H), 7.78 (s, 1H), 7.57 (dd, J=8.1, 1.3 Hz, 1H),
7.41 – 7.34 (m, 5H), 7.32 – 7.25 (m, 2H), 7.17 (s, 1H), 5.06 (s, 2H).
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1,3-diaza-1-benzyl-benzo(h)2-oxophenoxazine. 1-benzyl-5-bromo-N4-(2hydroxynaphthol)-cytosine (164 mg, 0.39 mmol) was combined with cesium fluoride
(591 mg, 3.9 mmol) under N2 and dissolved in butanol (4 mL). After heating at 101 oC
for 3 days the reaction was evaporated and purification via flash silica gel
chromatography (CH3OH in CH2Cl2) gave crude product (0.8 mg, 0.002 mmol).

8-chloro-1,3-diazal-2-oxophenoxazine. 8-chloro-1,3-diaza-1-benzyl-2oxophenoxazine (20 mg, 0.61 mmol) was dissolved in benzene (1.6 mL) and toluene (1.6
mL) under N2. 1M Boron tribromide (300 μL, 0.3 mmol) solution in dichloromethane
was added to the reaction and heated to 110 oC for 4.25 hours. Evaporation and
purification via flash silica gel chromatography resulted in product (6.7 mg, 0.28 mmol)
46% yield. 1HNMR (CD3OD) δ 7.75, 7.63.
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Carbon Tricyclic Cytosine Analogs

Figure 2-0-27: Synthesis of carbon tricyclic cytosine tCc

A carbon based tricyclic cytosine (tCC) is a target of interest because of its

potential fluorescence properties and its ability to present a triple acceptor hydrogen
bonding pattern. This bonding pattern would be potentially suitable for making new base
pairs (figure 2-0-27). It synthesis was claimed in the literature regarding testing for its
analgesic abilities, but there is little known as to its fluorescence properties.96 Extensive
testing of the reported routes in the laboratory has called into question the possibility that
the claimed molecules were those that were tested. Some new attempts at this molecule
will now be described.
Acetanilide was the initial starting material for this synthesis and it was combined
with phosphorous oxychloride in DMF to form the two distal rings of the nucleobase
(figure 2-0-28).97 In Vilsmeier chemistry, as seen in the synthesis of the oxygen analogs
above, the phosphorous oxychloride is attacked by the oxygen of the DMF with the
assistance of the amide nitrogen. This results in the leaving of one of the phosphorous
oxychloride chlorines as the anion. Chlorine then substitutes at the amide carbon of DMF
releasing the dichlorophosphate anion and generating the reactive iminium cation.
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Figure 2-0-28: Vilsmeier carbaldehyde synthesis. This is the first synthetic step in the synthesis of tCc.
Acetanilide is combined with phosphorous oxychloride in DMF to form the two distal rings of the nucleobase

This iminium cation is attacked at carbon by the π system of acetanilide and the
following deprotonation restores aromaticity. The chlorine of the iminium then leaves,
regenerating the cation. The enol tautomer of the acetanilide amide can attack the
iminium carbon forming the second ring of the ensuing nucleobase and elimination
releases diethylamine. The resulting double bond of this elimination can attack another
iminium cation resulting from the reaction of DMF and POCl3. The double bond is
restored by deprotonation. The amide carbonyl reacts with phosphorous oxychloride in a
manner similar to that of DMF, resulting in chlorine substitution and a carbon nitrogen
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bond in place of the carbonyl. Aqueous workup results in the hydrolysis of the remaining
iminium cation and the formation of the carbaldehyde of the aryl quinolone.

Figure 2-0-29: Quinolinamine synthesis. This is the second synthetic step in the synthesis of tCc. The
formylquinoline intermediate is reacted with the hydrochloride salt of guanidine to give the quinolinamine
which is the desired tricyclic structure.

The formylquinoline thus produced was then reacted with the hydrochloride salt
of guanidine to give the quinolinamine which is the tricyclic beginning of the desired
carbon tricyclic cytosine nucleobase (figure 2-0-29).96 Imine bond formation between the
guanidine nitrogen and the aldehyde of the formylquinoline, combined with nucleophilic
aromatic substitution by the other guanidine nitrogen at the chlorine forms the product.
increasing its nucleophilicity and it will attack the carbonyl carbon of the aldehyde.
Previous attempts in the lab to make the compound with exocyclic oxygen at the C2
position were unsuccessful, so this nitrogen version was synthesized to be later converted
to the oxygen containing compound. During early synthesis attempts potassium carbonate
was used to facilitate the nucleophilic attack of guanidine. Potassium Carbonate in
triethylamine was also tried, followed by sodium hydride. This hydride was the base of
choice because it could result in product when conditions were extremely dry.

Figure 2-0-30: Nitrosation. This is the third synthetic step in the synthesis of tCc. The
quinolinamine is converted to the quinolinol which has the correct nucleobase hydrogen
bonding face.

Attempted nitrosation of the quinolinamine to the quinolinol was made through
the use of acid followed by sodium nitrite and then base (figure 2-0-30).98 This is an
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established method for the synthesis of synthetic nucleosides, taking advantage of well
precedented diazonium chemistry.99 Dissociation of the nitrite allows the nitrite oxygen
anion to pick up protons from the acidic environment. Upon the second protonation,
water is formed and the group departs leaving nitric oxide. The primary amine of the
quinolinamine attacks the positively charged nitrogen of the nitric oxide and is then
deprotonated. Proton transfer of the other amine hydrogen to the oxygen of the nitric
oxide followed by additional protonation leads to water. Leaving of this water, generates
the diazonium intermediate which is highly reactive to substitution by the hydroxide
resulting in the alcohol product. Acetic acid performed better than HCl to give the
desired product in these conditions.100 Additionally, greater reactivity was observed when
the sodium nitrate was added as an aqueous solution, likely due to the increased
solubility. This reaction was performed in a pressure tube, but the sealed environment
was not shown to increase reaction performance.
Possible decomposition of the amine starting material during storage was avoided
through trapping the compound with an amine protecting group (figure 2-0-31). Boc
protection should be labile to the nitrosation conditions and so this protecting group was
installed on the quinolinamine. Starting material was combined with boc anhydride in dry
THF to yield the protected product through the mechanism discussed earlier for 5bromouracil protection. Reaction of this protected amine in acetic acid with aqueous
sodium nitrate led to the desired product as confirmed by mass spectroscopy.

92

Figure 2-0-31: Boc protected nitrosation. These conditions were used to stabilize the quinolinamine to avoid
decomposition prior to conversion to the quinolinol which has the correct nucleobase hydrogen bonding face.

93

Carbon Tricyclic Cytosine Analogs Experimental:

2-chloro-3-formylquinoline. Dimethylformamide (2.8 mL, 0.037 mol) was
cooled to 0 oC under N2. Phosphorous oxychloride (9.6 mL, 0.10 mol) was added. After
warming to room temperature, acetanilide (2 g, 0.015 mol) was added and the reaction
heated to 75 oC. 4 hours later the reaction mixture was added dropwise to ice and stirred.
Precipitated product was filtered (613 mg, 0.0032 mmol) 21% yield.

Pyrimido[4,5-b]quinolin-2-amine. Guanidine hydrochloride (1.8 g, 19 mmol)
was dissolved in DMF (22 mL) over 3 or 4 Å molecular sieves under N2. This solution
(15 mL) was transferred to a new flask over new sieves and sodium hydride (124 mg, 12
mmol) was added to the reaction and stirred for 30 minutes. 2-chlroro-3-formylquinoline
(600 mg, 3.1 mmol) was added and the reaction heated to 80 oC. After 3 hours the
reaction was cooled to room temperature, filtered through celite, washed with methanol
and evaporated. Purification via silica gel chromatography yielded product (419 mg, 2.1
mmol) in 68% yield.
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Pyrimido[4,5-b]quinolin-2-tert-butoxycarbonylamine. Pyrimido[4,5-b]quinolin2-amine (146mg, 0.74 mmol) was dissolved in THF (33 mL) under N2. Di-tertbutyl
bicarbonate (663 mg, 3.0 mmol) was added to the reaction and heated to 40 oC. After
additional di-tertbutyl bicarbonate (1.3 g, 5.8 mmol) was added and 20 hours, the reaction
was evaporated. Purification via silica gel chromatography resulted in the product (12.6
mg, 0.042 mmol) 6% yield.

Pyrimido[4,5-b]quinolin-2-ol. Pyrimido[4,5-b]quinolin-2-tertbutoxycarbonylamine (6 mg, 0.020 mmol) was dissolved in 10% acetic acid (1 mL) and
stirred for 20 minutes. Sodium nitrite (3.4 mg, 0.051 mmol) was added to the reaction
and stirred at room temperature for 90 minutes. More sodium nitrite (4.0 mg, 0.058
mmol) was added to the reaction and stirred another 90 minutes. Heating to 60 oC the
reaction was continued for 90 minutes and then neutralized with triethylamine ( 0.243
mL, 0.0017 mmol) Purification via preparatory thin layer chromatography resulted in the
product.
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Chapter Three: Nucleoside Directed Synthesis
Introduction
In this chapter will be a discussion of synthetic approaches to tricyclic cytidines
using nucleosides as starting materials (figure 3-0-1).101 The majority of the chapter
focuses on the oxygen substituted analogs (tCo derivatives), but elaborations of both the
oxygen and sulfur containing compounds (tCo and tC derivatives) are discussed as well as
some chemistry of other fluorescent nucleotides. Through these synthetic methods, it was
ultimately possible to obtain a set of pure nucleoside analogs which were subsequently
tested for photophysical properties as will be discussed in Chapter 4. Although
substituent effects had great impacts on the chemistry and many reaction conditions
tested had limited substituent tolerance, the methods developed were the most reliable
way to synthesize satisfactory yields of the entire small library of compounds. Some
reactions were developed with uniquely high yields for a single nucleoside analog, and
others were found to have usefully broad substrate scope.
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Figure 3-0-1: Nucleoside directed synthesis. Synthetic route for the substituted
nucleosides presented in this work.

The presence of the somewhat labile glycosidic bond made the nucleoside
directed synthesis less tolerant to harsh reaction conditions. A glycosylated starting
material endeavor was the known synthetic route to the unsubstituted oxygen tricyclic
cytosine analog tCo and therefore a reasonable avenue to the new substituted versions.3
Synthetic routes in which these compounds should be stable occasionally resulted in the
fracture of this bond, but eventually this sensitivity was managed, and the glycosidic
bond could be retained throughout the synthesis. Additionally, deamination like that seen
under reaction conditions in the previous chapter was also a problem with the synthesis of
nucleosides.
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Figure 3-0-2: Elaboration positions of analogs. R and R1 are places for further substitution
elaboration. R2 and R3 are positions for installation of functionality in the preparation of
nucleosides for oligonucleotide synthesis.

Obtaining the nucleosides was not the end of the synthetic work, as attempts to
incorporate the fluorophores into nucleic acids required additional synthetic manipulation
(figure 3-0-2). Other synthetic manipulations of the nucleosides were tested to further
modify the character of the chromophore and alter the photophysics after the completion
of the tricyclic system. A series of triphosphates of the nucleoside analogs were
synthesized in preparation for enzymatic incorporation into oligonucleotides.
Triphosphates of these analogs provide means to investigate enzyme utility (fidelity and
rates of nucleotide incorporation of these novel nucleotides as well, as will be discussed
in Chapter 5 of this work.
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Oxygen Tricyclic Cytidine Analogs
5-bromo-2’-deoxy-uridine is the starting material for the previously published
synthetic route to tCo, and many low yielding reactions in the course of optimization
motivated the synthesis of this commercially available starting material. Bromination was
achieved in good yields even when on large scale with dibromo-dimethylhydantoin
(figure 3-0-1). This brominating reagent behaves similarly to N-bromosuccinimide, but is
less expensive and less hazardous.102 The N1 nitrogen of bromouridine resonates to form
a double bond with the C6 carbon and the C5-C6 double bond on the nucleoside attacks
the electrophilic bromine of the DBH. The nitrogen anion thus formed deprotonates the
C5 carbon to reform the C5-C6 double bond and restore the N1 nitrogen lone pair.103
It is unnecessary to protect the 3’ and the 5’ hydroxyl groups from these
bromination conditions, but leaving free this functionality hindered reaction with the
carbonyl activators in secondary amine formation. To prevent this undesirable
interference, these oxygens were tied up in protecting groups as the next synthetic step.
Acetyl protecting groups were useful for the protection at these positions because they
are base labile.104 Acetic anhydride in pyridine provided the double protected product in
good yields. The reaction could be catalyzed with a small amount of DMAP, like the boc
protection conditions in the previous chapter, but this was not necessary. In the presence
of DMAP, the carbohydrate oxygen substitutes for DMAP at the carbonyl carbon of what
was the anhydride. DMAP nucleophilic attack of the acetic anhydride and reformation of
the carbonyl double bond released an acetate anion which could deprotonate the
carbohydrate oxygen. The 3’ OH underwent the same process. In the absence of DMAP,
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the hydroxyls attack directly the carbonyl carbon of acetic anhydride. In the absence of
these protecting groups, low yields result even from the most successful activation
conditions as will be discussed below.
A comparative standard was helpful during the synthesis of the tCo secondary
amines, to determine if the desired products were being formed. To have on hand the
intermediates from the synthesis of the parent compound was a helpful resource. The
synthesis of this compound is found in the literature and is discussed in the previous
chapter for its application towards the synthesis of the nucleobases.3 A 25mg scale
synthesis proved too small to provide thin layer chromatography standards of synthetic
intermediates, but use of a 200mg scale afforded the desired model compounds. To
determine if the synthesis of this parent compound could be improved through some
alternative carbonyl activation conditions a small investigation was made.
Using the Appel chemistry discussed in the previous chapter, 3’,5’-diacetyl-5bromo-2’-deoxyuridine was added to a mixture of triphenyl phosphine and carbon
tetrachloride (figure 3-0-4). After addition of the aminophenol and DBU, no nucleophilic
substitution was observed. Phosphorous oxychloride conditions, also discussed in the
previous chapter, were applied to synthesis of the unsubstituted tCo nucleoside (figure 30-5). The protected nucleoside starting material was reacted with a mixture of
phosphorous oxychloride and n-methylimidazole, leading to the appearance of product by
thin layer chromatography. The yield of the isolated desired product from this reaction
was not an improvement on the established sulphonylating conditions, which are
selective for C4 due to sterics.105
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For fluorescence measurement comparison it was necessary again to synthesize
unsubstituted tCo using the literature method. The yields were greatest when the reaction
time between the sulphonylated-bromouridine intermediate and aminophenol was limited
to two hours. Isolation from unreacted starting materials is aided by the removal of the
acyl protecting groups. Additionally, the presence of free alcohol at the 5’ position is
useful in the following synthetic step so the semi-pure reaction mixture was deprotected
through the literature method.3 Reaction with sodium methoxide in methanol efficiently
cleaves the ester protecting groups from both the 3’ and 5’positions while generally
leaving the other functionality of the secondary amine intact. Methoxide anions attacked
the carbonyl carbons of the protecting groups and reformation of the double bonds
expelled methyl esters to free 3’ and 5’ carbohydrate oxygens.106 Acidic workup of the
reaction led to the protonation of the oxygens to give the hydroxyl product. The
following is a table (table 3) of secondary amine formation conditions tested for the
oxygen tricyclic cytosine (tCo) analogs.
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MesCl
POCl3
POCl3
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4

7-Cl
7-Cl
7-Cl
7-Cl
7-Cl
7-Cl
7-Cl
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
POPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4

7-Cl
7-Cl
7-Cl
7-Ome
7-Ome
7-Ome
7-Ome
7-Ome
7-Ome
7-Ome
8-Ome

ACN/PYR

ACN/PYR

DCM

DCM

MesCl

7-Cl

102
44

44

44

44

44

44

44

44

44

44

44

44

44

40

44

-10

-10

RT

18
6
82
91
NA
1.6
NA
28
35
43
Quant.

15min at 0 500mg
10min at 0 500mg
25min at 0 500mg
50mg

21min at 0

20min at 0 211mg
15min at 0 211mg
15min at 0 500mg
15min at 0 500mg
15min at 0 500mg
15min at 0 500mg

5 hrs
5 hrs
5 hrs
7 hrs
5 hrs

6hrs
5 hrs

21

15min at 0 500mg
15min at 0 500mg

5hrs

4.5 hrs

13

15min at 0 500mg

4 hrs overnight rt 500mg

NA Not

2.50

50min at 0 500mg

5 hrs

NA

1g

13min 4 rt then 5C

NA

NA Yes

Deprotect.

Yield MS

NA Yes

overnight 300mg

9.5 300mg

Time

Scale

25min 4 rt then 5C 200mg

24hrs

RT overnight

Time

Solvent Temperature Activation Substitution

Activator

Analog

Table 3: Nucleoside secondary amine formation. Analog is the name of the substituted product referring to
figure 3-0-3. Some yields are approximations based on NMR and in the event that no yield is given isolated
product was not obtained. Some isolated reactions or those for purely production purposes are excluded from
this table.

PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4

8-Cl
7-Cl
8-Cl
8-Cl
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PPh3 DCM/CCL4
PPh3 DCM/CCL4
MesCl
MesCl
MesCl
MesCl
MesCl

PPh3 DCM/CCL4
PPh3 DCM/CCL4

8-Cl
8-Cl
8-F
8-F
8-F
8-F
8-F
8-F
8-F

DCM

DCM

DCM

DCM

DCM

PPh3 DCM/CCL4

8-Cl

DCM

MesCl

8-Cl

DCM

MesCl

8-Cl

PPh3 DCM/CCL4

7-Ome

9 hrs

44

overnight 500mg

4 500mg

2.25 250mg

5 hrs

NA
38

1hr at 0 500mg

NA

12

6 YES

0 NA

1g

3hrs overnight rt

RT overnight

RT overnight

RT overnight

5 150mg

25mg

Quant

15min at 44 500mg
4hrs

38

at 44 500mg

4.5hrs

41

5 hrs 44 for 15min 500mg

2.5hrs

19

18

1 hr at 44 211mg

rt 500gm

15min at 44 500mg

NA NA

NA NA

23

14

Yield MS

mono

RT overnight

40

25mg

24 782mg

3 days

500mg

20min at 0 500mg

Scale

5 hrs 1 at 0 the 44 500mg

5.5hrs

RT overnight

44

44

44

44

44

44

44

RT overnight

RT overnight

44

44

Solvent Temperature Activation Substitution

PPh3 DCM/CCL4

Activator

7-Ome

Analog

Table 3 Continued: Nucleoside secondary amine formation. Analog is the name of the substituted product
referring to figure 3-0-3. Some yields are approximations based on NMR and in the event that no yield is given
isolated product was not obtained. Some isolated reactions or those for purely production purposes are excluded
from this table.

DCM

MesCl
POCl3
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4

8-Ome
8-Ome
8-Ome
8-Ome
8-Ome
8-Ome
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MesCl
MesCl

tCo

PPh3 DCM/CCL4

8-OMe

tCo

PPh3 DCM/CCL4

8-OMe

MesCl

PPh3 DCM/CCL4

8-OMe

tCo

PPh3 DCM/CCL4

8-Ome

DCM

DCM

DCM

DCM

PPh3 DCM/CCL4

8-Ome

MesCl

PPh3 DCM/CCL4

8-Ome

tCo

PPh3 DCM/CCL4

8-Ome

ACN/PYR

DCM

8-Ome DMSO/NCS

PPh3 DCM/CCL4

8-F
2 hrs

5hrs

8 hrs

rt overnight

rt overnight

RT overnight

12

38

2hrs rt 850mg
rt 850mg

NA

3 hrs rt 200mg

88

15min at 0 500mg

NA

NA

15min at 0 500mg

25mg

21

500mg

3

14

10-19 min 500mg
7 hrs

500mg

NA

5g

36min at 0
5 hrs

6 hrs

NA

24

0 then rt 500mg
500mg

50

4 hrs overnight rt 500mg
6hrs

NA

1g

5hrs overnight rt

24 Yes

NA

11

500

287mg

7.5 487mg

NA

17

10min at 0
rt 200mg

20

Yield MS

15min at 0 500mg

Scale

overnight rt

RT overnight

44

44

44

44

44

44

44

44

40

40

40

-10

RT overnight

-23

44

44

Solvent Temperature Activation Substitution

PPh3 DCM/CCL4

Activator

8-F

Analog

Table 3 Continued: Nucleoside secondary amine formation. Analog is the name of the substituted product
referring to figure 3-0-3. Some yields are approximations based on NMR and in the event that no yield is given
isolated product was not obtained. Some isolated reactions or those for purely production purposes are excluded
from this table.

MesCl
MesCl
POCl3
PPh3 DCM/CCL4
BOP
MesCl
MesCl
MesCl

tCo
tCo
tCo
tCo
Tet
Tet
Tet
Tet
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MesCl
MesCl
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4
PPh3 DCM/CCL4

Tet
Tet
Tet
Tet
Tet
Tet
Tet
Tet
Tet
Tet

DCM

DCM

MesCl

Tet

DCM

DCM

DCM

DCM

CAN

ACN/PYR

DCM

DCM

DCM

MesCl

tCo

same

5 hrs

44

44

44

44

44

40

40

40

25mg

25mg

25mg

23 rt 500mg

9 300mg

3 192mg

2

4.5 150mg

7hrs

4
NA
NA
16
NA
13

4 hrs overnight rt 500mg
5g
3.3g

30 min at 0
17 min at 0

21 min at 0 500mg
0.4-0.5 at 0 500mg
15min at 0 500mg

5 hrs
6 hrs

15
0

5.5hrs

5 hrs

Yes
5 NA

19

52 Not

NA NA

1g

5hrs overnight rt

4hrs

RT overnight

RT overnight

RT overnight

RT overnight

RT overnight

days

rt 2 days 250 mg

at 0 500mg

61

76

2 hrs rt 850mg
rt 850mg

19

Yield MS

3hrs rt 850mg

Scale

25min overnight rt 200mg

RT overnight

rt

44

-10

rt overnight

rt overnight

Rt Overnight

Solvent Temperature Activation Substitution

Activator

Analog

Table 3 Continued: Nucleoside secondary amine formation. Analog is the name of the substituted product
referring to figure 3-0-3. Some yields are approximations based on NMR and in the event that no yield is given
isolated product was not obtained. Some isolated reactions or those for purely production purposes are excluded
from this table.

PPh3 DCM/CCL4

tet

POCl3

PPh3 DCM/CCL4

tet

triazole

PPh3 DCM/CCL4

Tet

CAN

CAN

PPh3 DCM/CCL4

Tet

PYBOP

PPh3 DCM/CCL4

Tet

Tet

PPh3 DCM/CCL4

Tet

44
8
25

15min at 0 500mg
15min at 0 500mg
14min at 0 500mg

5 hrs
4.5 hrs

106

60

1hr rt

80 ovrnt

60 ovrnt

8 hrs at 40

50 2.5 hrs

same Overnight 40 250mg
NA

26

32

15min at 0 500mg

5.5hrs

5hrs

500mg

9

15min at 0 500mg

Yield MS
19

Scale

15min at 0 500mg

4 hrs

0 30min at 0

40

44

44

44

44

44

44

44

Solvent Temperature Activation Substitution

PPh3 DCM/CCL4

Activation

Tet

Analog

Table 3 Continued: Nucleoside secondary amine formation. Analog is the name of the substituted product
referring to figure 3-0-3. Some yields are approximations based on NMR and in the event that no yield is given
isolated product was not obtained. Some isolated reactions or those for purely production purposes are excluded
from this table.

Figure 3-0-3: Secondary amines of substituted tCo. Intermediates synthesized en route to the corresponding
substituted tricyclic cytosine. R is an acetyl group prior to deprotection and then a hydrogen.

Initial attempts to make the tetracyclic secondary amine through the use of the
established tCo procedure with aminonaphthol did not result in the formation of the
desired product. Use of 2-mesitylenesulfonyl chloride to activate the carbonyl, followed
by substitution with aminonaphthol in the presence of DBU, resulted initially in the
appearance of potential secondary amine as shown by thin layer chromatography.
Evidence of a promising new compound was also present in proton NMR of the crude
reaction mixture. However, following purification aminonaphthol was the major
compound recovered. Repeating the reaction under the same conditions but modifying
the mobile phase of purification resulted in the recovery of a mixture that resembled that
of the crude reaction, so deamination as a result of purification had been avoided. Mass
spectroscopy of this crude mixture could not confirm the presence of the desired
secondary amine. The mixture was subjected to the standard deprotection conditions
discussed above (sodium methoxide in methanol), to attempt to make isolation easier.
The product from this reaction was utilized as a TLC standard for scale up of the
reaction. On a larger scale the same crude mixture was produced, but following the
deprotection conditions the apparent product remained prohibitively difficult to isolate.
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Decreasing the reaction time between the sulfonylmesitylene-bromouridine intermediate
and the aminonaphthol, as was shown to improve yield with the parent compound, did
not result in an increase in the recovered tetCo secondary amine. Utilizing purification by
preparatory thin layer chromatography it was possible to confirm the presence of the
desired product by mass spectroscopy, even though it remained contaminated by the
starting materials. Subjecting a larger scale reaction to these purification conditions and
then removing the protecting groups resulted in the recovery of a larger amount of the

Figure 3-0-4: Appel nucleoside synthesis. Alternative secondary amine formation conditions found to
be applicable to synthesis with all the substituted aminophenols in this work.

desired compound, but it remained contaminated with 5-bromo-2’-deoxyuridine.
Due to these isolation and low yield issues, an alternative method for activation of
the C4 carbonyl to substitution by the amine of aminonaphthol was investigated. Using
the Appel conditions it was possible to recover the desired product as a mixture with
triphenyl phosphine oxide. Deprotection of this product followed by purification lead to
the removal of triphenyl phosphine oxide, but the desired product was contaminated with
5-bromo-2’-deoxyuridine. Increasing the scale of the reaction in an effort to have as
much product to carry further as possible, resulted in a counterproductive decrease in
yield of the desired product. Returning to the original scale and altering the
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chromatographic mobile phase from ethyl acetate/methanol to cyclohexanes/ethyl acetate
resulted in some product as well as some potentially partially deprotected product.
Following subjection of the entire mixture to deprotection, a modest yield of isolated
tetCo secondary amine was obtained.
Believing that the conditions had been reasonably improved, scale up was again
attempted considering cyclohexanes/ethyl acetate chromatographic mobile phase.
Following flash chromatography, the recovered mixture which contained the desired
product was triturated with ethanol. This trituration appeared to improve the purity of the
compound, but when the product of trituration was subjected to the deprotection
conditions deamination ensued. Purified, 5-bromo-2’-deoxyuridine was all that was
recovered from chromatography of the deprotection reaction mixture. Reducing the scale
slightly led to the same results following deprotection, even though the trituration was
avoided. The original 500 mg scale was therefore revisited. Decreasing the reaction time
and temperature between the 5-bromo-4-chloro-2’deoxy-uridine intermediate and the
aminonaphthol resulted in an increase in the product recovered following deprotection.
Changing the reaction time at this lower temperature had adverse effects on the
production of desired product.
The ideal reaction time for this second step of the synthesis was determined to be
15 minutes. Altering the time of activation of the 5-bromo-2’-deoxyuridine with the
triphenyl phosphine also showed some influence on the recoverable amount of the
product, with the ideal reaction time at 44 degrees appearing to be 5 hours.
Chromatographic conditions were optimized with a selected mobile phase of
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dichloromethane and methanol that produces a mixture of desired product with triphenyl
phosphine oxide. This mixture is resolvable chromatographically following deacetylation.
Following deprotection, multiple purifications can be necessary to remove 5-bromo-2’deoxy-uradine which is either the result of: some deamination during the deprotection
conditions, some unreacted 3’,5’-diacetyl-5-bromo-2’-deoxyuridine which was carried
through from the previous synthetic step and then deprotected, or a combination of both
of these.
Although the improvement of yield was significant for these conditions over those
for the synthesis of the parent compound some alternatives were also tried. BOP and
PYBOP which are commonly used for peptide coupling were tested for utility as
activators for substitution. These do not react with amines, which could cut down on
possible fruitless side reactions.107 Although proton NMR showed some evidence of
product formation there was no product recovered following deprotection in either of
these experiments. Following the BOP reaction it was possible to recover the unreacted
starting materials indicating that little reaction was taking place or deamination was
rampant.
To synthesize the secondary amine of 7-Cl-tCo, 5-chloro-2-aminophenol was
substituted for aminophenol in the conditions for the synthesis of tCo (figure 3-0-3).
Activation with the 2-mesitylenesulfonyl chloride followed by addition of the
chloroaminophenol resulted in a mixture of many products. This mixture was purified by
flash silica gel chromatography followed by preparative thin layer chromatography. A
mixture of one potential product and 3’,5’-diacetyl-5-bromo-2’-deoxyuridine remained.
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Sending this mixture for mass spectroscopy resulted in detection of the molecular ion for
the desired secondary amine product. Extending the reaction times for activation and
substitution with these conditions resulted in a more complex mixture that contained a

Figure 3-0-5: Phosphorous oxychloride nucleoside synthesis. Alternative conditions for the synthesis of
substituted secondary amines that were successful for synthesis with chloro-aminophenols.

similar amount of the product.
Attempting the phosphorous oxychloride conditions previously discussed resulted
in a product that appeared different by proton NMR than that isolated under the parent
compound conditions, but had the same mass as confirmed by mass spectroscopy (figure
3-0-5). Under these conditions, the product was produced in a similarly small yield as
that recovered from the other conditions above. Scaling up this reaction, it was possible
to isolate 40mg of product and recover a large amount of product that was a mixture with
3’,5’-diacetyl-5-bromo-2’-deoxyuridine. Deprotection of this mixture resulted in desired
product in high yield.
The Appel chemistry was also attempted on the 500 mg scale which was useful in
the synthesis of tetCo secondary amine. These conditions resulted in the apparent product
by proton NMR, but mass spectral analysis of the compound showed high molecular
weight adducts that lacked the expected bromine isotope peaks. At a later date, the
reaction was retried with activation at a higher temperature for a longer period of time,
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followed by substitution at a lower temperature for a shorter stint. This resulted in a
mixture of triphenyl phosphine oxide and apparent product that was subjected to
deprotection conditions. Following this cleavage reaction it was possible to recrystallize
the desired product from ethanol. This ethanol recrystallization was applied to the
protected secondary amine following chromatography and appeared to clean up the
product slightly. It is possible to create a large amount of secondary amine through the
use of a multiple batch system where no reaction has more than 500mg of starting
material. These batches can be combined for purification. With the batch system and the
optimized chromatography conditions, discussed for other analogs above, it is possible to
recover mixtures of triphenyl phosphine oxide and product. These compounds can be
separated following the removal of the acyl groups from the 3’ and 5’ positions of the
secondary amine. Whether in a two batch or a four batch system the yields are
comparable. Decreasing the reaction time of the 5-bromo-4-chloro-2’deoxy-uridine
intermediate and chloro-aminophenol from fifteen minutes to ten minutes increased the
recovery of the desired product. Decreasing the reaction time for the activation of the
carbonyl did not result in the same positive effect, and the previously selected 5 hour
reaction time was maintained.
Synthesis of the secondary amine sister analog where the chlorine substituent is
located in the neighboring position was a more challenging endeavor. 8-Cl-tCo was
attempted using the tCo parent compound synthetic route as a starting point (figures 3-06, 3-0-3). A small scale test reaction resulted in a crude mixture that did not appear to
contain any of the secondary amine. On a larger scale it was possible to see the
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appearance of potential product by thin layer chromatography in the course of the
reaction and in the crude material by proton NMR. Unfortunately, following
chromatography is was not possible to recover the product that had appeared.
Switching to the Appel activation method at 44 degrees followed by substitution
at 0 degrees did not result in the appearance of any secondary amine product by thin layer
chromatography (figure 3-0-4). The temperature was maintained at 44 degrees for the
substitution and this resulted in the recovery of a mixture of product and 3’, 5’-diacetyl5-bromouridine. Following multiple attempts at purification, the mixture remained with
mostly unchanged composition. This mixture was subjected to the standard deacetylation
conditions, resulting in the removal of only one of the ester groups, necessitating a
repetition of deprotection. With substitution taking place at the same temperature, an
attempt was made to hurry carbonyl activation. This decrease in first step reaction time
did not result in an increase in the product recovered, but upon the change to the
optimized chromatography conditions discussed above, secondary amine recovery was
increased. Decreases in the substitution reaction time from one day to one hour and then
from one hour to fifteen minutes resulted in corresponding increases in product yield.
Mass spectroscopy confirmation of the product was made from a four batch reaction in
which activation was 5 hours and substitution 15 minutes at 44 degrees after adding
chloroaminophenol mixture at 0 degrees.
A substituent in the same position with similar character was different enough to
change the overall reactivity under these conditions. 8-F-tCo was the first new analog
synthesized because it was the easiest to access through the parent analog synthesis
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conditions (figure 3-0-6). A small scale test of the synthesis of the secondary amine
resulted in the recovery of a complex mixture even following purification. Still, this
mixture gave evidence that it may have contained some of the product. Scaling up under
these conditions led to the isolation of some apparent product following purification.
After subjecting this product to the deprotection conditions, any product had been
deaminated and 5-bromo-2’-deoxyuridine was all that remained. Further increasing the
scale of the reactants and shortening the time of substitution between the sulfonylatedbromouridine intermediate and the aminophenol resulted in product that could be isolated
following deprotection. Mass spectroscopy confirmed that this isolated compound was
indeed the desired product. Continued increase in scale resulted in apparently increasing
yield of the secondary amine, but either the product was impure or was being deaminated
during the deprotection conditions. Yields of the 3’ and 5’ hydroxyl secondary amine
product were unusually low considering the apparent protected product that was being
deprotected.

Figure 3-0-6: Sulfination synthesis of nucleoside analogs. Literature synthetic method for formation of
secondary amines that was useful in synthesis with flour-aminophenol.

Initially the Appel conditions seemed to be a less effective route to the synthesis
of 8-F-tCo secondary amine, as there was not a great deal of product produced and it was
present as a mixture with a large amount of triphenylphosphine oxide (figure 3-0-4).
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After extensive testing of conditions it was determined that the Appel chemistry could be
higher yielding. Activation for five hours at 44 degrees and substitution at 0 degrees for
15 minutes gave a mixture of product and triphenylphosphine oxide. This mixture did not
appear as sensitive to deamination during purification and/or under deprotection
conditions. Substitution for a shorter amount of time resulted in a decrease in the yield of
the desired product.
The related analog which has a methoxy functional group in the place of the
fluorine had mass spectral confirmation of the desired secondary amine intermediate
upon the first synthetic attempt. Reactions were made in parallel to compare the synthesis
of 8-OMe-tCo under the Appel conditions and by the parent compound synthetic method
(figure 3-0-6, 3-0-4). Both of these reactions resulted in the desired product, with the
greater yield coming from the triphenyl phosphine reaction and the product of greater
purity being isolable from the sulfonylating procedure. The product from the former was
a mixture with a minor amount of triphenyl phosphine oxide and a large amount of
unreacted methoxy-aminophenol. Deprotection of this mixture followed by purification
gave the compound in fair yield. Scale up of this reaction, as was seen with the other
analogs under these conditions, resulted in a significant decrease in yield. Using a batch
method instead (a set of smaller scale reactions run in parallel), it was possible to
synthesize hundreds of milligrams of secondary amine intermediate that could be isolated
following deacetylation. To ensure that the maximum performance of these conditions
was being observed, the reaction time for carbonyl activation was increased and the time
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for substitution was decreased. These measures resulted in a decrease in the yield of the
desired product, and so were discarded.
In one instance under these conditions, the protecting groups were lost from the
carbohydrate moiety and this resulted in a significant decrease in the yield of the desired
product. The protecting groups are likely preventing unwanted side reactions in both the
activation and the substitution steps of secondary amine synthesis. With substitution at
lower temperature the reaction was again tested for performance on a larger scale but this
was unsuccessful. Combining the batch method with low temperature substitution it was
possible to obtain pure product following deprotection in good yield.

Figure 3-0-7: Active DMSO for secondary amine formation. Alternative conditions for the synthesis
for substituted secondary amines that were not successful in activating 5-bromouradine to
substitution.

As a check, the phosphorous oxychloride conditions were tried with the
methoxy-aminophenol, although a large number of new compounds appeared to be
produced during the reaction, there was no desired product isolated following
purification. Another interesting procedure that was tried with this analog was the
activation of the carbonyl for substitution using NCS and DMS. “Active DMSO” like
that seen in Corey-Kim oxidation is formed when the sulfur of DMS abstracts the
chlorine from NCS (figure 3-0-7). The nitrogen anion substitutes for the chlorine at
sulfur, and this sulfur cation is activated to attack by the C4 carbonyl oxygen to release
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the succinimide. The succinimide can find a hydrogen from the N3 nitrogen. The
aminophenol is then added to substitute at C4 and release DMSO. There was no
substitution observed under these conditions.
When the methoxy substituent is located in the neighboring position to this analog
(synthesis of 7-OMe-tCo), so that the functionality is electron donating by resonance
through its position para to the amine of the aminophenol, it is a brilliant purple color
and significantly more expensive. Due to the expense of this starting material, and its
more limited commercially availability, its synthesis required less procedural
optimization. The majority of the challenges had already been solved the synthesis of
related compounds. Smaller scales were used for the synthesis of this analog, as a result
of the aforementioned starting material availability. The first attempted synthesis of 7OMe-tCo was under the Appel conditions on a fairly small scale. The desired secondary
amine product appeared to be isolated in a semi-crude state following chromatography of
the reaction mixture. Attempting to repurify this semi-pure mixture resulted in recovery
of a small amount of product the identity of which could not be confirmed. A larger scale
reaction using the established multiple batch system (as used for other substituted tCo
analogs) was successful in producing a mixture of the product with 3’,5’-diacetyl-5bromo-2’-deoxy-uridine and triphenylphosphine oxide. Following removal of the acetyl
groups and multiple purifications it was possible to remove the triphenylphosphine oxide
from this mixture. Further optimization resulted in a slight decrease in the time allowed
for substitution of the methoxyaminophenol at the 3’5’diacetyl-5-bromo-4-chloro2’deoxy-uridine intermediate. The multiple batch system was applied with these
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optimized conditions to accumulate enough of this intermediate to proceed to the closure
of the center ring and establishment of the chromophore. The mass of the product was
confirmed following deprotection of the mixture from a two-batch reaction. One
interesting approach that was attempted with this aminophenol was the attempted use of
triphenyl phosphine oxide in the place of the triphenyl phosphine under the Appel
conditions. Although there was evidence of a small amount of substitution, deprotection
of this product resulted in deamination and deglycosylation.

Figure 3-0-8: Silylation for triazole formation. Alternative protecting group was used for protection of 3’ and
5’ hydroxyls of 5-bromouradine to overcome solubility issues in synthesis of highly reactive triazole
intermediate. This intermediate is desirable for reaction with substituted aminophenols to create secondary
amines.

Not unlike the synthesis of the nucleobase analogs of tCo, a triazole intermediate

of the nucleoside was targeted for synthesis, rationalized by its likely high reactivity to
substitution (figure 3-0-8). After adding the phosphorous oxychloride and triethylamine
to the reaction of triazole and 3’,5’-diacetyl-5-bromo-4-chloro-2’-deoxyuridine and
warming from 0 oC to room temperature there was no reaction. Heating the reaction to
40, 60 or even 80 oC could not cause reaction of the starting material. Changing the
solvent from acetonitrile to trimethylphosphate was done to see if the slight decrease in
polarity would increase solubility. This resulted in the appearance of reaction products
by thin layer chromatography. Unfortunately, the apparent product could not be isolated
from the trimethylphosphate using chromatography.
118

To investigate whether the literature protection groups would overcome the lack
of reactivity of the starting material to the triazole, a silyl protection of 5-bromo-2’deoxyuridine was made (figure 3-0-8). The di-tertbutyl silyl was attached through the
combination of the silyl triflate with 5-bromo-2’-deoxyuridine and imidazole in DMF.108
The triflate leaving group was easily substituted by imidazole forming the reactive N-tertditertbutylsilyl imidazole silylating reagent. This activated reagent silylated the 5’
hydroxyl and the imidazole deprotonated the oxygen. The second silylation happens at
the neighboring hydroxyl of the nucleoside by the same method. This silylated nucleoside
was subjected to the above conditions for triazole activation and again no reaction was

Figure 3-0-9: Nucleosides. Substituted oxygen tricyclic cytosine analogs synthesized in this work.

observed even upon heating.
Even without this more reactive intermediate, it was possible to accumulate
enough of the deprotected secondary amines of these substituted oxygen tricyclic
cytosine compounds to perform the ring closure step to complete the substituted
nucleosides (figure 3-0-1). The secondary amine of tCo was reacted using the literature
method for synthesis and this resulted in the desired fluorescent product, but in low yield.
The 5’ hydroxyl oxygen provided assistance via attack at the C6 carbon for the leaving of
the bromine at the C5 carbon (figure 3-0-9). Fluorine anions are better leaving groups and
may take the place of bromine at the C5 position, and then are substituted for by the 2119

Figure 3-0-11: Ring closure of tCo nucleosides. Assistance of 5' OH is implicated in the proposed mechanism.
Conditions shown are the optimized reagents selected for tolerance of the variety of R groups in this work.

hydroxyl oxygen, closing the second ring and creating the conjugated chromophore.109
Deprotonation of the ring oxygen and reprotonation of the carbohydrate hydroxyl gives
the final product.
18-crown-6 ether was added with the starting material under these reaction
conditions to increase the dissociation of potassium from the fluoride anions, and this
resulted in an apparent increase in yield in a shorter reaction time, but this may have been
due to the much smaller scale of the test reaction. Changing the solvent of the reaction
from ethanol to diglyme and increasing the temperature led to the conversion of starting
material within a few minutes. After purification the yield of the desired compound was
low and so the literature method was reconsidered. Yields of around 50% eventually
resulted by combining the literature reaction conditions with the laboratory purification
conditions discussed below. This was an effective combination for accumulation of

Figure 3-0-10: Diol chromatography media. Stationary phase used in place of normal silica gel for the
purification of nucleosides.
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enough compound for further studies to be conducted.
Because of the greater success in the secondary amine formation when using
fluoro-aminophenol, the first substituted nucleoside that was synthesized was the 8-F-tCo.
Refluxing in ethanol with potassium fluoride and purification via preparatory thin layer
chromatography resulted in a fluorescent compound that was confirmed to have the
desired mass spectroscopically. Scaling up required longer reaction times even at the
same concentration and made purification more difficult. Complete loss of compound and
deglycosylation were some of the issues encountered during purification via flash silica
gel chromatography. Preparatory thin layer chromatography was not a reasonable means
by which to isolate a meaningful amount of compound, so different stationary phases
were investigated in the laboratory as will be discussed below. Ultimately a diol media
was found to be an efficient way to purify the reaction mixture.110 This media has an
ether chain immobilized on the silica which terminates with a secondary and primary
alcohol (figure 3-0-11). Using this less polar stationary phase it is possible to recover
more material while removing undesirable impurities. Using diglyme as the solvent and
heating the starting material to 120 oC with potassium fluoride and 18-crown-6 affords
the desired product in under an hour in reasonable yields.
After the fluorine substituted nucleoside analog was synthesized, it was confirmed
that the same conditions could be used to form the tetracyclic tetCo. Purification being an
issue at this time, normal phase HPLC was attempted. Method development with
cyclohexanes and ethyl acetate was attempted, but the desired product remained difficult
to isolate. Preparatory thin layer chromatography was used to develop a standard for
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synthesis of the product that was confirmed by mass spectroscopy. Eventually using flash
chromatography (diol media and dichloromethane/methanol mobile phase) the product
could be recovered and the desired mass confirmed spectroscopically. The following is a
table (table 4) of the various reaction conditions used for the ring closure of substituted
and unsubstituted oxygen tricyclic cytidine analogs.
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KF 18crown6

KF 18crown6

KF 18crown6

7-Cl

7-Cl

7-Cl

CsF

CsF

7-Cl

7-Ome

CsF

NA

NA

NA

NA

NA

NA

7-Cl

NA

NA

CsF

CsF

7-Cl

NA

7-Cl

CsF

7-Cl

NA

CsF

CsF

7-Cl

NA

7-Cl

CsF

7-Cl

NA

CsF

CsF

7-Cl

NA

7-Cl

CsF

7-Cl

NA

CsF

KF

7-Cl

NA

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

Additive Equivalents

7-Cl

KF

7-Cl

Analog Fluoride

10mg

48mg

45mg

50mg

40mg

79mg

NMP

10mg

diglyme 904mg

diglyme

diglyme 200mg

NMP 100mg

NMP 150mg

NMP 200mg

diglyme

NMP 150mg

DMF

DMF

DMF 100mg

DMF 100mg

NMP 100mg

NMP 100mg

NMP

EtOH

120

120

120

120

120

120

120

120

120

100

100

100

100

120

120

120

85

80

35min

35min

25min

8hrs

43min

1.5hrs

45min

45min

30min

31min

23min

3days

3days

Time

25mg/ml

100mg/ml

23min

30min

40mg/ml 100min

40mg/ml

40mg/ml

40mg/ml

40mg/ml

31mg/ml

30mg/mL

18mg/ml

20mg/mL

20mg/mL

20mg/mL

167mg/ml

200mg/ml

25mg/ml

10mg/ml

8.75mg/ml

Scale Temperature Concentration

EtOH 175MG

Solvent

75

24

3.40

NA

14

37

<9

NA

NA

Not P

22

1.20

7

8

messy

26

NA

deamination

Yield MS

Table 4: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure 3-0-9.
Some yields are approximations based on NMR and in the event that no yield is given isolated product was not
obtained. Some isolated reactions or those for purely production purposes are excluded from this table.

CsF

CsF

CsF

CsF

CsF

KF 18crown6

KF 18crown6

7-Ome

7-Ome

7-Ome

7-Ome

7-Ome

7-Ome

7-Ome
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CsF

CsF

CsF

CsF

CsF

CsF

8-Cl

8-Cl

8-Cl

8-Cl

8-Cl

8-Cl

KF 18crown6

7-Ome

NA

NA

NA

NA

NA

NA

NA

KF 18crown6

7-Ome

KF

KF 18crown6

7-Ome

8-Cl

KF 18crown6

7-Ome

NA

NA

NA

NA

NA

NA

CsF

7-Ome

NA

CsF

10

10

10

10

10

10

10

5

10

10

10

10

10

10

10

10

10

10

10

10

Additive Equivalents

7-Ome

Analog Fluoride

30mg

10mg

25mg

40mg

45mg

10mg

40mg

90mg

10mg

63mg

50mg

10mg

diglyme 12.5mg

NMP

NMP

NMP

NMP

DMF 521mg

EtOH

diglyme 252mg

diglyme 150mg

diglyme

diglyme 100mg

diglyme 200mg

diglyme 130mg

DMF

NMP

NMP

120

120

120

120

120

100

85

120

120

120

120

120

120

120

120

120

120

120

120

100

30mg/mL

25mg/ml

31mg/ml

31mg/ml

25mg/ml

208mg/ml

10mg/ml

252mg/ml

50mg/ml

100mg/ml

40mg/ml

18

NA

11

50

44
NA

1.2 hr
2.1 hr

25

8

1.1 hr

8hrs

NA

deamination
1hr

1hr

3days Lost on column

20min

15min

1.2hr

30min

75

1.7 hr
40mg/ml

11

40mg/ml 1.75 hr

15

14

NA

NA

NA

NA

Yield MS

10

40min

25min

25min

27min

23min

18min

Time

30min

40mg/ml

30mg/ml

25mg/ml

24mg/ml

25mg/ml

25mg/ml

50mg/ml

Scale Temperature Concentration

NMP 2.4mg

NMP

NMP

DMF

Solvent

Table 4 Continued: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure
3-0-9. Some yields are approximations based on NMR and in the event that no yield is given isolated product
was not obtained. Some isolated reactions or those for purely production purposes are excluded from this table.

CsF

CsF

KF 18crown6

KF 18crown6

KF 18crown6

KF 18crown6

KF 18crown6

8-Cl

8-Cl

8-Cl

8-Cl

8-Cl

8-cl

8-Cl
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KF 18crown6

8-F

KF

KF 18crown6

8-F

8-Ome

KF 18crown6

8-F

KF

KF

8-F

8-Ome

KF

8-F

KF

KF

8-F

8-Ome

KF 18crown6

8-Cl

NA

NA

NA

NA

NA

NA

KF 18crown6

8-Cl

NA

NA

NA

CsF

8-Cl

NA

CsF

10

10

10

10

10

10

10

10

10

5

5

10

10

10

10

10

10

10

10

10

Additive Equivalents

8-Cl

Analog Fluoride

2.4g

39mg

5mg

42mg

28mg

73mg

EtOH 390mg

EtOH

EtOH

diglyme

diglyme 150mg

diglyme 100mg

EtOH 100mg

EtOH

EtOH

diglyme 753mg

diglyme

diglyme 500mg

diglyme 603mg

diglyme 200mg

diglyme 100mg

diglyme 273mg

NMP 200mg

NMP 200mg

diglyme 150mg

80

80

80

120

120

120

80

80

80

120

120

120

120

120

120

120

120

120

120

120

24

1.1 hr

39mg/ml

10mg/ml

9mg/ml

73mg/ml

3days

3days

3days

1hr

<2.4 Yes

NA NA

13

<5

11

30mg/mL 40 min

NA

0 NA

25 Yes

<29

22

3days

3days

26hrs

30min

18

12%

1.1 hr

30min

messy

8

19

1

1hr

1.2 hr

50min

2hrs

75

5 hrs
4

65

Yield MS

1 hr

Time

35min

20mg/mL

10mg/ml

4mg/ml

5mg/ml

251mg/ml

267mg.ml

125mg/ml

121mg/ml

100mg/ml

67mg/ml

55mg/ml

40mg/ml

40mg/ml

30mg/mL

30mg/mL

Scale Temperature Concentration

NMP 150mg

Solvent

Table 4 Continued: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure
3-0-9. Some yields are approximations based on NMR and in the event that no yield is given isolated product
was not obtained. Some isolated reactions or those for purely production purposes are excluded from this table.

CsF

CsF

CsF

CsF

CsF

CsF

CsF

8-Ome

8-Ome

8-Ome

8-Ome

8-Ome

8-Ome

8-Ome

AgBF4

8-Ome

CsF

AgBF4

8-Ome

8-Ome

AgBF4

8-Ome

CsF

CsF

8-Ome

8-Ome

CsF

8-Ome

CsF

CsF

8-Ome

8-Ome

KF

8-Ome

AgBF4

KF

8-Ome

8-Ome

KF

8-Ome

Analog Fluoride
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NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

sieves

NA

NA

NA

NA

NA

NA

NA

NA

EtOH

EtOH

EtOH

EtOH

10

10

10

10

10

10

10

10

10

10

2

1

1

10mg

10mg

15mg

15mg

15mg

50mg

NMP

NMP

NMP

NMP

50mg

40mg

10mg

10mg

DMF 100mg

DMF

NMP 100mg

NMP 100mg

NMP

dioxane

EtOH

EtOH

EtOH

85

85

85

85

85

120

120

120

120

100

100

120

120

120

85

85

85

85

15mg Rt 24, et3N 85

15mg

25mg

50mg

40mg

EtOH 100mg

80

2days

1day

3days

3days

3days

Time

25mg/ml

25mg/ml

25mg/ml

25mg/ml

20mg/mL

20mg/mL

143mg/ml

100mg/ml

25mg/ml

25mg/ml

37mg/ml

21mg/ml

21mg/ml

30min

15min

15min

15min

45min

30min

32min

17min

1day

ovrnt

1day
ethanol
21mg/ml added

37mg/ml

19mg/ml

20mg/mL

10mg/ml

10mg/ml

10mg/ml

Scale Temperature Concentration

EtOH 136mg

Solvent

1 DCE/EtOH

10

10

10

10

10

10

Additive Equivalents

12

20

11

NA

21

3

7

NA

5%

No P

NA

NA

NA

NA

1%

NA

NA

NA

NA

1%

Yield MS

Table 4 Continued: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure
3-0-9. Some yields are approximations based on NMR and in the event that no yield is given isolated product
was not obtained. Some isolated reactions or those for purely production purposes are excluded from this table

CsF

CsF

CsF

KF 18crown6

KF 18crown6

KF 18crown6

KF 18crown6

8-Ome

8-Ome

8-Ome

8-Ome

8-Ome

8-Ome

8-Ome
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KF

KF

KF

tCo

Tet

Tet

NA

NA

KF 18crown6

tCo

KF 18crown6

8-Ome

KF 18crown6

KF 18crown6

8-Ome

tCo

KF 18crown6

8-Ome

KF

KF 18crown6

8-Ome

tCo

KF 18crown6

8-Ome

NA

NA

NA

NA

CsF

8-Ome

NA

CsF

10

10

10

10

10

10

5

10

10

10

10

10

10

10

10

10

10

10

10

10

Additive Equivalents

8-Ome

Analog Fluoride

50mg

10mg

30mg

30mg

EtOH

EtOH

90mg

25mg

EtOH 653mg

diglyme

EtOH

EtOH 300mg

diglyme 750mg

diglyme 500mg

diglyme 200mg

diglyme 200mg

diglyme 200mg

diglyme 100mg

diglyme 300mg

diglyme 100mg

diglyme 200mg

NMP 200mg

NMP 150mg

NMP

NMP

80

80

9mg/ml

10mg/ml

50mg/ml

20mg/mL

90then 120
95

20mg/mL

20mg/mL

251mg/ml

125mg/ml

100mg/ml

100mg/ml

100mg/ml

100mg/ml

60mg/ml

40mg/ml

40mg/ml

40mg/ml

25mg/ml

50mg/ml

25mg/ml

25mg/ml

90

85

120

120

120

120

120

120

120

120

120

120

120

120

120

120

Scale Temperature Concentration

NMP 200mg

Solvent

3days

4days

8 Yes

NA Not

50.3

3 days

Combined

2 days

36

12

3 days

10min

NA

20

NA

7

1

NA

3

10

27

1

21

11

NA

NA

Yield MS

30min

1hr

1hr

1hr

1hr

1.3hr

1.3hr

1hr

25min

42min

1hr

30min

Time

Table 4 Continued: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure
3-0-9. Some yields are approximations based on NMR and in the event that no yield is given isolated product
was not obtained. Some isolated reactions or those for purely production purposes are excluded from this table
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CsF

CsF

KF 18crown6

KF 18crown6

KF 18crown6

KF 18crown6

Tet

Tet

Tet

Tet

Tet

Tet

NA

NA

NA

NA

NA

NA

CsF

NA

NA

Tet

CsF

Tet

NA

CsF

CsF

Tet

NA

Tet

CsF

Tet

NA

CsF

CsF

Tet

NA

Tet

KF

Tet

NA

CsF

CsF

Tet

NA

Tet

KF

Tet

NA

CsF

KF

Tet

NA

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

10

Additive Equivalents

Tet

KF

Tet

Analog Fluoride

40mg

33mg

50mg

10mg

50mg

50mg

40mg

10mg

10mg

90mg

71mg

72mg

diglyme 100mg

diglyme 200mg

diglyme

diglyme 100mg

NMP 100mg

NMP

NMP 100mg

NMP

NMP

NMP

NMP

NMP

NMP 100mg

NMP

dioxane

EtOH 377mg

120

120

120

120

120

120

120

120

120

120

120

120

120

120

85

85

90

85

80

80

40mg/ml

40mg/ml

29mg/ml

20mg/mL

40mg/ml

28mg/ml

25mg/ml

25mg/ml

25mg/ml

25mg/ml

25mg/ml

164mg/ml

100mg/ml

25mg/ml

50mg/ml

47mg/ml

50-17mg/mL

10mg/ml

10mg/ml

10mg/ml

Scale Temperature Concentration

EtOH 350mg

EtOH

EtOH

EtOH

Solvent

31

32

ww

23

38 Yes

Yield MS

50min

1hr

NA

71

8

52

<8

1.2 hr
37min

6

NA

NA

3

27

ww

deamination

42min

15min

43min

43min

40min

35min

34min

Ugly
Product w/NMP
35min
38%
and SM+
deamination

2days

2days

3days

3days

3days

Time

Table 4 Continued: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure
3-0-9. Some yields are approximations based on NMR and in the event that no yield is given isolated product
was not obtained. Some isolated reactions or those for purely production purposes are excluded from this table

3
44min
40mg/ml
120
10
KF 18crown6

diglyme 200mg

70
45min
154mg/ml
129
5
KF 18crown6
Tet

diglyme 309mg

31
20min
83mg/ml
120
83mg
diglyme
KF 18crown6
Tet

5

NA
2.5hrs
70mg/ml
91
diglyme 140mg
10
KF 18crown6
Tet

Analog Fluoride

Additive Equivalents

Solvent

Scale Temperature Concentration

Time

Yield MS

Table 4 Continued: Ring closure of nucleosides. Analog is the name of the substituted product referring to figure
3-0-9. Some yields are approximations based on NMR and in the event that no yield is given isolated product
was not obtained. Some isolated reactions or those for purely production purposes are excluded from this table
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Using cesium fluoride as the fluorine source gave similar yields to the reactions
with potassium fluoride, but scaling up required multiple rounds of purification due to the
large amount of insolubles produced in the reaction. Using this more dissociative fluoride
source in dioxane resulted in a complex mixture even after column chromatography.
Dioxane is not only a solvent that allows the reaction to be done at higher temperatures,
but it also is less likely to solvate the ions necessary for the reaction. NMP was suggested
by Dr. Stephen Buchwald in a personal communication regarding amination as a solvent
for similar reasons. Ring closure was attempted in these solvents at higher temperature.
Reaction at 120 oC gave the desired product, but it was difficult to remove the NMP and
there was evidence of some deamination under these conditions. Additionally, scaling up
the starting materials reacted under these conditions resulted in significant decreases in
yield. Eventually 18-crown-6 in combination with potassium fluoride in ethanol were
selected as the best reaction conditions followed by flash chromatography on a diol
column to give yields up to 70% for the desired tetracyclic fluorescent nucleoside analog.
18-crown-6 is used to capture the potassium ions in solution to make the fluorine anion a
more “naked nucleophile.” In the absence of its counterion, it is more available to be an
intermediate for substitution.
Initial attempts to synthesize the 7-Cl-tCo secondary amine under the standard
literature conditions resulted in disappearance of the starting material, but this was due to
deamination not nucleophilic aromatic substitution. A less concentrated reaction on
smaller scale resulted in enough product that the desired mass could be confirmed by
mass spectroscopy. Attempting to scale up the dilute reaction resulted in a messy mixture
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of product and chloro-aminophenol, which again indicated deamination, so the switch
was made to NMP and cesium fluoride. Using evaporation under ambient conditions to
remove the NMP and then flash silica gel chromatography it was possible to isolate the
product in fair yield. This evaporation method was less applicable to larger scale
reactions, and this resulted in significantly decreased yields for isolable product. DMF
was tested for its greater volatility. Purification in the absence of the NMP was not a
significantly simpler task. Comparable yields to those from the literature methods were
seen with purification via alumina stationary phase following extraction of the crude
reaction material with methanol. Returning to the NMP as a reaction solvent because of
its assistance in the purification of the compounds, various combinations of evaporation
under ambient conditions and purification were attempted. Reactions were even
performed in one solvent and then crude mixtures dissolved in smaller quantities of the
reaction solvent or an alternative solvent for purification. The greatest success was
achieved by flash chromatography on a diol column followed by evaporation under
ambient conditions but this did not always result in the removal of the NMP. Ultimately
the 18-crown-6 addition to potassium fluoride in diglyme reaction conditions were
selected. Using a column with the diol stationary phase for purification followed by hot
trituration with a 1:1 mixture of ethanol to water resulted in pure compound. This
trituration, although important to achieve high purity, results in the loss of a significant
amount of desired product. With the use of a well-conditioned diol column, trituration
could be avoided and the yields of 7-Cl-tCo greatly increased.
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The 8-Cl-tCo analog in which the chlorine is located at the neighboring position to
the analog discussed above was not isolable as the ring closed fluorophore from the
parent compound synthetic method. Initial evidence of potential product formation was
found by TLC. Following flash silica gel chromatography the initial compound
representing potential product was not isolated. Using Cesium fluoride in DMF resulted
in evidence of deamination of the starting material. In NMP at even greater temperature,
than reaction in alcohol or DMF, and using the same fluoride source the product was
produced in fair yield in about an hour. These conditions resulted in product that could be
confirmed by mass spectroscopy. Scaling up but maintaining the same concentration it
was possible to increase yield of the product, but purification required column
chromatography followed by watch-glass evaporation and then further column
chromatography. Greater yields were observed in diglyme at the same temperature as the
NMP but the purification remained an elaborate combination of chromatography and
trituration. The 18-crown-6 ether with potassium fluoride in diglyme conditions were
ultimately selected because the starting material concentration could be increased
significantly with little loss in reactivity or necessary increase in purification complexity.
When the substituent at this position meta to the second ring nitrogen was a
methoxy group instead of chlorine (8-OMe-tCo), it should have been electron donating to
the hydroxyl oxygen acting as a nucleophile in this reaction. The 8-OMe-tCo secondary
amine was subjected to the conditions discussed for the analogs above as well as some
unique reaction environments in attempts to create the fluorescent nucleoside product.
Confirmation of the desired mass of the product with mass spectroscopy was achieved
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through the examination of the product from the parent compound synthesis method of
refluxing in ethanol for three days. Only a portion of this product could be isolated and
purification at this stage via flash silica gel chromatography was highly unreliable. Using
cesium fluoride in ethanol with this secondary amine analog, an investigation was made
into the necessary quality of the solvent for the reaction. No significant difference in
reaction performance was seen with either the extra dry or the reagent grade ethanol, both
reactions had little product after refluxing 24 hours. A smaller amount of starting material
in greater concentration did lead to the desired product with the use of cesium fluoride in
refluxing ethanol.

Figure 3-0-12: Silver tetrafluoroborate ring closure. Alternative ion to the fluoride used in literature synthesis
of ring closed tricyclic cytosine analogs.

As with the nucleobase analogs, silver tetrafluoroborate with its weakly
coordinating anion was used as a substitute for potassium fluoride (figure 3-0-12). A
reaction initially attempted in dichloroethane at room temperature to which ethanol was
added and heat applied failed to result in reaction of the starting material. Beginning with
ethanol at 85 oC did not make a difference; there was no reaction under these conditions
either. Performing the reaction over molecular sieves to ensure that interference from
water was minimized was of no assistance, there continued to be no reaction of the
starting material. Adding an additional equivalent of the tetrafluoroborate salt was a last
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effort to encourage reaction under these conditions but the starting material remained
unreacted.
Cesium fluoride in dioxane resulted in no product formation but this fluoride
source in NMP was an effective means of synthesizing the desired 8-OMe-tCo on small
scale. In larger quantities, the removal of NMP was again a challenge. This challenge was
compounded by the tendency of the methoxy secondary amine to produce two fluorescent
products. This is possibly the result of anomeric isomerization, but the mass spectral
analysis of these two compounds was inconclusive. Switching the solvent to DMF
requires a decrease in the reaction temperature from 120 oC to 100 oC and this change
could be part of the reason that the reaction performance is decreased. Isolated amounts
from larger scale reactions were greater from reactions with DMF, but the better reaction
performance in NMP made it an attractive solvent to revisit. In one larger scale reaction,
calcium carbonate was added to clear away the fluorine ions that were hypothesized to be
the reason behind the difficulties in purification, but this did not improve isolation.
Multiple diol chromatographic exercises did result in the accumulation of some
fluorescent nucleoside. The 18-crown-6 ether conditions with potassium fluoride in
diglyme at 120 oC were selected for the synthesis of the product. In the likely event that
multiple chromatographic runs are necessary to purify the compound, evaporation onto
celite was shown to lead to greater recovery of product than using alumina to load
material for diol chromatography. Occasionally recrystallization from a 1:1 mixture of
ethanol and water is a useful purification method as well but the drawbacks of this
technique was described above.
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The methoxy secondary amine where the ether is in the electron withdrawing
position meta to this nucleophilic hydroxyl was not subjected to the ring closure
conditions of the parent compound, only under more optimized conditions due to its
general scarcity. On small scale a good yield of the 7-OMe-tCo fluorescent nucleoside
was achieved from the secondary amine with cesium fluoride in NMP. Larger scales with
which a mass spectroscopy sample could be afforded were not successful until the
solvent was changed from NMP to DMF. This material was stubbornly difficult to
isolate until the diol columns began to be used for purification In diglyme with 18-crown6 ether and potassium fluoride, the secondary amine of 7-OMe-tCo affords the greatest
amount of the desired product from reactions of the largest scale.
Individual reaction conditions may outperform those that have been selected for
the synthesis of these substituted tCos, but the conditions selected are the only ones that
are reliable for the production of the entire small library(figure 3-0-10). These conditions
made it possible to produce the compound for florescence investigation and for enzyme
tolerance studies as will be discussed in the remainder of the document. Hopefully an
improved synthetic route to these compounds will be one day developed.
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Oxygen Tricyclic Cytidine Analogs Experimental:

5-bromo-2’-deoxyuradine. 2’-deoxyuridine (500 mg, 2.19 mmol) was dissolved
in dry DMF (5 mL) under N2. 1,3-dibromo-5,5-dimethylhydantoin (345 mg, 1.21 mmol)
was added and the reaction stirred at room temperature. After 30 minutes the reaction
was evaporated and then co-evaporated with acetonitrile to give product (463 mg, 1.51
mmol) in 69% yield. 1HNMR ((CD3)2SO) δ 11.78-11.74 (m, 1H), 8.38(s, 1H), 6.10 (t,
J=6.5 Hz, 1H), 5.22 (d, J=4.4 Hz, 1H), 5.14(t, J=4.9 Hz, 1H), 4.28-4.20 (m, 1H), 3.80 (q,
J=3.3 Hz, 1H), 3.67-3.53 (m, 2H), 2.20-2.05 (m, 2H).

3’,5’-diacetyl-5-bromo-2’deoxyuradine. 2’-deoxy-5-bromouradine (463 mg, 1.51
mmol) was dissolved in pyridine (4.6 mL) under N2. Acetic anhydride (569 μL, 6.02
mmol) was added and the reaction maintained at room temperature. 18 hours later the
reaction was diluted with ethyl acetate (15 mL) washed with 0.121 M HCl (15 mL), dried
and evaporated. Purification via flash silica gel chromatography (CH3OH in CH2Cl2)
gave the product (500 mg, 1.28 mmol) in 85% yield. 1HNMR (CD3OD) δ 8.07(s, 1H),
6.25(dd, J=8.0, 5.9 Hz, 1H), 5.30 (dt, J=6.7, 2.4Hz, 1H), 4.45-4.40 (m, 1H), 4.37-4.32 (m,
2H), 2.52 (ddd, J=14.5, 6.0, 2.4 Hz, 1H), 2.42 (ddd, J=14.5, 8.1, 6.6Hz, 1H), (2.18 (s,
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3H), 2.12 (S, 3H).13CNMR ((CD3)2SO) 171.00, 170.94, 159.97, 150.61, 140.87, 97.21,
85.96, 82.42, 74.72, 64.50, 36.96, 21.69, 21.57.
General Procedures for formation of 3’,5’-diacetyl-5-bromo-N4-(2hydroxyphenyl)-2’deoxyxytidines.
Method A: 3’,5’-diacetyl-5-bromo-2’deoxyuradine (850 mg, 2.17 mmol) is
combined with 4-dimethylaminopyridine (13 mg, 0.106 mmol) under N2. This was
dissolved in dichloromethane (10 mL) and triethylamine (1.2 mL, 8.7 mmol) was added
followed by 2-mesitylenesulfonyl chloride (950 mg, 4.34 mmol) and the reaction stirred
at room temperature. After 19 hours, 1,8-diazabicycloundec-7-ene (650 μL, 4.35 mmol)
was added followed by aminophenol (4.35 mmol) and the reaction continued at room
temperature. After reaction appeared complete via thin layer chromatography, the
mixture was evaporated. The crude residue was suspended between ethyl acetate and
sodium bicarbonate, then organics were dried and evaporated. Purification via silica gel
flash chromatography (CH3OH in CH2Cl2) gives a semi-crude mixture that is subjected to
following reaction conditions.
Method B: N-methylimidazole (410 μL, 5.11 mmol) was dissolved in dry
acetonitrile (1.2 mL) under N2. After cooling in a calcium chloride ice bath, phosphorous
oxychloride (140 μL, 1.53 mmol) in dry acetonitrile (1.2 mL) was added to the reaction
dropwise. 3’,5’-diacetyl-5-bromo-2’deoxyuradine (200 mg, 0.511 mmol) which had been
evaporated two times from dry acetonitrile was added to the reaction in dry acetonitrile
(1.5 mL) and the reaction was warmed to room temperature. Aminophenol (5.11 mmol)
which had been evaporated from dry pyridine was added to the reaction in dry pyridine (2
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mL) after it had been at room temperature 15 minutes. Triethylamine (700 μL, 5.07
mmol) was added to the reaction and it was kept at room temperature then cooled to 5
degrees. Dilution with water and evaporation of the reaction mixture was followed by coevaporation with ethyl acetate. Residue dissolved in chloroform was washed with sodium
bicarbonate and then brine, dried and evaporated. Purification via flash silica gel
chromatography (EtOAc in Cyclohexanes) gives semicrude product used for further
synthetic application without further purification.
Method C: Dry carbon tetrachloride (4 mL) was mixed with dry dichloromethane
(4 mL) under N2. Triphenylphosphine (639 mg, 2.44 mmol) was added and the reaction
was stirred at room temperature 15 minutes until yellow in color. 3’,5’-diacetyl-5-bromo2’-deoxyuridine 4 (500 mg, 1.28 mmol) was added to the reaction which was then heated
to 44 °C. After 5 hours the reaction was cooled to room temperature and then to 0 °C. 2aminophenol (1.278 mmol) with DBU (190 μL, 1.278 mmol) in dry dichloromethane (1
ml) was added to the reaction and stirred at 0 °C until thin layer chromatography showed
deamination of the product. The reaction was evaporated and purified via flash
chromatography (CH3OH in CH2Cl2) to yield semi-crude product that was subjected to
the next synthetic sequence.
Method D: Dry carbon tetrachloride (4 mL) was dissolved in dry dichloromethane
(4 mL) under N2. Triphenylphosphine (639 mg, 2.44 mmol) was added and the reaction
was stirred at room temperature 15 minutes until yellow in color. 3’,5’-diacetyl-5-bromo2’-deoxyuridine 4 (500 mg, 1.28 mmol) was added to the reaction which was then heated
to 44°C. After 5 hours 2-aminophenol (1.278 mmol) with DBU (190 μL, 1.278 mmol) in
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dry dichloromethane (1 ml) was added to the reaction and stirred at 44 °C until thin layer
chromatography showed deamination of the product. The reaction was evaporated and
purified via flash chromatography (CH3OH in CH2Cl2) to yield semi-crude product that
was subjected to the next synthetic sequence.

3’,5’-diacetyl-5-bromo-N4-(2-hydroxyphenyl))-2’-deoxycytidine. Synthesized in
crude via methods A B and C from 2-aminophenol. 1H NMR ((CD3)2SO) δ 10.23 (s, 1H),
8.92 (s, 1H), 8.13 (dd, J=8.0, 1.6 Hz, 1H), 8.10 (s, 1H), 7.02 (ddd, J=8.8, 6.3, 1.6 Hz,
1H), 6.93 (dd, J=8.1, 1.5 Hz, 1H), 6.89 – 6.80 (m, 1H), 6.15 (dd, J=7.7, 6.3 Hz, 1H), 5.19
(dq, J=7.3, 4.3, 3.6 Hz, 1H), 4.29 (dd, J=4.6, 1.5 Hz, 2H), 4.24 (td, J=4.5, 2.8 Hz, 1H),
2.44 – 2.35 (m, 2H), 2.09 (s, 3H), 2.07 (s, 3H).

3’,5’-diacetyl-5-bromo-N4-(2-hydroxynaphtol)-2’-deoxycytidine. Synthesized
via methods A and C from 2-aminonapthol. 1H NMR ((CD3)2SO) δ 11.00 (s, 0H), 8.85 (s,
1H), 8.17 (s, 1H), 7.77 – 7.73 (m, 1H), 7.71 –7.67 (m, 1H), 7.36 (ddd, J=8.1, 6.9, 1.3 Hz,
1H), 7.33 – 7.28 (m, 1H), 7.26 (s, 1H), 6.18 (dd, J=7.6, 6.3 Hz, 1H), 5.22 (dt, J=6.2, 2.9
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Hz, 1H), 4.31 (dd, J=4.5, 2.2 Hz, 2H), 4.26 (tt, J=4.4, 2.3 Hz, 1H), 2.46– 2.39 (m, 2H),
2.09 (s, 3H), 2.08 (s, 3H).

3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-4-chlorophenyl)-2’-deoxycytidine.
Synthesized in crude via methods A, B, and C from 2-amino-5-chlorophenol. 1H NMR
((CD3)2SO) δ 8.40 (s, 1H), 8.11 (s, 1H), 8.10 – 8.06 (m, 1H), 6.94 (t, J=2.3 Hz, 1H), 6.93
– 6.88 (m, 1H), 6.14 (dd, J=7.8, 6.3 Hz, 1H), 5.19 (dt, J=6.3, 2.8 Hz, 1H), 4.29 (dd, J=4.6,
1.7 Hz, 2H), 4.23 (td, J=4.5, 2.7 Hz, 1H), 2.46 – 2.37 (m, 2H), 2.08 (s, 3H), 2.07 (s, 3H),
1.23 (s, 1H).

3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-5-chlorophenyl)-2’-deoxycytidine.
Synthesized via method D from 2-amino-4-chlorophenol. 1H NMR ((CD3)2SO) δ 10.69
(s, 1H), 8.32 (d, J=2.7 Hz, 1H), 8.14 (s, 1H), 7.06 (dd, J=8.6, 2.7 Hz, 1H), 6.93 (d, J=8.6
Hz, 1H), 6.15 (t, J=6.9 Hz, 1H), 5.20 (dt, J=6.2, 2.9 Hz, 1H), 4.29 (dt, J=4.5, 2.1 Hz, 2H),
4.27 – 4.24 (m, 1H), 2.45 – 2.39 (m, 2H), 2.08 (s, 3H), 2.07 (s, 3H).
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3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-5-fluorophenyl)-2’-deoxycytidine.
Synthesized in semicrude form and used for further synthetic application without further
purification via methods A and C from 2-amino-4-fluorophenol. 1H NMR ((CD3)2SO) δ
10.41 (s, 1H), 8.22 (dd, J=10.9, 3.0 Hz, 1H), 8.15 (s, 1H), 6.91 (dd, J=8.9, 5.4 Hz, 1H),
6.84 (td, J=8.6, 3.1 Hz, 1H), 6.15 (dd, J=7.6, 6.3 Hz, 1H), 5.20 (dt, J=6.2, 2.9 Hz, 1H),
4.29 (dt, J=5.4, 2.5 Hz, 2H), 4.25 (tt, J=4.6, 2.0 Hz, 1H), 2.46 – 2.37 (m, 2H), 2.08 (s,
3H), 2.07 (d, J=3.1 Hz, 3H).

3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-5-methoxyphenyl)-2’-deoxycytidine.
Synthesized in semicrude form and used for further synthetic application without further
purification via methods A and C from 2-amino-4-methoxyphenol. 1H NMR ((CD3)2SO)
δ 9.83 (s, 1H), 8.11 (s, 1H), 7.94 (d, J=3.1 Hz, 1H), 6.84 (d, J=8.8 Hz, 1H), 6.61 (dd,
J=8.8, 3.0 Hz, 1H), 6.15 (dd, J=7.7, 6.3 Hz, 1H), 5.20 (dt, J=6.2, 2.9 Hz, 1H), 4.29 (dd,
J=4.5, 2.0 Hz, 2H), 4.26 – 4.22 (m, 1H), 3.68 (s, 3H), 2.45 – 2.35 (m, 2H), 2.09 (s, 3H),
2.07 (s, 3H).
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3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-4-methoxyphenyl)-2’-deoxycytidine.
Synthesized in semicrude form and used for further synthetic application without further
purification via method C from 2-amino-5methoxyphenol. 1H NMR ((CD3)2SO) δ 8.04
(s, 1H), 7.77 (d, J=8.8 Hz, 1H), 6.49 (d, J=2.7 Hz, 1H), 6.43 (dd, J=8.9, 2.8 Hz, 1H), 6.14
(dd, J=8.0, 6.2 Hz, 1H), 5.18 (dt, J=6.4, 2.9 Hz, 1H), 4.28 (dd, J=4.4, 1.5 Hz, 2H), 4.22
(td, J=4.5, 2.8 Hz, 1H), 3.71 (s, 3H), 2.41 – 2.32 (m, 2H), 2.09 (s, 3H), 2.06 (s, 3H).
General Procedures for formation of 5-bromo-N4-(2-hydroxyphenyl)2’deoxycytidines.
Method E: 3’,5’-diacetyl-5-bromo-N4-(2-hydroxyphenyl)-2’deoxycytidine (265
mg, 0.512 mmol) was dissolved in HPLC grade methanol (3 mL) under N2. Sodium
methoxide (380 μL, 2.05 mmol) 30% solution in methanol was added to the reaction and
stirred at room temperature until thin layer chromatography revealed reaction completion.
Acetic acid (117 μL, 2.05 mmol) was added to the reaction and it was evaporated.
Purification via flash silica gel chromatography (CH3OH in CH2Cl2) to give the product.
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5-bromo-N4-(2-hydroxyphenyl))-2’-deoxycytidine. Synthesized via methods E
from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxyphenyl))-2’-deoxycytidine. Yields ranging
from 12-76% over two steps. 1HNMR (CD3OD) δ 8.58 (s, 1H), 8,47 (dd, J=8.1, 1.6 Hz,
1H), 7.01 (td, J=7.7, 1.6 Hz, 1H), 6.93-6.85 (m, 2H), 6.35 (t, J=6.1 Hz, 1H), 4.59 (s, 1H),
4.42 (dt, J=6.3,4.3 Hz, 1H), 4.00 (q, J-3.3 Hz, 1H), 3.90 (dd, J=12.1, 2.9 Hz, 1H), 3.79
(dd, J=12.1, 3.3 Hz, 1H), 2.470 (ddd, J=13.7, 6.2, 4.5 Hz, 1H), 2.23 (dt, J=13.7, 6.2 Hz,
1H). 13CNMR ((CD3)2SO) 157.00, 153.16, 148.03, 141.86, 125.99, 125.04, 122.09,
119.00, 114.92, 87.56, 85.73, 69.66, 60.64, 40.80, 30.69.

5-bromo-N4-(2-hydroxynaphtol)-2’-deoxycytidine. Synthesized via method E
from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxynaphthol))-2’-deoxycytidine. Yields ranging
from 5-65% over two steps. 1HNMR ((CD3)2SO) δ 11.02 (s, 1H), 8.68-8.59 (m, 1H), 8.56
(s, 1H), 7.78-7.73 (m, 1H), 7.74-7.69 (m, 1H), 7.37 (ddd, J=8.1, 6.9, 1.4 Hz, 1H), 7.32
(ddd, J=8.1, 6.8, 1.4 Hz, 1H), 7.28 (s, 1H), 6.15 (t, J=6.2 Hz, 1H), 5.29 (d, J=4.4 Hz, 1H),
5.24 (t, J=4.9Hz, 1H), 4.27 (dq, J=7.9, 4.1 Hz, 1H), 4.13 (q, J=5.3 Hz, 1H), 3.74-3.67 (m,
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1H) 3.62 (dt, J=11.9, 4.1 Hz, 1H), 2.26 (ddd, J=13.2, 6.2, 4.1 Hz, 1H), 2.13 (dt, J=13.0,
6.3 Hz, 1H). MS (ESI) calcd. for C19H19BrN3O5 448.1, found 448.1 (MH+).

5-bromo-N4-(2-hydroxy-4-chlorophenyl)-2’-deoxycytidine. Synthesized via
methods E from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-4-chlorophenyl))-2’deoxycytidine.Yields ranging from 2.5-82% 1HNMR ((CD3)2SO) δ 10.94 (s, 1H), 8.49 (s,
1H), 8.36 (s, 1H), 8.18 (d, J=8.6 Hz, 1H) 6.98-6.86 (m, 2H), 6.11 (t, J=6.2 Hz, 1H), 5.26
(d, J=4.2 Hz, 1H), 5.22 (d, J=5.2 Hz, 1H), 4.25 (s, 1H), 3.83 (q, J=3.4 Hz, 1H), 3.68 (dt,
J=11.9, 3.6 Hz, 1H) 3.60 (dt, J=12.1, 3.6 Hz, 1H), 2.22 (ddd, J=13.2, 6.2, 4.1 Hz, 1H),
2.09 (dt, J=13.0, 6.3 Hz, 1H). MS (ESI) calcd. for C15H15BrClN3O5 434.0, found 434.0
(MH+).

5-bromo-N4-(2-hydroxy-5-chlorophenyl)-2’-deoxycytidine. Synthesized via
method E from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-5-chlorophenyl))-2’deoxycytidine. Yields from 18-41%. 1HNMR ((CD3)2SO) δ 10.72 (s, 1H), 8.53 (s, 1H),
8.39 (s, 1H)*, 8.33 (d, J=10.1 Hz, 1H) 7.06 (dd, J=8.6, 2.6 Hz, 1H), 6.95 (d, J=8.6 Hz,
1H), 6.11 (t, J=6.2 Hz, 1H), 5.28 (d, J=4.4 Hz, 1H), 5.22 (t, J=5.0 Hz, 1H), 4.34-4.22 (m,
144

1H), 3.85 (q, J=3.4 Hz, 1H), 3.69 (ddd, J=11.9, 5.0, 3.3 Hz, 1H) 3.60 (ddd, J=11.9, 4.8,
3.3 Hz, 1H), 2.24 (ddd, J=13.2, 6.2, 4.2 Hz, 1H), 2.10 (dt, J=13.0, 6.2 Hz, 1H). MS (ESI)
calcd. for NaC15H14BrClN3O5 456.0, found 456.0 (MNa+).

5-bromo-N4-(2-hydroxy-5-fluorophenyl)-2’-deoxycytidine. Synthesized via
method E from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-5-fluorophenyl))-2’deoxycytidine. Yields from 6-31%. 1HNMR ((CD3)2SO) δ 10.45 (s, 1H), 8.54 (s, 1H),
8.32 (s, 1H), 8.28 (dd, J=10.9, 3.1 Hz, 1H) 6.92 (dd, J=8.9, 5.4 Hz, 1H), 6.84 (td, J=8.5,
3.2 Hz, 1H), 6.12 (t, J=6.2 Hz, 1H), 5.28 (d, J=4.4 Hz, 1H), 5.26-5.17 (m, 1H), 4.26 (dq,
J=7.4, 4.1 Hz, 1H), 3.85 (q, J=3.4 Hz, 1H), 3.72-3.65 (m, 1H), 3.61 (ddt, J=11.9, 7.8, 4.1
Hz, 1H), 2.24 (ddd, J=13.3, 6.2, 4.2 Hz, 1H), 2.18-2.05 (m, 1H). MS (ESI) calcd. for
NaC15H15BrFN3O5 438.0, found 438.0 (MNa+).

5-bromo-N4-(2-hydroxy-5-methoxyphenyl)-2’-deoxycytidine. Synthesized via
method E from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-5-methoxyphenyl))-2’deoxycytidine. Yields ranging from 3-88%. 1HNMR ((CD3)2SO) δ 9.86 (s, 1H), 8.50 (s,
1H), 8.32 (s, 1H), 8.00 (d, J=3.0 Hz, 1H) 6.85 (d, J=8.7 Hz, 1H), 6.61 (dd, J=8.8, 3.1 Hz,
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1H), 6.12 (t, J=6.3 Hz, 1H), 5.27 (d, J=4.4 Hz, 1H), 5.22 (t, J=5.0 Hz, 1H), 4.25 (dt,
J=7.9, 4.0 Hz, 1H), 3.84 (q, J=3.4 Hz, 1H), 3.70 (s, 3H), 3.70-3.65 (m, 1H), 3.60 (dt,
J=12.0, 3.8 Hz, 1H), 2.23 (ddd, J=13.3, 6.2, 4.1 Hz, 1H), 2.10 (dt, J=13.0, 6.2 Hz, 1H).
MS (ESI) calcd. for C16H18BrN3O6 430.0, found 430.1 (MH+).

5-bromo-N4-(2-hydroxy-4-methoxyphenyl)-2’-deoxycytidine. Synthesized via
method E from 3’,5’-diacetyl-5-bromo-N4-(2-hydroxy-4-methoxyphenyl)-2’deoxycytidine. Yields ranging from 2-56%. 1HMR ((CD3)2SO) δ 8.42 (d, J= 0.7 Hz, 1H),
8.34 (s, 1H), 7.85 (d, J = 8.8 Hz, 1H), 6.50 (d, J=2.8 Hz, 1H) 6.44 (dd, J=8.9, 2.8 Hz,
1H), 6.12 (q, J=6.3 Hz, 1H), 5.23 (d, J=30.8 Hz, 2H), 4.25 (dq, J=7.4, 4.1 Hz, 1H), 3.82
(dq, J=6.3, 3.3 Hz, 1H), 3.66 (td, J=11.9, 3.3 Hz, 1H), 3.59 (dt, J=9.1, 2.8 Hz, 1H), 3.37
(s, 3H), 2.24-2.15 (m, 1H), 2.14-2.04 (m, 1H). MS (ESI) calcd. for C16H18BrN3O6 430.0,
found 430.1 (MH+).
General Methods for the synthesis of 1,3-diaza-2-oxophenoxazine 2’-deoxy-βD-ribofuranosides.
Method F: 5-bromo-N4-(2-hydroxyphenyl)-2’-deoxycytidine (653 mg, 1.64
mmol) was dissolved in ethanol (13 mL) under N2. Potassium fluoride (953 mg, 16.4
mmol) was added and the reaction was heated to reflux. After 3 days the starting material
appears completely converted by thin layer chromatography and the reaction is cooled to
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room temperature and evaporated. Purification off of celite via diol chromatography
(CH3OH in CH2Cl2) yields the product.
Method G: 5-bromo-N4-(2-hydroxyphenyl)-2’-deoxycytidine (500 mg, 0.967
mmol) was combined with 18-crown-6 (1.28 g, 4.83 mmol) under N2. This was dissolved
in dry diglyme (4 mL) and heated to 120 oC to dissolve. Potassium fluoride (281 mg, 4.83
mmol) was added and the reaction was heated to 120 oC and stirred until thin layer
chromatography revealed complete conversion of the starting material. Cooling to room
temperature followed by purification of the reaction via diol chromatography (CH3OH in
CH2Cl2) to yield the product.
Method H: 5-bromo-N4-(2-hydroxyphenyl)-2’-deoxycytidine (150 mg, 0.277
mmol) was combined with cesium fluoride (421 mg, 2.77 mmol) under N2. This was
dissolved in dry diglymea (5 mL) or dry NMPb (6 mL) or dry DMFc (7.5 mL) and heated
to 120 oC. The reaction was stirred until tin layer chromatography revealed complete
conversion of the starting material. Cooling to room temperature followed by purification
of the reaction via diol chromatography (CH3OH in CH2Cl2) to yield the product.

8-fluoro-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. Synthesized
via methods F and G from 5-bromo-N4-(2-hydroxy-5-fluorophenyl)-2’-deoxycytidine.
Yields up to 25%. 1HNMR ((CD3)2SO) δ 10.88 (s, 1H), 7.51 (s, 1H), 6.80 (dd, J=8.9, 5.0
Hz, 1H), 6.66 (td, J=8.6, 3.0 Hz, 1H), 6.60 (dd, J=9.4, 3.0 Hz, 1H) 6.12 (dd, J=7.4, 6.0
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Hz, 1H), 5.24 (s, 1H), 5.12 (s, 1H), 4.22 (dt, J=6.2, 3.1 Hz, 1H), 3.77 (q, J=3.3, 1H), 3.59
(td, J=10.5, 9.1, 3.6 Hz, 2H), 2.10-1.97 (m, 2H).13CNMR ((CD3)2SO) 158.80, 156.91,
153.13, 152.16, 138.90, 127.15, 115.60, 115.52, 109.23, 109.04, 87.29, 84.73, 70.27,
61.13. AMM (ESI) calcd. for C15H14N3O5F 335.09, found 336.10 (MH+).

1,3-diaza-benzo(h)2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. Synthesized
via methods F, G and Hb from 5-bromo-N4-(2-hydroxynaphthol)-2’-deoxycytidine.
Yields from 3-71%. 1HNMR ((CD3)2SO) δ 8.56 (s, 1H), 7.72 (s, 1H), 7.70-7.63 (m, 2H),
7.38-7.28 (m, 2H), 7.27 (s, 1H), 7.21 (s, 1H), 6.16 (s, 1H), 5.41 (s, 2H), 4.28 (s, 1H), 3.79
(s, 1H), 3.63 (t, J=4.0 Hz, 2H), 2.10 (s, 2H). 13CNMR ((CD3)2SO) 172.77, 165.20,
152.45, 142.21, 130.39, 130.29, 126.63, 126.59, 126.42, 125.13, 124.94, 121.52, 113.28
110.34, 87.37, 84.83, 72.43, 60.97. AMM (ESI) calcd. for C19H17N3O5 367.12, found
368.12 (MH+).

7-chloro-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. Synthesized
via methods F, G, Hb and Hc from 5-bromo-N4-(2-hydroxy-4-chlorophenyl)-2’148

deoxycytidine. Yields ranging up to 60%. 1HNMR ((CD3)2SO) δ 10.89 (s, 1H), 7.48 (s,
1H), 6.98-6.86 (m, 2H), 6.77 (d, J=8.4 Hz, 1H), 6.13 (dd, J=7.4, 6.1 Hz, 1H), 5.24 (s,
1H), 5.13 (s, 1H), 4.23 (dt, J=6.1, 3.1 Hz, 1H), 3.78 (q, J=3.3, 1H), 3.64-3.56 (m, 2H),
2.12-1.97 (m, 2H). 13CNMR ((CD3)2SO) 153.23, 152.37, 143.32, 134.76, 127.05, 126.51,
123.23, 120.21, 119.13, 114.78, 87.25, 84.70, 70.44, 61.25, 48.61. AMM (ESI) calcd. for
C15H14N3O5Cl 351.06, found 703.13 (2MH+).

8-chloro-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. Synthesized
via methods F, G, Ha and Hb from 5-bromo-N4-(2-hydroxy-5-chlorophenyl)-2’deoxycytidine. Yields ranging up to 75%. 1HNMR ((CD3)2SO) δ 7.48 (s, 1H), 6.83 (dd,
J=8.5, 2.5 Hz, 1H), 6.80-6.68 (m, 2H), 6.12 (dd, J=7.3, 6.0 Hz, 1H), 4.24 (dt, J=6.3, 3.3
Hz, 1H), 3.76 (q, J=3.3 Hz, 1H), 3.58 (t, J=3.6 Hz, 2H), 2.10-1.98 (m, 2H). 13CNMR
((CD3)2SO) 172.76, 153.65, 152.38, 141.66, 127.21, 126.71, 122.53, 119.98, 117.55,
115.93, 87.22, 84.66, 70.21, 61.11. AMM (ESI) calcd. for C15H14N3O5Cl 351.06,
found 703.13 (2MH+).
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8-methoxy-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside.
Synthesized via methods F, G, Hb and Hc from 5-bromo-N4-(2-hydroxy-5methoxyphenyl)-2’-deoxycytidine. Yields ranging up to 51%. 1HNMR ((CD3)2SO) δ
10.63 (s, 1H), 7.56 (s, 1H), 6.75 (d, J=8.6 Hz, 1H), 6.45-6.37 (m, 2H), 6.14 (dd, J=7.4,
6.0 Hz, 1H), 5.24 (s, 1H), 5.12 (s, 1H), 4.24 (dt, J=6.2, 3.1 Hz, 1H), 3.79 (q, J=3.3, 1H),
3.68 (s, 3H), 3.59 (dd, J=9.7, 3.5 Hz, 2H), 2.09 (ddd, J=13.1, 6.0, 3.2 Hz, 1H), 2.02 (ddd,
J=13.2, 7.5, 5.9 Hz, 1H). 13CNMR ((CD3)2SO) 172.86, 153.75, 152.43, 141.69, 127.26,
126.72, 122.52, 119.97, 117.62, 115.93, 87.21, 84.68, 70.27, 69.54, 61.16, 60.34. AMM
(ESI) calcd. for C16H17N3O6 347.11, found 348.12 (MH+)

7-methoxy-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside.
Synthesized via methods G, Hb and Hc from 5-bromo-N4-(2-hydroxy-4-methoxyphenyl)2’-deoxycytidine. Yields ranging up to 75%.1HNMR ((CD3)2SO) δ 7.46 (s, 1H), 6.75 (d,
J=8.6 Hz, 1H), 6.49 (dd, J=8.6, 2.7 Hz, 1H), 1H), 6.45 (d, J=2.7 Hz, 1H), 6.15 (t, J=6.8,
1H), 5.25 (s, 1H), 4.23 (d, J=5.3 Hz, 1H), 3.78 (q, J=323, 1H), 3.69 (s, 3H), 3.58 (s, 2H),
2.11-1.96 (m, 2H). ). AMM (ESI) calcd. for C16H17N3O6 347.11, found 348.12 (MH+).
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Synthesis of Other Oxygen Tricyclic Cytidine Analogs
A nitro tricyclic cytosine analog has been previously reported; it was designed for
its’ FRET acceptor abilities.62 In this work, a new synthesis was designed for a dinitrosubstituted tCo analog has been synthesized with the goal of studying its photophysical
properties. This dinitro-tCo is synthesized in one step through the reaction of difluorodinitrobenzene with 5-hydroxycytidine (figure 3-0-13). In DMF and with triethylamine as
base, the reaction works without the protection of the 3’ and 5’ hydroxyl groups. This
reaction operates through double nucleophilic aromatic substitution reactions between the
amine and the phenol of the nucleoside and 1,2-difluoro-4,5-dinitrobenzene. This double
substitution results in a deep red compound that has absorptive but not fluorescence
properties as will be discussed in the following chapter.

Figure 3-0-13: Dinitro tCo synthesis. Dinitro tricyclic cytosine analog 7,8-NO2-tCo that was synthesized in
one step from hydroxy cytidine by reaction with difluoro-dinitro-benzene.

This dinitro-tCo 7,8-NO2-tCo analog was used as a precursor for the synthesis of a

diamino analog because of the desire for amine functionality to direct photophysics as
discussed in the previous chapter. Palladium on charcoal was combined with ammonium
formate in methanol in initial attempts to reduce the nitro groups to amines.111 As was
discussed for the hydrogenolysis of benzyl protecting groups previously, the ammonium
formate serves as an in situ hydrogen source. The hydrogen serves as a source for protons
which are combined with two electrons from the palladium to reduce the nitro to the
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dinitro through loss of water. An additional two protons with an additional two electrons
reduce the nitroso to the hydroxylamine. The final two protons and two electrons and the
loss of water afford the amine from the hydroxylamine.

Figure 3-0-14: Diamine from reduction of 7,8-NO2-tCo. Hydrazine was used to reduce the nitro groups
to amine en route to alkyl amine functionality.

When the above reaction conditions failed to produce a reaction, hydrazine
monohydrate was substituted for the ammonium formate and the solvent was switched to
ethanol and heated at 95 oC (figure 3-0-14).112 Reduction of aromatic nitro compounds is
known to proceed through the short lived reducing agent diimide.113 This reaction formed
a deeper red color and evidence of two new compounds were seen but they were not
recovered in purification. Repeating these conditions at 70 oC yielded some potential
product which was purified via preparatory thin layer chromatography. This product was
dissolved in pyridine with acetic anhydride to acetylate the amines. Complete conversion
of the starting material was seen but proton NMR revealed that likely what had occurred
was deglycosylation. An in-situ acetylation was attempted following the reduction of the
dinitro under the above conditions but the results of this experiment were inconclusive as
the product showed evidence of the sugar portion of the product but not all of the
expected aromatic hydrogens.
To have the option to avoid this glycosidic lability, and forgo expense of the
starting material the synthesis was attempted from cytosine. Elbs persulfate oxidation is
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useful in the hydroxyl substitution of the nucleobase.114 Reacting the nucleobase with
potassium persulfate in potassium hydroxide followed by acidification with hydrochloric
acid generates the sulfate intermediate (figure 3-0-15).115 Oxidation of the base is
achieved through the deprotonation of the N1 nitrogen by hydroxide and the resonance of
the nucleobase to the C5 carbanion. These electrons are used to attack the peroxide
oxygen of the peroxodisulfide expelling the other sulfate. Potassium provides the
counterion for the sulfate, and the deprotonation of C5 is followed by resonance back to
the nitrogen anion which is then protonated. During workup the N3 nitrogen is protonated
to generate the zwiterionic intermediate.

Figure 3-0-15: Hydroxy-cytosine synthesis. Elbs persulfate oxidation synthesis was implemented in
conversion of cytosine to starting material for the synthesis of dinitro tricyclic cytosine nucleobase.

Reaction of this sulfate intermediate with additional hydrochloric acid followed
by neutralization yielded 5-hydroxycytosine. Hydrolysis of the sulfate is achieved
through the protonation of the sulfate oxygen and then substitution at C5 by water to
expel this leaving group. Deprotonation of this new oxygen to the hydroxyl and of the N3
nitrogen to the neutral species in workup results in the desired product. Reaction of this
nucleobase precursor with difluoro-dinitro-benzene resulted in the production of a
number of new compounds but not the desired nucleophilic aromatic substation that was
seen with the nucleoside, perhaps a result of additional competing nucleophilic sites on
the nucleobase.
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To begin a protecting group strategy to direct the reaction of the hydroxyl
cytosine and difluoro-dinitro-benzene, the N4 nitrogen of 5-hydroxycyosine was tested
for protection as a phthalimide (figure 3-0-16).116 The starting material was reacted with
phthalic anhydride in hydrochloric acid and then potassium bicarbonate to neutralize.
Acidification of the phthalic anhydride increases its electrophilicity. Nitrogen of the
primary amine at the N4 of the cytosine attacks the carbonyl carbon of the protonated
anhydride. Reformation of the double bond expels the anhydride oxygen which can
deprotonated the nitrogen cation. Attack at the other carbonyl carbon forms the
phthalimide and water is expelled upon reformation of the carbon oxygen double bond.
Although a purple solid was generated under these conditions, it was not the desired
phthalimide protected 5-hydroxycytosine. Following purification starting material was
the only isolated compound.

Figure 3-0-16: Phthalamide protection of hydroxy-cytosine. Protection of the exocyclic amine of hydroxy
cytosine so the N1 nitrogen could be protected to prevented unwanted side reactions in tricyclic cytosine
nucleobase formation.

Additional attempts at a more successful reduction of the dinitro nucleoside were
made using sodium borohydride and sulfur in THF (figure 3-0-17). Sulfurated sodium
borohydride has been used to reduce aromatic dinitro compounds to the corresponding
amines.117 Sodium borohydride reacts with sulfur to generate the sulfurated sodium
borohydride and this then reacts with the nitro starting material.118 The hydride shift is
the first step of the mechanism and the oxygen can attack the boron to form the borate.119
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The sulfur is also believed to be implicated in the reduction mechanism but the
mechanistic role of all elements is not fully understood.120 Initially under these conditions
no reaction was observed so additional sulfurated borohydride was generated and added
to the reaction but to no avail. Sulfur flowers were substituted as the sulfur source in the
generation of the borohydride, but this still did not result in reduction of the nucleoside
even when subjected to 220 oC.

Figure 3-0-17: Reduction with sulfurated borohydride. Sulfurated borohydride was used to reduce the nitro
groups to amines en route to alkyl amine functionality.

The same starting material as that used to form the dinitro analog was used in the
synthesis of the tetrafluoro analog through the same chemistry (figure 3-0-18).
Hexafluoro-benzene was combined with the starting material in DMSO with potassium
carbonate.121 The basic environment increases the nucleophilicity of the cytosine
hydroxyl and amine functionalities and they undergo nucleophilic aromatic substitution at
the hexafluorobenzene to give the desired tetrafluoro tricyclic cytosine product.

Figure 3-0-18: Tetrafluoro-tCo synthesis. Tetrafluoro tricyclic cytosine analog that was synthesized in one step
from hydroxy cytidine by reaction with hexafluoro-benzene.
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Other Oxygen Tricyclic Cytidine Analogs Experimental:

7,8-dinitro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside.
2’deoxycytidine (150 mg, 0.617 mmol) was combined with 1,2-difluoro-4,5dinitrobenzene (126 mg, 0.617 mmol) under N2. Triethylamine (350 μL, 2.5 mmol) was
added and the reactants dissolved in dry DMF (7.5 mL) and heated to 65 degrees. 18
hours later the reaction was evaporated and purified via flash silica gel chromatography,
and triturated with methanol to give product (60 mg, 0.147 mmol) in 24% yield 1HNMR
(CD3OD) δ 7.78 (s, 1H), 7.40 (s, 1H), 7.28 (s, 1H), 6.20 (t, J = 6.5 Hz, 1H), 4.38 (dt,
J=6.4, 3.6 Hz, 1H), 3.93 (d, J=3.2 Hz, 1H), 3.87 – 3.64 (m, 2H), 2.31 (s, 1H), 2.16 (dt,
J=13.4, 6.6 Hz, 1H), 0.89 (dd, J=15.3, 8.6 Hz, 3H).
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7,8-diamino-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. 7,8dinitro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside (19 mg, 0.0466 mmol)
was combined with 10% palladium on charcoal (1 mg) and dissolved in ethanol (1mL)
under N2. After heating to 70 oC, hydrazine monohydrate (48 μL, 0.982 mmol) was added
dropwise and the reaction continued at 70 degrees. After 3 hours the reaction was cooled
to room temperature and purified via preparatory thin layer chromatography to give crude
product that was used in acetylation reaction.

Hydrogen cytosine-5-sulfate monohydrate. Cytosine (2.08 g, 18 mmol) was
dissolved in 1N potassium hydroxide (100 mL). Potassium persulfate (7.3 g, 27 mmol)
was added to the reaction and stirred at room temperature. After 20 hours concentrated
hydrochloric acid (9 mL) was added to the reaction and product precipitated. Chilled
filtration, washing with water and acetone gave product (1.7 g, 8.2 mmol) in 45% yield.
1H NMR ((CD3)2SO) δ 8.11 (s, 6H), 7.47 (s, 1H).
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5-hydroxycytosine. Hydrogen cytosine-5-sulfate monohydrate (1.5 g, 7.2 mmol)
was dissolved in 6 N hydrochloric acid (3.5 mL) and this was stirred at 100 oC. After 15
minutes the reaction was chilled on ice. Filtered product was dissolved in was deionized
water (30 mL) and brought to pH 7 by addition of potassium hydroxide. Product was
filtered, washed with water and acetone to give product (677 mg, 5.3 mmol) in 74%
yield. 1H NMR ((CD3)2SO) δ 8.31 (s, 1H), 7.40 (s, 1H), 6.90 (s, 3H).

6,7,8,9-tetrafluoro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside.
2’deoxy-5-hydroxycytidine (120 mg, 0.494 mmol) was combined with hexafluorobenzene (47 μL, 0.494 mmol) in N2 and dissolved in DMSO (6 mL). Potassium carbonate
(274 mg, 1.98 mmol) was added to the reaction and it was heated to 50 oC. After 18 hours
the reaction was cooled to room temperature and spread on a watch-glass to evaporate.
The residue was purified via flash silica gel chromatogrpahy to give the prodcut (66 mg,
0.169 mmol) in 34% yield. 1HNMR (CD3OD) δ 7.46 (s, 1H), 6.20-6.14 (m, 1H), 4.34 (dt,
J=6.3,3.3 Hz, 1H), 3.86 (q, J=3.2 Hz, 1H) 3.78-3.65 (m, 2H), 2.21-2.10 (m, 2H). 19F
NMR (CD3OD) δ -159.95, -167.35, -167.80, -169.79.
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Oxygen Tricyclic Cytidine Analogs Elaboration
The nucleosides that were synthesized under these synthetic methods were
elaborated upon to apply them to further investigations. Triphosphates are popular with
biochemists because it makes the nucleoside a substrate for enzymes. These are useful for
experimental investigations of cellular activity that take advantage of the photophysics of
the nucleotide as well as using enzymes to produce nucleic acids which contain the new
fluorophores.

Figure 3-0-19: Triphosphate synthesis. Ludwig method was used in the synthesis of triphosphates from
substituted tCo nucleosides for enzymatic incorporation.

The high yielding ribose nucleoside of tricyclic cytosine converted to the
triphosphate via the Ludwig method.122 Phosphorous oxychloride provides the alpha
phosphate and tributyl ammonium pyrophosphate is the source of the beta and the gamma
(figure 3-0-19). Substitution for the chlorine of phosphorous oxychloride by the 5’
hydroxyl oxygen followed by deprotonation gives the intermediate monophosphate
analog. Tributylamine serves as a base to deprotonated the tributylammonium
pyrophosphate and it will substitute for chlorine on this analog of monophosphate
creating the nucleotide triphosphate. Water substitutes for the final chlorine and
deprotonation gives triphosphate that is recognizable by polymerase enzymes. Ion
exchange chromatography of the reaction mixture was attempted in triethylammonium
acetate buffer and this was not an effective mobile phase. Switching to triethylammonium
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bicarbonate buffer was much more effective in eluting the various phosphate versions of
the fluorescent nucleotide in high yield. To garner compounds with higher purity, the
eluent from ion exchange column of the next reaction mixture was subjected to HPLC
purification with triethylammonium bicarbonate buffer and acetonitrile. This process was
repeated to make the triphosphate of the deoxyribose version of tricyclic cytosine as well.
Ion exchange chromatography being a potentially automated process, the reaction
mixture was used as a demonstration of flash ion exchange chromatography. This
demonstration was unsuccessful, and the compound was never recovered. To possibly
increase the reactivity of the compounds, proton sponge was added to the reaction as this
was shown to be beneficial for other triphosphate synthesize.123 No evidence of reaction
between the nucleoside and either the phosphorous oxychloride or the pyrophosphate was
observed in these conditions, and the proton sponge was never used again. Skipping the
ion exchange altogether, and instead purifying multiple times by HPLC led to the desired
product of the tetrafluoro analog previously described. 7,8-NO2-tCo-dRTP to which the
tetrafluoro analog was to be paired for incorporation investigations was also prepared this
way. The same method resulted in the confirmation through mass spectroscopy of the
triphosphate nucleotide of tetCo.
Changing to a new HPLC column required a restart in method development for
the purification of these compounds, and with concentrations low it is difficult to get
reliable phosphorous spectra for all nucleotide products. Mass spectral analysis was
turned to as a means to confirm the presence of the desired product, but it was later
determined by enzymatic incorporation that compounds which did not have the predicted
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molecular ion detected by mass spectroscopy were in fact the triphosphate product.
HPLC analysis in combination with proton and phosphorous NMR were used to
determine the potential triphosphate products of the other substituted tCo analogs.
Analytical HPLC analysis of the reaction provided a means of investigating the
reactivity of the nucleosides in these conditions. Reaction with phosphorous oxychloride
happens quickly as is evidenced by a large shift in the retention time of a sample of the
reaction following reactant addition. Reaction with tributylammonium pyrophosphate is
less obvious and appears to be a slower process. Coordination between the analytical
column and the preparatory column was difficult because elution profiles were very
different, even though the stationary phases were the same.

Figure 3-0-20: Solid phase DNA synthesis preparation. Installation of dimethoxytrityl group at the 5’ and
phosphoramidite group at the 3’ position of nucleosides for solid phase DNA synthesis to incorporate these
substituted tCo analogs.

For solid phase DNA synthesis, a dimethoxytrityl group must be installed in the
place of phosphate at the 5’ position of the nucleoside and a phosphoramidite group
placed at the 3’ position (figure 3-0-20).
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Because of the greater reactivity of the 5’

hydroxyl, the dimethoxy trityl group is installed first. The hydroxyl oxygen attacks the
tertiary carbocation of the trityl after chlorine has departed in a unimolecular substitution
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mechanism. Deprotonation affords the desired neutral product. In the parent compound
synthesis the crude reaction mixture from the ring closure step is protected. Attempting
this crude tritylation with the tetCo compound resulted in a large mess that even after
purification by preparatory thin layer chromatography could not be resolved. 8-OMe-tCo
which had been purified and evaporated from dry solvent showed limited reactivity to the
tritylchloride as well, and purification was difficult. Multiple additions of the trityl
chloride to the 2’deoxyribose of tC gave evidence of product formation but purification
was difficult. The 7-Cl-tCo was the first analog to show complete conversion of starting
material under these conditions, but the protecting group was cleaved during purification
by column or by plate. Other reactions showed dimethoxytritylation of the ribose but
fracturing of the glycosidic bond as well. Adding triethylamine to the mix, to promote
reaction, was attempted but showed no increased reactivity of starting material.
Triethylamine in combination with DMAP showed an improvement in reaction, but
purification issues persisted. After testing several possible sets of reaction conditions, the
best reactivity was obtained using DMAP in combination with the starting material and
dimethoxytritylchloride in pyridine. Starting materials that were as dry as possible were
important to the reaction, as well as keeping reactants as concentrated as possible.
Purification via flash silica gel chromatography with dichloromethane and methanol with
1% triethylamine resolves the desired product effectively. Unfortunately the
triethylammonium ions that result from this purification strategy are difficult to remove.
These ions do not appear to have an effect on the installation of the phosphoramidite
group so the dimethoxytritylated compounds produced were carried on as a
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triethylammonium salt. Purification via diol chromatography was attempted, but
conditions where separation and elution both occur have yet to be determined.
With the dimethoxytritylgroup installed, it was time to work on the
phosphoramidites.125 The 3’ hydroxyl oxygen attacks the phosphorous of the 2cyanoethyl-diisopropylamino-chlorophosphoramidite substituting for chlorine to give the
desired product. Early reaction between the 5’ protected dinitro analog and
phosphoramidite precursor with diisopropylamine in THF went quickly at room
temperature but multiple products were difficult to distinguish. Similar results were seen
months later with the tetCo. Over a year and a half later, the solvent was switched from
THF to dichloromethane and this had positive effects on yield. Lowering the temperature
of the reaction increased the selectivity. Diisopropyl ammonium tetrazolide as an additive
to promote the reaction did lead to appearance of the desired product, but much
decomposition occurred upon any attempts to purify the reaction mixture. It was
ultimately found that Hunigs base gave the greatest yield of isolable product from the
reaction. Purification via flash silica gel chromatography with dichloromethane and
methanol with 1% triethylamine is sometimes effective to separate product but creates
similar issues to those described above. Alternatively, purification via a diol stationary
phase with a gradient from hexanes to dichloromethane can give pure product.
Unfortunately, the yield from these two steps is not large enough to produce compounds
in amounts suitable for solid phase DNA synthesis even when starting from 150mg of the
pure nucleoside. The 8-OMe-tC analog, which can be generated in great amounts, has
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been subjected to these reaction conditions and after application of the optimized
purification conditions, may be suitable for this means of nucleic acid production.

Figure 3-0-21: Trifluoromethylation of fluorescent nucleotides. Trifluoromethyl group substitution was made
to determine effects of this functionality on photophysical properties. Conditions were tested on Pyrrolo-dC
prior to reaction with the tCo compounds.

Another elaboration that was considered was the trifluoromethylation of the
oxygen tricyclic cytosine. This electron withdrawing group could provide some
potentially interesting fluorescence properties like those seen in the following chapter.
Moreover, electron withdrawing groups tend to minimize photobleaching by raising the
oxidation potential. To check the utility of trifluoromethylation, a non tC fluorescent
nucleoside was trifluoromethylated firs, pyrrolo-dC (figure 3-0-21). This biphasic
reaction helps to control the reagent addition to the reaction.
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Tert-butoxide becomes

the butoxy radical with the assistance of zinc. This radical abstracts an electron from the
sulfinate anion generating the sulfinate radical which becomes the trifluoromethyl radical
upon loss of sulfur dioxide. Trifluoromethyl radical reacts with the double bond of the
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nucleotide and hydroxide radical from tert-butoxide abstracts a hydrogen to give the
product and radical as neutral species and another butoxy radical for the cycle.126 To
ensure the solubility of the starting material in the organic phase, the hydroxyls were
acetylated. This reaction with pyrrollo-dC and with tCo can be tricky because of the
potential to acetylate the amine of the chromophore which is evidenced by a loss of
fluorescence of the compound. Success in the trifluoromethylation of the non-tricyclic
compound was encouraging, but selectivity may be an issue with the trifluoromethylation
of the tC compounds.
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Oxygen Tricyclic Cytidine Analogs Elaboration Experimental:

5’-triphosphate-tC-β-D-ribonucleoside. tC-β-D-ribonucleoside (22 mg, 0.065
mmol) was dissolved in dry trimethyl phosphate (1 mL) and cooled to -6 oC.
Phosphorous oxychloride (6.7 μL, 0.071 mmol) in trimethyl phosphate (200 μL) was
added dropwise to the reaction stirred at -25 oC. After 3 hours tributyl ammonium
pyrophosphate (251 mg, 0.455 mmol) in dry dimethyl formamide (0.5 mL) was added to
the reaction followed by 7 drops of tributylamine and stirred at -23 oC 2.5 hours then at
room temperature 1 hr. The reaction was poured into 100 mL of 0.1 M triethyl
ammonium bicarbonate buffer and evaporated. Purification via a 6cm column of
Sephadex A-25 ion exchange resin that had been swollen with 1M sodium hydroxide and
washed with millipure water for 2 hours. The crude residue was diluted with 140 mL
deionized water and loaded on to the column. 300 mL of water were run through the
column followed by 30 mL each of 20, 40, 60, 80 and 100% triethylammonium
bicarbonate buffer and sometimes HPLC in a gradient of the buffer to acetonitrile to give
the product as the triethylammonium salt in less than 15% yield.
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2’-deoxy-5’-triphosphate-tC-β-D-ribonucleoside. 2’-deoxy-tC-β-Dribonucleoside (27 mg, 0.08 mmol) was stirred in trimethyl phosphate (2 mL) over
molecular sieves. Heated to 33 oC to dissolve and then cooled to 0 oC. 1.78 M
phosphorous oxychloride in trimethyl phosphate (100 μL, 0.056 mmol) was added
dropwise to the reaction and stirred at 0 oC for 2 hours. After 2 hours at room
temperature, tributyl ammonium pyrophosphate (306 mg, 0.56 mmol) in dry dimethyl
formamide (0.56 mL) was added to the reaction followed by several drops of
tributylamine and stirred at 0 oC 1 hour then at room temperature. Following 1 hour the
reaction was poured into 100 mL of 0.1 M triethyl ammonium bicarbonate buffer and
evaporated. The crude residue was diluted with 100 mL deionized water and loaded on to
the column. 100 mL of water were run through the column followed by 30 mL each of
20, 40, 60, 80 and 60 mL of 100% 1M triethylammonium bicarbonate buffer. NMR of
eluent samples identified which fractions contained compounds of interest from this ion
exchange. Samples with proton or phosphorous peaks that indicated presence of desired
product were diluted with water (1 mL) and injected onto the HPLC and run (CH3CN in
0.1M TEAB) to give the product as the triethylammonium salt in less than 14% yield.
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6,7,8,9-tetrafluro-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. 6,7,8,9-tetrafluoro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-Dribofuranoside (30 mg, 0.077 mmol) dry from desiccation was dissolved in dry trimethyl
phosphate (1 mL) under N2, heated to 40 oC to dissolve and then cooled to 0 oC. Dry
phosphorous oxychloride (16 μL, 0.171 mmol) was added to the reaction and stirred at 0
o

C for 1 hour. After 4 hours at room temperature, tributyl ammonium pyrophosphate (298

mg, 0.54 mmol) in dry dimethyl formamide (0.7 mL) was added to the reaction followed
by 7 drops of tributylamine and stirred at room temperature. The reaction was poured into
100 mL of 0.1 M triethyl ammonium bicarbonate buffer and evaporated. The crude
residue was diluted with water filtered and injected onto the HPLC and run (CH3CN in
0.1M TEAB) to give the product (3.3 mg, 0.0052 mmol) in 7 percent yield.

7,8,-dinitro-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. 7,8-dinitro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside
(15mg, 0.0368 mmol) was dissolved in dry trimethyl phosphate (0.55 mL) under N2,
heated to 47 oC to dissolve and then cooled to 0 oC. Dry phosphorous oxychloride (7.6
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μL, 0.0815 mmol) was added to the reaction and stirred at 0 oC for 1 hour. After 5 hours
at room temperature, tributyl ammonium pyrophosphate (142 mg, 0.259 mmol) in dry
dimethyl formamide (0.25 mL) was added to the reaction followed by 4 drops of
tributylamine and stirred at room temperature. Following two hours, the reaction was
poured into 50 mL of 0.1 M triethyl ammonium bicarbonate buffer and evaporated. The
crude residue was diluted with water filtered and injected onto the HPLC and run
(CH3CN in 0.1M TEAB) to give the product (0.2 mg, 0.000309 mmol) in 0.8 percent
yield.

8-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. 8-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. (50
mg, 0.142 mmol) was dissolved in dry trimethyl phosphate (0.55 mL) under N2, then
cooled to 0 oC. Dry 1M phosphorous oxychloride in trimethyl phosphate (156 μL, 0.156
mmol) was added dropwise to the reaction and stirred at 0 oC for 15 minutes then at room
temperature 2 hours. Recooled to 0 oC, additional dry 1M phosphorous oxychloride in
trimethyl phosphate (156 μL, 0.156 mmol) was added dropwise to the reaction and stirred
at 0 oC. After 30 minutes it was warmed to room temperature and stirred 2 hours at room
temperature. Recooled to 0 oC, tributyl ammonium pyrophosphate (951 mg, 1.73 mmol)
in dry dimethyl formamide (1 mL) was added to the reaction dropwise followed by 14
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drops of tributylamine and stirred at 0 oC for 35 minutes then warmed to room
temperature. The reaction was evaporated, diluted with 5 mL of 0.1 M triethyl
ammonium bicarbonate buffer filtered and injected onto the HPLC and run (CH3CN in
0.1M TEAB) to give the product (1.9 mg, 0.00321 mmol) in 2 percent yield.

1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-D-ribofuranoside was
synthesized for analytical method development. Samples were diluted with water and
then injected (20 μL) onto the HPLC and run (CH3CN in 0.1M TEAB). 1,3-diaza-2oxophenoxazine-2’-deoxy-β-D-ribofuranoside (28 mg, 0.0898mmol) was dried overnight
in vacuo then dissolved in dry trimethyl phosphate (0.5 mL) under N2 (Sample A).
Reaction was cooled to 0 oC. Dry 1M phosphorous oxychloride in trimethyl phosphate
(98 μL, 0.098 mmol) was added dropwise to the reaction and stirred at 0 oC for 20
minutes (Sample B) then at room temperature 1 hour (Sample C). Chilled tributyl
ammonium pyrophosphate (246 mg, 0.45 mmol) in dry dimethyl formamide (0.3 mL)
was added to the reaction dropwise followed by 8 drops of tributylamine and stirred for 1
hour (Sample D). After an additional hour (Sample E) and at 3 total hours (Sample F).
General Methods for the synthesis of 1,3-diaza-2-oxophenoxazine-2’-deoxy5’triphosphate-β-D-ribofuranosides.
Method I: 1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranosides (50 mg,
0.142 mmol) that have been dried overnight in vacuo are dissolved in dry
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trimethylphosphate (0.4 mL) under N2. Heated and sonicated to dissolve, the reaction is
then cooled to 0 oC. Chilled 1M phosphorous oxychloride solution in dry
trimethylphosphate that has been dried over 3 angstrom molecular sieves (156 μL, 0.156
mmol) is added dropwise to the reaction and stirred at 0 oC. After 30 minutes the reaction
is warmed to room temperature and stirred for one hour then returned to 0 oC. A 0.4 M
solution of tributylammonium pyrophosphate in dry dimethylformamide that has been
dried over 3 angstrom molecular sieves (1.8 mL, 0.72 mmol) was added dropwise to the
reaction followed by several drops of tributylamine. After stirring at 0 oC for 30 minutes,
the reaction is warmed to room temperature. Following 3 hours at room temperature the
reaction is poured into 0.1 M triethyl ammonium bicarbonate buffer (50 mL) and
evaporated. Dilution of the crude residue to 10 mL with 0.1M triethyl ammonium
bicarbonate buffer, syringe filtration and preparatory HPLC purification (CH3CN in
0.1M TEAB) gives the product (2.6 mg, 0.00439 mmol) in 3% yield.

7-methoxy-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. Synthesized via method I from 7-methoxy-1,3-diaza-2-oxophenoxazine2’-deoxy-β-D-ribofuranoside. Less than 5% yield
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8-methoxy-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. Synthesized via method I from 8-methoxy-1,3-diaza-2-oxophenoxazine2’-deoxy-β-D-ribofuranoside. Less than 2% yield

1,3-diaza-benzo(h)2-oxophenoxazine-2’-deoxy-5’-triphosphate-β-Dribofuranoside. Synthesized via method I from 1,3-diaza-benzo(h)2-oxophenoxazine-2’deoxy-β-D-ribofuranoside. Less than 1% yield.

7-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. Synthesized via method I from 7-chloro-1,3-diaza-2-oxophenoxazine-2’deoxy-β-D-ribofuranoside. Less than 3% yield
General Methods for the synthesis of 1,3-diaza-2-oxophenoxazine-2’-deoxy-5’dimethoxytrityl-β-D-ribofuranosides.
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Method J: 1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranosides (100 mg,
0.272 mmol) that have been dried overnight in vacuo with dimethylaminopyridine (1.7
mg, 0.0139 mmol) and dimethoxytrityl chloride (115.6mg, 0.322 mmol) were dissolved
in dry pyridine (0.4 mL) under N2 and stirred at room temperature until reaction stopped
proceeding as apparent by thin layer chromatography. Purification via flash silica gel
chromatography (CH3OH in CH2Cl2 with 1% TEA) gives the semicrude product.

8-chloro-1,3-diaza-2-oxophenoxazine-5’-dimethoxytrityl-2’-deoxy-β-Dribofuranoside. Synthesized via method J from 8-chloro-1,3-diaza-2-oxophenoxazine-2’deoxy-β-D-ribofuranoside in less than 21% yield.

7-chloro-1,3-diaza-2-oxophenoxazine-5’-dimethoxytrityl-2’-deoxy-β-Dribofuranoside. Synthesized via method J from 7-chloro-1,3-diaza-2-oxophenoxazine-2’deoxy-β-D-ribofuranoside in less than 10% yield.

173

8-methoxy-1,3-diaza-2-oxophenoxazine-5’-dimethoxytrityl-2’-deoxy-β-Dribofuranoside. Synthesized via method J from 8-methoxy-1,3-diaza-2-oxophenoxazine2’-deoxy-β-D-ribofuranoside in less than 46% yield.

1,3-diaza-benzo(h)2-oxophenoxazine-5’-dimethoxytrityl-2’-deoxy-β-Dribofuranoside. Synthesized via method J from 1,3-diaza-benzo(h)2-oxophenoxazine-2’deoxy-β-D-ribofuranoside in less than 15% yield.
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8-methoxy-tC-5’-dimethoxytrityl-2′-deoxy-β-D-ribonucleoside. Synthesized via
method J from 8-methoxy-tC-2′-deoxy-β-D-ribonucleoside in less than 61% yield.
General Methods for the synthesis of 1,3-diaza-2-oxophenoxazine-5’dimethoxytrityl-2’-deoxy-3’phosphormaidite-β-D-ribofuranosides.
Method J: 1,3-diaza-2-oxophenoxazine-5’-dimethoxytrityl-2’-deoxy-β-Dribofuranosides (29.6 mg, 0.0455 mmol) that have been dried overnight in vacuo with
dimethylaminopyridine (0.3 mg, 0.00228 mmol) were dissolved in dry dichloromethane
(0.3 mL) under N2 and cooled to 0 oC. Ethyl-diisopropylamine (10 μL, 0.0605 mmol) and
2-cyanoethyl-diisopropylamino-chlorophosphoramidite (11 μL, 0.0455 mmol) were
added dropwise. After reaction appeared complete by thin layer chromatography
(5minutes) reaction was diluted with methanol and evaporated. Purification via flash
silica gel chromatography (CH3OH in CH2Cl2 with 1% TEA) gives the crude product.
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8-chloro-1,3-diaza-2-oxophenoxazine-5’-dimethoxytrityl-3’-phosphoramidite2’-deoxy-β-D-ribofuranoside. Synthesized via method K from 8-chloro-1,3-diaza-2oxophenoxazine-2’-deoxy-β-D-ribofuranoside in less than 12% yield.

8-methoxy-1,3-diaza-2-oxophenoxazine-5’-dimethoxytrityl-3’-phosphoramidite2’-deoxy-β-D-ribofuranoside. Synthesized via method K from 8-methoxy-1,3-diaza-2oxophenoxazine-2’-deoxy-β-D-ribofuranoside in less than 32% yield.
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1,3-diaza-benzo(h)2-oxophenoxazine-5’-dimethoxytrityl-3’-phosphoramidite-2’deoxy-β-D-ribofuranoside. Synthesized via method J from 1,3-diaza-benzo(h)2oxophenoxazine-5’-dimethoxytrityl-2’-deoxy-β-D-ribofuranoside in less than 7% yield.

8-methoxy-tC-5’-dimethoxytrityl-3’-phosphoramidite-2’-deoxy-β-Dribofuranoside. Synthesized via method J from 8-methoxy-tC-5’-dimethoxytrityl-2’deoxy-β-D-ribofuranoside in less than 10% yield.
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3’,5’diacetyl-Pyrrolo-dC. Pyrrolo-dC (50 mg, 0.188 mmol) was placed dissolved
in dry pyridine (0.6 mL) under N2. Acetic anhydride (60 μL, 0.636 mmol) was added and
the reaction stirred at room temperature until completed as seen by thin layer
chromatography. Purification via flash silica gel chromatography resulted in product. (13
mg, 0.372 mmol) in 20% yield. 1H NMR (CDCl3) δ 12.62 (s, 1H), 8.12 (s, 1H), 6.44 (dd,
J=7.7, 5.6 Hz, 1H), 5.85 (q, J=1.2 Hz, 1H), 5.24 (dt, J=6.6, 2.4 Hz, 1H), 4.48 – 4.33 (m,
3H), 2.88 (ddd, J=14.4, 5.6, 2.3 Hz, 1H), 2.49 (d, J = 1.2 Hz, 3H), 2.17 – 2.11 (m, 1H),
2.10 (s, 3H), 2.07 (s, 3H).

3’,5’diacetyl-7-trifluoromethyl-Pyrrolo-dC. Zinc trifluoromethanesulfinate (9.3,
0.0596 mmol) was dissoved in dichlormethane (0.25 mL) under N2. 3’,5’diacetylPyrrolo-dC (6.6 mg, 0.019 mmol) was dissolved in dichloromethane and added to the
reaction followed by deionized water (0.2 mL). An additional water (0.2 mL) and
dichlormethane (0.75 mL) were added to the reaction and cooled to 0 oC. 70% tertbutoxide (13 μL, 0.108 mmol) was added dropwise and the reaction stirred. Following
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completion of reaction via thin layer chromatography, the reaction was diluted with water
and dichlormethane. The aqeuous layeres were washed with dichloromethane 2 times and
the combined organics were dried and evaoporated. Purification via flash silica gel
chromatography resulted in product (2.2 mg, 0.00527 mmol) 28% yield. 1H NMR
(CDCl3) δ 8.37 (s, 1H), 6.44 (dd, J=7.8, 5.6 Hz, 1H), 5.26 (d, J=6.4 Hz, 1H), 4.42 (q,
J=4.9, 3.9 Hz, 3H), 2.91 (ddd, J=14.7, 5.7, 2.0 Hz, 1H), 2.66-2.61 (s, 3H), 2.19 – 2.13 (m,
1H), 2.12 (d, J=0.8 Hz, 3H), 2.08 (d, J=0.8 Hz, 3H). 19F (55.40).
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Chapter 4 Photophysics of Tricyclic Cytosine Analogs
Introduction

Figure 4-0-1: Analogs investigated for relationships between structure and photophysical properties

Analogs were investigated for the changes in photophysical behavior from parent
compounds tC and tCo imparted by the substitutions that were appended to the
fluorophore skeleton in the course of the synthetic work (Chapters 2-3,figure 4-0-1). As
discussed in the introduction to this dissertation, there is a complicated relationship
between a molecule’s structure and its ability to interact with light. This relationship is so
complicated that it is difficult to make predictions on what substitutions will lead to a
desirable effect, and therefore the ability to use rational design is limited when planning
synthesis for desired properties. Through the series of closely related compounds
synthesized in this work it was possible to look for patterns in how the substituent
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character influenced quantum efficiency. A goal of this work is to use these substituent
effects in future rounds of iterative design. Photophysical characterizations were made in
both an aqueous and an organic environment. Mixtures of solvents were utilized in order
to determine the sensitivity of these photophysical properties to the environment of study.
Although wavelength of maximum absorbance varied only slightly through the
series of compounds, the absorptivity displayed some interesting variance and solvent
sensitivity. The absorptivity contributes to the brightness of an analog, and therefore it is
desirable to have the greatest absorptivity. Molecules that exhibit an increase in
fluorescence brightness upon formation of higher order structures, such as single strands
double strands of nucleic acids or as part of an enzyme, are desirable experimental
tools.31 A turn on signal is easy to distinguish, and eliminates much background signal.
The degree to which a compound interacts with the light is an intrinsic property and
therefore the experiments are limited by the probes and labels that are available.31

Figure 4-0-2 Analog peripherally investigated. 7,8-NO2-tCo-dRTP was not included in the free nucleoside study
but absorbance and emission data were collected in buffer.

Emission wavelength and the dependent Stokes shift of some of the analogs
showed variation from the parent compound. Quantum yield varies between the
molecules investigated, as well as the brightness, which is the mathematical product of
the varying absorptivities and quantum yields. These variances when examined
collectively do not correlate with the characteristic Hammett values or the differences in
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the Hammett value from that of the parent compounds. However, when looking at
individual positions of substitution on the chromophore, some correlation to Hammett
constant occurs. Conflicting results on the solvent sensitivity of the substituted tricyclic
cytosine analogs were obtained from a Reichardts dye comparison study and examination
of the photophysical behavior of the compounds in dioxane versus buffer. This lack of
correlation is not necessarily surprising, because the polarity of an environment is
determined by multiple factors. Polarity comes from the dielectric relaxation of the
solvent, or how long the dielectric constant takes to change in response to a stimulus.
Electronic polarizability affects polarity, as the tendency of the charge distribution of the
media to be distorted. Solvent quadrupole reorientation also determines environment
through the configuration of the dipoles.38 Explanations of these substituent effects are
difficult, but data can be compared to the results form similar investigations.
Additionally, the dinitro analog triphosphate was investigated in buffer, for its
absorbance and fluorescence properties (figure 4-0-2). Comparisons between this analog
are aided by the characterization of a single nitro substitution on the tC framework that is
found in the literature.61
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Figure 4-0-3 Reichardts dye. This is the solvent sensitivity standard used for comparison with the substituted tC
analogs.

Tricyclic cytosine analogs are seen to be stabilizing to the duplex, and generally
the greatest stability is seen to result in the lowest quantum yield, likely because of
excited state relaxation through a charge transfer mechanism.31 Dipole moment
differences between the excited and the ground state can lead to an influence on emission
wavelength of the compound by the environment. 6 Time resolved measurements would
provide information on the dynamics of the excited state and the decay pathways of the
fluorophore, but this investigation focused on the steady state behavior of the compounds.
In a Reichardts dye comparison experiment, the analogs are placed in various
mixtures of a polar and nonpolar solvent and the change in Stokes shift is compared to
the absorbance wavelength of the aforementioned dye (figure 4-0-3). The dye has a
change in absorbance wavelength depending on solvent polarity because of polarity
differences in the ground and excited states. Ground state zwitterion dye molecules
become neutral upon excitation.127 Therefore nonpolar solvents result in a smaller
HOMO-LUMO energy gap than polar solvents, and the wavelength of absorbance is
affected accordingly. From this experiment it was shown that the most sensitive to
environment polarity was the 7-OMe-tC analog followed closely by tetCo. Contrarily, the
greatest difference in Stokes shift between the two solvents for a compound was found
with the exceptionally bright 8-Cl-tCo with 43 nm difference
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Absorption of analogs
Once the substituted analogs had been synthesized through the means discussed
above, it was possible to investigate their interactions with light from an absorbance
standpoint. The unsubstituted oxygen tricyclic cytosine analog tCo was observed to have
an average absorbance wavelength of 356 nm in buffer and 357 nm in dioxane. This
indicates there was little difference in the polarity of the ground versus the excited state
as the energy gap was unchanged between these solvents. This is close to the literature
value reported for this compound in buffer that was determined to be the result of a single
absorption transition moment.42 Investigations of this compound also revealed that there
were not strong effects of pH, salt or temperature, like the lack of change observed in
different environments in this investigation. There is a large absorbance centering around
220 nm as well as one the one discussed above. The 356nm absorbance is a desirable
wavelength for probe absorbance because it is removed from the absorbance of the
natural nucleosides and avoids potentially complicating coupling effects.66
An aqueous absorptivity for tCo of 6800 M-1 cm-1 is increased to 7400 M-1 cm-1 in
dioxane. A value of 6800 M-1 cm-1 in buffer is lower than that which is reported in the
literature, and is not as significantly better than the sulfur containing homologue.
Differences in measurements are not uncommon, and therefore tC was utilized as a
second standard in all measurements made.128 This difference in absorptivity depending
on environment is not surprising given that there are slight changes in the fluorescence
intensity and lifetime reported for the molecule upon incorporation in nucleic acid
oligomers. Although there is some slight fine structure in the spectra collected, there is
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not the vibrational mode display discussed in the literature for this molecule.61 The
following Table 5 is a table of the absorptive properties of the analogs investigated.101
Table 5: Absorbance of analogs are presented with wavelengths in nm and absorptivities of M-1 cm-1.

Analog

Solvent

TetCo

Buffer

TetCo

Dioxane

7-Cl-tCo

Buffer

7-Cl-tCo

Dioxane

8-Cl-tCo

Buffer

8-Cl-tCo

Dioxane

8-F-tCo

Buffer

8-F-tCo

Dioxane

8-OMe-tCo

Buffer

8-OMe-tCo

Dioxane

7-OMe-tCo

Buffer

7-OMe-tCo

Dioxane

tCo

Buffer

tCo

Dioxane

tC

Buffer

tC

Dioxane

8-OMe-tC

Buffer

8-OMe-tC

Dioxane

7-OMe-tC

Buffer

7-OMe-tC

Dioxane

λ Abs

7,8-NO2-tCo-dRTP Buffer

Ε
361

5.3E+03

362

6.7E+03

357

6.7E+03

363

8.7E+03

361

5.6E+03

366

8.5E+03

360

1.8E+03

366

2.7E+03

361

4.0E+03

360

4.8E+03

361

3.0E+03

358

2.7E+03

356

6.8E+03

357

7.4E+03

377

4.7E+03

369

4.3E+03

379

3.8E+03

372

3.8E+03

379

2.0E+03

372
281

2.2E+03
1.9 E+04

o

A slightly larger environmental difference was seen for tC in extinction
coefficient than that observed for tC, and unlike tC, this compound is more absorbing in
dioxane. The change from a bent to a planar conformation upon absorption by the tC
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compound could explain why it is more sensitive, as this has also been used to explain
this compound’s larger Stokes shift which is discussed later.61 The smaller change in
absorption coefficient due to environment agrees with the literature decreasing upon base
stacking in oligonucleotides.129 The values acquired for this parent compound agree more
closely with the literature value of 4500 M-1 cm-1 in buffer.129 An absorbance wavelength
shift reported in the literature for the analogs upon stacking is not mimicked in switching
sample solvent, in dioxane the absorbance wavelength went 8 nm to the blue, whereas
upon stacking the absorbance maximum was shown to shift 25nm to the red.129
The absorptivities of the members of this tricyclic family are smaller than some of
the other analogs that are available, but they are better upon evaluation by the other
criteria discussed. pH-sensitive analogs that are also fluorine NMR probes have large
absorptivities in methanol, from 18000-38000 M-1 cm-1.130 Alkynyl derivatives of uridine
have absorptivities ranging from 4100 to 19450 M-1 cm-1.131 Comparative extinction
coefficients ranging from 2420-15000 M-1 cm-1 are seen by Pyrrolo-C analogs.132 Being
able to absorb more photons is beneficial because it increases the energy that could
potentially be emitted as photons. Generally increasing the size of the chromophore can
increase the absorptivity.6

186

Figure 4-0-4: Absorbance spectra of tCo analogs. Spectra obtained in dioxane and in buffer have been
normalized to emphasize spectral shape and maximum wavelength.

By this rationale, tetCo would be expected to have a greater absorptivity, but this

was not observed to be the case with the system under study. The absorption cross section
is proportional to the extinction coefficient, but this larger aromatic system did not
increase.6 A great decrease of 1533 M-1 cm-1 in absorptivity was seen upon the addition
of the fourth ring to the skeleton in buffer and there was a less but still measurable 704
M-1 cm-1 decrease in absorptivity from tCo to tetCo in dioxane.101 The additional
conjugation provided in this analog is expected to lower the HOMO and the LUMO
energies and result in the absorbance having a red shift.133 This decrease in energy does
not explain the decreased population of the excited state for this compound. A sizable
1413 M-1 cm-1 absorptivity difference between the environments tested suggests that this
may be an environment issue. Non-degenerate interaction causes a decrease in the
intensity of absorption of nucleic acids in DNA and perhaps hydrophobic interactions
create a similar interaction with these extended compounds in aqueous solvent.25
The addition of another aromatic ring to the chromophore did not significantly
alter the absorbance wavelength of this system, or the sensitivity of this property to the
environment. FBAs with extended aromatic surfaces were shown to have absorbance
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bands shift, making tetCo unique.6 TetCo had an average absorbance wavelength in buffer
of 361 nm and in dioxane of 362 nm. Red shifting upon stacking of the tricyclic cytosine
analog was not simulated by the nonpolar solvent in the study, and could potentially be
extended by the tetracyclic version. Further red shifting than the sulfur parent compound
due to enhanced stacking by tetCo might just land an absorbance wavelength in a
desirable FRET pairing region. There would also be an expectation of an increase in the
fine structure of the tetCo compound absorbance spectra, because of the different
conformations that are possible and the different vibrational levels for each of the energy
states. Shouldering in the absorbance peak indicates the presence of several different
transitions.31 As predicted, there is a greater degree of structure in the absorbance for this
compound compared with the other substitutions studied.
Greater absorptivity was only seen when a chlorine substituent was present, and
only in dioxane was this increase observed. In dioxane, 1094 M-1 cm-1 greater
absorptivity was had by the 7-Cl-tCo in comparison to the parent compound and even
greater still the 8-Cl-tCo analog increased 1275 M-1 cm-1. An absorptivity increase has
been seen in the substitution of aniline by chlorine as well.134 In this work the position of
the chlorine substituent had only slight influence on the absorptivity as well. In buffer
these analogs had a decreased absorptivity of 1175 M-1 cm-1 and 67 M-1 cm-1
respectively. The 2853 M-1 cm-1 difference in absorptivity between solvents for the 8-CltCo analog is the largest that was seen for the analogs in this investigation followed by the
1925 M-1 cm-1 difference for the 7-Cl-tCo compound. 101 Solvent dependency of this
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phenomena could possibly be a result of the fact that the dipole moments of compounds
can be dependent on the position of the chlorine substituent.
In previous studies, substitutions to the framework (methoxy excluded) have been
shown to have a collective decrease in the HOMO and the LUMO energies resulting in a
bathochromic shift in absorbance wavelength.135 It would be beneficial to have
absorbance shift far enough to overlap with the emission of another analog, as this would
be the beginnings of a potential Forster resonance energy transfer pair. Significant shifts
were not seen for any of the analogs, but the largest of 9 nm comes in dioxane from the 8Cl-tCo and the 8-F-tCo analogs (figure 4-0-4). This 8-F substitution had the largest
influence on the absorptivity as well, decreasing 5008 M-1 cm-1 in buffer and 4687 M-1
cm-1 in dioxane compared to tCo. This is opposite of the trend seen with other fluorescent
nucleosides which had absorptivity increase upon the fluorine substitution.136 It has been
shown that the resonance effects of a substituent are more important than their inductive
influence, and that is why the substituents can be seen to have an energy lowering effect
in terms of the HOMO-LUMO transition.135 The 7-Cl-tCo analog which has a different
position on the ring has a shift of only 6 nm compared to the parent absorbance
maximum. This is the same degree of shifting that is seen for 8-Cl-tCo in buffer. Aqueous
environments decrease the shifting of 8-F-tCo as well to only 5 nm and 7-Cl-tCo is shifted
less than the variance in the measurements.
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Figure 4-0-5: Absorbance spectra of tC analogs. Spectra obtained in dioxane and in buffer have been
normalized to emphasize spectral shape and maximum wavelength.

Aqueous environments were seen to increase the shifting in absorbance maximum
for the methoxy substituted compounds. The 7-OMe-tCo and 8-OMe-tCo shift 5 and 6 nm
respectively in buffer while falling underneath the threshold of experimental variance
with the degree of shifting observed in dioxane. Shifts were not seen to be in the
bathochromic direction as has been seen by ether substitution of other aromatic
compounds.137 However going from buffer to dioxane does result in blue shifts for these
compounds. The hydrogen bonding effects of this substituent group are possibly more
apparent in a polar solvent. Other shifts that were less than the variance seen in the
measurements were those of 7 and 8-OMe-tC (figure 4-0-5). They are not observably
different from the absorbance maximum of tC at 369 nm in dioxane and 377 nm in buffer
However of all of the methoxy substituents on either framework, which join tC in having
an average red shift in buffer versus dioxane, the sulfur versions show a stronger shift.
This greater difference in absorbance based on environment is interesting for the tricyclic
cytosine analog because it has been found to be more environmentally insensitive than
other fluorescent probes and labels.42 A difference in absorptivity is seen for tricyclic
cytosine between these two environments as well with 4300 M-1 cm-1 in dioxane
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becoming 4700 M-1 cm-1 in buffer. The opposite trend is observed for 7 and 8-OMe-tC
which are both lower in absorptivity than the parent compound. A decrease of 919 M-1
cm-1 for the 8-OMe-tC in buffer from the absorptivity of the parent compound is
tempered to only 477 M-1 cm-1 in dioxane. A difference of only 79 M-1 cm-1 in the
absorptivity of 8-OMe-tC between the environments is interesting. The 7-OMe-tC
behaves similarly although to a greater extent, having absorptivity decrease 2696 M-1 cm1

in buffer and only 2144 M-1 cm-1 in dioxane.
The opposite trend is seen for this same electronic group when on the tCo

framework. Absorptivities decreased 4668 M-1 cm-1 in dioxane for 7-OMe-tCo in
comparison to unsubstituted tCo 3796 M-1 cm-1 in buffer. This was the only oxygen
containing analog observed to have a stronger interaction with light when in an aqueous
environment. 8-OMe-tCo had a less solvent dependent 2594 M-1 cm-1 decrease in
absorptivity in dioxane, close to the 2791 M-1 cm-1 decrease in buffer.
The addition of a nitro substituent has been shown to be strongly shifting in
previous work.62 For the dinitro compound studied, there was a shift observed in the
absorbance maxima to the blue (figure 4-0-2). This is another unexpected occurrence, as
generally this functionality has been observed to shift absorbance in the opposite
direction.62 When there is a dinitro substitution a maximum absorption wavelength of 280
nm was observed. The absorptivity of this compound was found to be much higher than
the other analogs in buffer as the triphosphate 16000 M-1 cm-1.
Absorbance wavelength was shown to have no correlation to any Hammett
constant in either position of substitution (figure 4-0-7). Absorptivity on the other hand
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has some correlation (figure 4-0-8). In either solvent system, the absorptivity is much
more strongly correlated to the substitution at the 7 position. This placement on the
analog is in the position that is para to the nitrogen. The Hammett constant that gave the
best coefficient of determination was the + Hammett constant. These constants attempt to
account for both resonance and inductive effects of the substituent. The correlation is
slightly less in buffer, which is possible due to the greater influence of hydrogen bonding
in this environment.
There is less influence on the absorption than the emission by the polarity of the
solvent, because the absorption is assumed to be instantaneous and therefore only subject
to the average solvent shell around the chromophore.138 Polar fluorophores are likely to
have enlarged dipoles in the excited state which increases the charge transfer character
and leads to a greater dependence of wavelengths on the polarity of the solvent.
Hybridization induced tautomerization could also change the electronic nature and thus
the photophysics of the chromophore.35 The absorption also occurs too quickly to allow
for motion of the fluorophore or the solvent. Not only do the different water dioxane
mixtures have differing polarity, but they have different hydrogen bonding capabilities
which complicates the experiments observed.45
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Figure 4-0-6: Absorbance correlation between substituent Hammett constant and analog absorbance
wavelength. No linear relationship is seen with substitution at either position of the tricyclic framework.
Change refers to the difference in photophysical property as compared to the unsubstituted compound
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Figure 4-0-7: Absorbance correlation between substituent Hammett constant and analog absorptivity.
No linear relationship is seen with substitution at position 8 of the tricyclic framework but linear
relationship seen between substitution at position 7 in either dioxane or buffer. Change refers to the
difference in photophysical property as compared to the unsubstituted compound
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Absorbance Experimental:
UV/VIS spectroscopy was performed using a Varian Cary 100 Bio UV-visible
spectrophotometer. Absorbance spectra were obtained using a wavelength range of 600200nm, an averaging time of 0.100 s with a data interval of 1 nm. The scan rate was
600 nm per minute with the source changing over set to occur at 200 nm to prevent the
jump in absorbance from lamp changing occurring in the area of interest. A baseline
correction of the solvent being used was made prior to sample collection and the signal
band width was 2.0 nm. Samples were taken from a stock 6mM solution of each of these
analogs and diluted to desired concentrations with the solvent for investigation. A sample
of known concentration would be measured for absorptivity, and this value used to
calculate concentrations to which the absorbance would be less than 0.1. A 1 cm path
length was used. 1X PBS buffer was made from dissolution of phosphate buffered saline
tablet in millipure water. One tablet in 200 mL of water gives 0.01 M phosphate buffer,
0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4. 0.1 M H2S04 was
made from dilution of concentrated sulfuric acid with millipure water. Spectroscopic
grade dioxane was used. Quinine sulfate standards was made from dissolution of a
measure of quinine hemisulfate in DMSO to create a stock 6mM solution. Average
absorbance wavelengths from 6-13 measurements are reported with standard deviations.
Average absorptivities from 2-3 measurements are reported with standard deviations to
represent the difference between the measurements.
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8-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 18, 16, 14, 12, 10, 8, 6, and 4 μM or 14, 12, 10, 8, 6, and 4
μM in 0.1 M H2SO4 were used in comparison with 8-Cl-tCo in 1X PBS buffer at
concentrations of 14, 12, 10, 8, 6, and 4 μM and in dioxane at concentrations of 12, 10, 8,
6, 4 and 2 μM. Absorbance maxima of 361 ± 2 nm in buffer 366 ± 1 nm in dioxane.
Absorptivity of 5619 ± 1016 M-1 cm-1 in buffer 8472 ± 1018 M-1 cm-1 in dioxane.

tC 2′-deoxy-β-D-ribonucleoside. Quinine Sulfate diluted to concentrations of 14, 12, 10,
8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison with tC in 1X PBS buffer at
concentrations of 22, 20, 18, 16, 14, and 12 μM or 22, 21, 20, 18, 16, and 12 μM or 24,
20, 12, 8, and 4 μM and in dioxane at concentrations of 22, 20, 18, 16, 14, and 12 μM or
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22, 20, 16, 12, 8 and 4 μM. Absorbance maxima of 377 ± 2 nm in buffer 369 ± 1 nm in
dioxane. Absorptivity of 4678 ± 207 M-1 cm-1 in buffer 4314 ± 113 M-1 cm-1 in dioxane.

1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate diluted to
concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison
with tCo in 1X PBS buffer at concentrations of 14, 12, 10, 8, 6, and 4 μM and in dioxane
at concentrations of 12, 10, 8, 6, 4, and 2 μM in duplicate. Absorbance maxima of 355 ±
2 nm in buffer 357 ± 4 nm in dioxane. Absorptivity of 6794 ± 181 M-1 cm-1 in buffer
7378 ± 585 M-1 cm-1in dioxane.

1,3-diaza-benzo(h)2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with tetCo in 1X PBS buffer at concentrations of 20, 18, 16, 14, 12, and 10
μM or 20, 16, 12, 8, 4, and 2 μM and in dioxane at concentrations of 12, 10, 8, 6, 4, and 2
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μM in duplicate. Absorbance maxima of 360 ± 1nm in buffer 362 ± 2 nm in dioxane.
Absorptivity of 5261 ± 548 M-1 cm-1 in buffer 6674 ± 1257 M-1 cm-1 in dioxane.

7-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with 7-Cl-tCo in 1X PBS buffer at concentrations of 12, 10, 8, 6, 4, and 2 μM
and in dioxane at concentrations of 10, 8, 6, 4, 2, and 1 μM in duplicate. Absorbance
maxima of 357 ± 2 nm in buffer 363 ± 2 nm in dioxane. Absorptivity of 6278± 541 M-1
cm-1 in buffer 8653 ± 179 M-1 cm-1 in dioxane.

7-methoxy-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with 7-OMe-tCo in 1X PBS buffer at concentrations of 42, 34, 26, 18, 10, and
2 μM or 36, 30, 24, 18, 12, and 6 μM or 25, 20, 15, 10, 5, and 2.5 μM and in dioxane at
concentrations of 36, 34, 32, 30, 28, and 26 μM or 34, 26, 18, 10, and 2 μM.
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Absorbance maxima of 360± 2 nm in buffer 358 ± 1 nm in dioxane. Absorptivity of
2999± 945 M-1 cm-1 in buffer 2709 ± 7 M-1 cm-1 in dioxane.

8-methoxy-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with 8-OMe-tCo in 1X PBS buffer at concentrations of 24, 20, 16, 12, 8, and
4 μM and in dioxane at concentrations of 36, 34, 32, 30, 28, and 26 μM or 18, 15, 12, 9,
6, 3 μM or 18, 14, 10, 8, 6, and 3 μM. Absorbance maxima of 361 ± 1 nm in buffer 360 ±
1 nm in dioxane. Absorptivity of 4004 ± 414 M-1 cm-1 in buffer 4783 ± 411 M-1 cm-1 in
dioxane.
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8-fluoro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with 8-F-tCo in 1X PBS buffer at concentrations of 80, 70, 60, 50, 40, and 30
μM or 50, 40, 30, 20, 10, and 5 μM and in dioxane at concentrations of 42, 34, 26, 18, 10,
and 4 μM or 50, 40, 30, 20, 10, and 5 μM. Absorbance maxima of 360 ± 1 nm in buffer
366 ± 2 nm in dioxane. Absorptivity of 1787± 491 M-1 cm-1 in buffer 2690 ± 628 M-1 cm1

in dioxane.

7-methoxy-tC-2′-deoxy-β-D-ribonucleoside. Quinine Sulfate diluted to concentrations of
14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison with 7-OMe-tC in
1X PBS buffer and in dioxane at concentrations of 25, 20, 15, 10, 5, or 2.5 μM in

200

duplicate. Absorbance maxima of 379 ± 2 nm in buffer 372 ± 3 nm in dioxane.
Absorptivity of 1982 ± 351 M-1 cm-1 in buffer 2170 ± 180 M-1 cm-1 in dioxane.

8-methoxy-tC-2′-deoxy-β-D-ribonucleoside. Quinine Sulfate diluted to concentrations of
14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison with 8-OMe-tC in
1X PBS buffer at concentrations of 24, 20, 16, 12, 8, and 4 μM or 30, 23, 15, 11, 7, and 3
μM in duplicate and in dioxane at concentrations of 36, 34, 32, 30, 28, and 26 μM or 24,
20, 16, 12, 8, and 4 μM. Absorbance maxima of 379 ± 4 nm in buffer 371 ± 1 nm in
dioxane. Absorptivity of 3758 ± 261 M-1 cm-1 in buffer 3837 ± 37 M-1 cm-1 in dioxane.

7,8,-dinitro-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-D-ribofuranoside.
Absorbance spectra were obtained with the source changing over set to occur at 350 nm
which is the visible jump in the spectra. Anthracene diluted to concentrations of 15, 10, 6,
5, 4, 3, 2, 1 and 0.5 μM in ethanol were used in comparison with 7,8-NO2-tCo in 1X PBS
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buffer at concentrations of 10, 6, 5, 4, 3, 2, 1 and 0.5 μM. Absorbance maxima of 280 ±
1 nm in buffer. Absorptivity of 18600 ± 12210 M-1 cm-1.
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Fluorescence of Oxygen tricyclic cytosine analogs
A large Stokes shift is desirable because the further red shifted the emission the
more useful a probe will be in biological applications. In these experiments tCo was
observed to have a fair Stokes shift of 105 nm in buffer landing the emission wavelength
at 460 nm which is slightly blue shifted compared to tC and compared to the value
reported in the literature.37 The sulfur version of this molecule has a preferable Stokes
shift of 126 nm landing emission at 503 nm. Both of these parent compounds were
observed to have a blue shift when placed in a less polar environment. Sulfur skeleton tC
emission maxima falls to 472 nm in dioxane and tCo slides a lesser 18 nm in this solvent.
The quantum yield is more favorable in the opposite solvent to that which has the larger
Stokes shift. 0.217 higher quantum yield is seen in dioxane for tCo and 0.251 higher is the
quantum yield for tC in this environment. Upon incorporation there is a slowing of the
nonradiative decay processes, which allow for an increase in QY of this FBA when away
from the aqueous solvents. The nonradiative decay of these parent compounds being
equal, it is assumed that the increase in the fluorescence comes from an increase in the
fluorescence rate constant which comes from increased oscillator strength. 61 Below is a
table of the fluorescence properties of the analogs tested.101
Table 6: Fluorescence of Analogs are presented with wavelengths of emission and Stokes shift in nm, and
brightness in M-1 cm-1.

Compound

Solvent

λ Em

Φ

Stokes

ϕE

TetCo

Buffer

434

0.27

74

1400

TetCo

Dioxane

438

0.43

76

2900

7-Cl-tCo

Buffer

456

0.35

99

2400

203

7-Cl-tCo

Dioxane

446

0.46

83

4000

8-Cl-tCo

Buffer

455

0.35

94

2000

8-Cl-tCo

Dioxane

417

0.49

51

4200

8-F-tCo

Buffer

462

0.18

101

310

8-F-tCo

Dioxane

452

0.41

85

1100

8-OMe-tCo

Buffer

487

0.05

125

200

8-OMe-tCo

Dioxane

449

0.38

89

1800

7-OMe-tCo

Buffer

487

0.05

126

160

7-OMe-tCo

Dioxane

449

0.37

90

1000

tCo

Buffer

460

0.24

105

1700

tCo

Dioxane

442

0.46

85

3400

tC

Buffer

503

0.09

126

430

tC

Dioxane

472

0.34

103

1500

8-OMe-tC

Buffer

538

0.01

159

42

8-OMe-tC

Dioxane

490

0.28

118

1100

7-OMe-tC

Buffer

508

0.05

129

100

7-OMe-tC

Dioxane

477

0.27

105

580

7,8-NO2-tCo-dRTP

Buffer

389

0.03

108

570
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Figure 4-0-8: Emission spectra of tC analogs. Spectra obtained in dioxane and in buffer have been normalized to
emphasize spectral shape and maximum wavelength.

The presence of the fluorine did not have a great effect in either of the
environments on shifting the emission maxima. A slight blue shift of 10 nm in emission
wavelength was seen for 8-F-tCo from buffer at 462 nm to 452 nm in dioxane. The
quantum yield was little changed (12-25 percent) with this substitution as well, differing
from the parent compound by only 0.053 and 0.069 with the greatest difference coming
in an aqueous environment. The presence of fluorine in the major groove has been shown
to not have rotation restricted.139 Rotation effects on quenching will be mentioned later in
discussion of the methoxy analog, but a lack of quantum yield difference is interesting.
This lack of influence observed for the fluorine substitution is in comparison to
the tetracyclic analog which shifts the emission wavelength in buffer 26 nm to 434nm but
only 4 nm in dioxane. Due to the previously discussed decrease in the HOMO-LUMO
gap from extended aromaticity the decrease in Stokes shift is not surprising for tetCo. The
solvent dependence of this decrease is perhaps explained better by examination of the
parent compound because the Stokes shift difference between the solvents for tetCo is
only 2nm.Vibrational modes are used to explain the photophysical behavior of tCo.61
Visibility of the distinct transitions shows different energy levels are likely being
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populated. Quantum yield for this analog was more environmentally sensitive, and was
higher than that for the parent compound in buffer but lower in dioxane by almost the
same amount.

Figure 4-0-9: Emission spectra of tCo analogs. Spectra obtained in dioxane and in buffer have been normalized
to emphasize spectral shape and maximum wavelength.

TetCo had the greatest observed decrease in Stokes shift in an aqueous

environment, and the greatest increase was seen with the methoxy substituents. An
explanation for this phenomenon could be greater stability of the excited state provided
by this electron donating group. This pattern holds true for both the sulfur and the oxygen
containing analogs. 7-OMe-tCo, 8-OMe-tCo, 8-OMe-tC have emission wavelength
differences of 27, 26, 35 nm from the parent compounds respectively. The shifts are in
the same direction but not to as large an extent when the compounds are compared in
dioxane. 7-OMe-tC has a slight shift from the parent compound in either solvent which is
surprising given that the 8-OMe-tC had the most significant influence on emission
wavelength. If the substitution causes the excited and ground state geometries to be more
similar, this would have a greater effect on tC versus tCo because it has a greater
difference to overcome.61 Stokes shifts are 2-15 nm larger for these analogs in this nonhydrogen bonding solvent. Methoxy substituents caused twice the decrease in quantum
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yield for analogs in buffer compared to experiments in dioxane. but they consistently
decrease the emission of the compounds. Opposite to the influence on wavelength, the
decrease in quantum yield from these ether groups was strongest on the oxygen
framework. Fair (45-90%) 0.041 and 0.081 decreases were observed for 7 and 8-OMe-tC
respectively in phosphate buffer experiments. Modifications that allow for rotation create
competition for fluorescence in the form of torsional relaxation, and this is a potential
explanation of the quenching observed by the presence of the ether substitution.45 With
tCo having the greater fluorescence rate constant, the substitution influence on decay
processes may have a more significant impact on the oxygen framework. Although 8-CltCo shifts the emission 25 nm to 417 nm in dioxane it only has a Stokes shift difference of
11 nm compared to the parent compound in buffer. When this substituent is in the para
position (7-Cl-tCo) there is almost no difference in emission wavelength in buffer and a
slight 6 nm change from tCo in dioxane. Both analogs which contain this heavy atom
show a change in quantum yield of greater than 0.1 in phosphate buffer. These quantum
yield enhancements from the chlorine do not translate to nonpolar environments with
0.031 and 0.001 change in comparison to the parent in dioxane.101 This is interesting
when compared to the literature which suggests that heavy atoms promote intersystem
crossing. Other explanations have been offered to explain halogen’s enhancement of
fluorescence, such as an increase in fluorescence lifetime which increases the quantum
yield.140 Below are the graphs for Hammett constant correlation for fluorescence
characteristics.
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Figure 4-0-10: Emission correlation between substituent Hammett constant and analog emission
wavelength. Change refers to the difference in the photophysical property as compared to the unsubstituted
parent compound. No linear relationship is seen with substitution at position 7 of the tricyclic framework
but linear relationship seen between substitution at position 8 in either dioxane or buffer.
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Figure 4-0-11: Emission correlation between substituent Hammett constant and analog quantum yield.
Linear relationships are seen with substitution at positions 7 and 8 with stronger correlation at the 7
position for analogs in dioxane and at the 8 position for analogs in buffer. Change refers to the difference
in the photophysical property as compared to the unsubstituted parent compound.
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The emission wavelength correlates with substitution at the 8 position with a more
linear relationship for measurements made in buffer versus those in dioxane. In buffer the
+ Hammett constant is closest match to the substituent effect on emission wavelength.
Contrarily, in dioxane the – Hammett constant relates strongest to the effects that the
substitutions had. Differences in Stokes shift in buffer are clearly more correlated with
this same position on the chromophore which places the substituent para to the second
ring nitrogen. In dioxane there is a fair correlation to either position. Quantum yield has a
similar closeness in correlation with both positions in the different environments. The 8
position relate slightly better in buffer and the 7 position is closer in dioxane. Opposite to
the emission wavelength Hammett constants, the + Hammett value is closet in dioxane
and the – in buffer.
The product of emission quantum yield and absorptivity is a quality termed
brightness. A 768 M-1cm-1 increase in brightness was observed for 8-Cl-tCo in dioxane
followed closely by 7-Cl-tCo in buffer. Buffer measurements are useful because even
though this is the free nucleoside, and the environment within nucleic acids is sheltered
from the solvent, this is the media in which double and single stranded DNA are likely to
be studied. The greatest decrease 2399 M-1cm-1 is seen by 7-OMe-tC in dioxane. Solvent
susceptibility as will be discussed later can explain some of what is seen, the overall trend
in brightness with compounds in dioxane is 8-Cl-tCo>7-Cl-tCo>tCo>tetCo>8-OMetCo>tC>8-Fl-tCo>8-OMe-tC>7-OMe-tCo>7-OMe-tC. In buffer the overall trend is 7-CltCo>8-Cl-tCo>tCo>tetCo>tC>8-Fl-tCo>8-OMe-tCo>7-OMe-tCo>7-OMe-tC>8-OMe-tC.
Brightness correlation with Hammett values is presented below.
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Figure 4-0-12: Brightness correlation between substituent Hammett constant and analog brightness (product of
quantum yield and absorptivity). No linear relationship is seen with substitution at position 8 of the tricyclic
framework and slight linear relationship is seen between substitution at position 7 in either dioxane or buffer.
Change refers to the difference in the photophysical property as compared to the unsubstituted parent
compound
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Brightness correlates best with substitution at the 7 position on the nucleoside, in
either solvent, but this deviates somewhat from linearity for electron donating
substituents. With the many factors affecting each property, it makes sense that a strong
relationship between Hammett values and this photophysical property is not evident. In
dioxane, the + and – constant values relate almost equally to the data for changes in
brightness.
Although there is no fine structure apparent in the absorbance spectra of the tC
analogs following smoothing, there does appear to be some shouldering on either side of
the emission maximum when looking at the emission of these analogs in buffer. This
shouldering is indicative of vibrational levels of the excitation. Shouldering is less
apparent when the tC compounds are in dioxane, and this is the opposite of the trend that
is seen with the oxygen analogs. 8-F-tCo and the other meta position substituents show
some fine structure like the unsubstituted tCo analog in buffer but this is much more
intense in dioxane. Other FBAs have been shown to have single fluorescence decays as
free molecules in solution that become an ensemble in higher order structures due to the
different environments that are encountered.
The dinitro analog shows significant loss of fluorescence, which was also
observed with the addition of a single nitro substituent onto the sulfur skeleton. This
decrease has been attributed to vibrational deactivation, because it is temperature
dependent and at a frequency which indicates an internal conversion process. There have
been two calculated low energy coordinates for the tC nitro compound on the potential
energy surface of this compound.62 It has also been hypothesized that quenching from
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phosphate can occur as a kinetic process.50 The presence of the phosphate groups alters
the pKa of the nucleobase, and this may have some influence on the photophysics that
were observed as well.8
7-OMe-tC and tetCo were shown to be the most environmentally sensitive in the
Reichardts dye (RD) study discussed in the introduction to this chapter. However these
both have differences in brightness between buffer and dioxane that are less than that of
the parent compound and many of the other members of the family. 7-OMe-tC has the
smallest decrease in brightness when going from dioxane to buffer out of all the analogs
tested 474 M-1cm-1. The analog that was seen to have a large change in brightness
between the environments of 2204 M-1cm-1 was the 8-Cl-tCo analog. All other analogs
show a brightness sensitivity that is less than that of the parent compounds. However
because of the limited change in Stokes shift, this analog tested very insensitive in the RD
experiment measuring polarity sensitivity. Viscosity differences in the solvent mixtures
have been used to explain the behavior of analogs which have rotor like appendages, and
therefore are subject to the effects of the viscosity of the solvent as well.141 In the
Reichardts dye experiment measuring solvent sensitivity it was seen that 8-Cl-tCo was the
least sensitivity to polarity, followed by 7-OMe-tCo. Although not the most different in
brightness between the two solvents, this para methoxy analog has one of the most
significantly different quantum yields between dioxane and buffer. The smallest change
in Stokes shift between the two solvents was seen with the tetCo, but it has a change in
brightness on the larger side of the spectrum. In previous work it has been shown that
combinations of twisted intramolecular charge transfer and conformational effects have
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been used to explain these strange observations. Hydrogen bonding may stabilize a
certain conformation over another which results in the observed changes in the
photophysics.142 Environmental sensitivity needs to be further studied for the analogs but
sensitivity or lack thereof can be useful. Those analogs that do show some sensitivity to
their environment can report dynamics information while those that are not can maintain
fluorescence through environment changes.
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Fluorescence Experimental:
Fluorescence spectroscopy was performed using a Varian Cary Eclipse
Fluorescence Spectrophotometer. Emission spectra were obtained using a wavelength
range of 15nm past the excitation wavelength to 600 or 700nm, an averaging time of
0.100s with a data interval of 1 nm. The scan rate was 600 nm per minute with excitation
and emission slit widths of 5nm and a medium PMT voltage with no applied correction.
A baseline signal of the solvent being used was taken prior to sample collection and
subtracted from the data acquired. Correction data were not available for the entire
wavelength range of interest, so they were developed by the comparison of the emission
intensity of 1,1,4,4-tetraphenyl-1,3-butadiene, Coumarin 153, and 4-(dicyanomethylene)2-methyl-6-(p-dimethylaminostyryl)-4H-pyran to standard literature values.143 The
emission spectra were then integrated and the integrations used in comparison with
quinine sulfate standard and absorption data above to give quantum yield. Samples were
taken from a stock 6mM solution of each of these analogs and diluted to desired
concentrations with the solvent for investigation. A sample would be measured for
absorbance and emission in the same cuvette (which was marked for repetitive
orientation) at the same time. 1X PBS buffer was made from dissolution of phosphate
buffered saline tablet in millipure water. One tablet in 200 mL of water gives 0.01 M
phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4. 0.1
M H2SO4 was made from dilution of concentrated sulfuric acid with water from a
Millipore filtration system. Spectroscopic grade dioxane was used. Quinine sulfate
standards were made from dissolution of a measure of quinine hemi-sulfate in DMSO to
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create a stock 6mM solution Average emission wavelengths from 6-13 measurements are
reported with standard deviations. Average quantum yields from 2 measurements are
reported with standard deviations to represent half of the difference between the
measurements.

tC 2′-deoxy-β-D-ribonucleoside. Quinine Sulfate diluted to concentrations of 14,
12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison with tC in 1X PBS
buffer at concentrations of 22, 20, 18, 16, 14, and 12 μM or 22, 21, 20, 18, 16, and 12
μM or 24, 20, 12, 8, and 4 μM and in dioxane at concentrations of 22, 20, 18, 16, 14,
and 12 μM or 22, 20, 16, 12, 8 and 4 μM. Emission maxima of 503 ± 4 nm in buffer 472
± 2 nm in dioxane. Quantum Yields of 0.093 ± 0.002 in buffer 0.344 ± 0.016 in dioxane.
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1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with tCo in 1X PBS buffer at concentrations of 14, 12, 10, 8, 6, and 4 μM
and in dioxane at concentrations of 12, 10, 8, 6, 4, and 2 μM in duplicate. Emission
maxima of 460 ± 4 nm in buffer 442 ± 2 nm in dioxane. Quantum Yield of 0.244 ± 0.016
in buffer 0.461 ± 0.030 in dioxane.

1,3-diaza-benzo(h)2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine
Sulfate diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used
in comparison with tetCo in 1X PBS buffer at concentrations of 20, 18, 16, 14, 12, and 10
μM or 20, 16, 12, 8, 4, and 2 μM and in dioxane at concentrations of 12, 10, 8, 6, 4, and 2
μM in duplicate. Emission maxima of 434 ± 2 nm in buffer 438 ± 1 nm in dioxane.
Quantum Yield of 0.270 ± 0.016 in buffer 0.433 ± 0.002 in dioxane.
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7-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine Sulfate
diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in
comparison with 7-Cl-tCo in 1X PBS buffer at concentrations of 12, 10, 8, 6, 4, and 2 μM
and in dioxane at concentrations of 10, 8, 6, 4, 2, and 1 μM in duplicate. Emission
maxima of 456 ± 4 nm in buffer 446 ± 1 nm in dioxane. Quantum Yield of 0.355 ± 0.032
in buffer 0.460 ± 0.022 in dioxane.
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8-chloro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine
Sulfate diluted to concentrations of 18, 16, 14, 12, 10, 8, 6, and 4 μM or 14, 12, 10, 8, 6,
and 4 μM in 0.1 M H2SO4 were used in comparison with 8-Cl-tCo in 1X PBS buffer at
concentrations of 14, 12, 10, 8, 6, and 4 μM and in dioxane at concentrations of 12, 10, 8,
6, 4 and 2 μM. Emission maxima of 455 ± 3 nm in buffer 417 ± 40 nm in dioxane.
Quantum yields of 0.0349 ± 0.041 in buffer 0.492 ± 0.034 in dioxane.
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7-methoxy-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine
Sulfate diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used
in comparison with 7-OMe-tCo in 1X PBS buffer at concentrations of 42, 34, 26, 18, 10,
and 2 μM or 36, 30, 24, 18, 12, and 6 μM or 25, 20, 15, 10, 5, and 2.5 μM and in dioxane
at concentrations of 36, 34, 32, 30, 28, and 26 μM or 34, 26, 18, 10, and 2 μM. Emission
maxima of 487 ± 6 nm in buffer 449 ± 4 nm in dioxane. Quantum Yield of 0.053± 0.001
in buffer 0.369 ± 0.006 in dioxane.
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8-methoxy-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine
Sulfate diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used
in comparison with 8-OMe-tCo in 1X PBS buffer at concentrations of 24, 20, 16, 12, 8,
and 4 μM and in dioxane at concentrations of 36, 34, 32, 30, 28, and 26 μM or 18, 15,
12, 9, 6, 3 μM or 18, 14, 10, 8, 6, and 3 μM. Emission maxima of 486 ± 6 nm in buffer
449 ± 2 nm in dioxane. Quantum Yield of 0.050 ± 0.000 in buffer 0.380 ± 0.012 in
dioxane.
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8-fluoro-1,3-diaza-2-oxophenoxazine-2’-deoxy-β-D-ribofuranoside. Quinine
Sulfate diluted to concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used
in comparison with 8-F-tCo in 1X PBS buffer at concentrations of 80, 70, 60, 50, 40, and
30 μM or 50, 40, 30, 20, 10, and 5 μM and in dioxane at concentrations of 42, 34, 26, 18,
10, and 4 μM or 50, 40, 30, 20, 10, and 5 μM. Emission maxima of 462± 2 nm
in buffer 452 ± 2 nm in dioxane. Quantum Yield of 0.175 ± 0.006 in buffer 0.408 ± 0.000
in dioxane.
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7-methoxy-tC 2′-deoxy-β-D-ribonucleoside. Quinine Sulfate diluted to
concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison
with 7-OMe-tC in 1X PBS buffer and in dioxane at concentrations of 25, 20, 15, 10, 5, or
2.5 μM in duplicate. Emission maxima of 508± 14 nm in buffer 477± 2 nm in dioxane.
Quantum Yield of 0.052 ± 0.001 in buffer 0.266 ± 0.004 in dioxane.
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8-methoxy-tC 2′-deoxy-β-D-ribonucleoside. Quinine Sulfate diluted to
concentrations of 14, 12, 10, 8, 6, and 4 μM in 0.1 M H2SO4 were used in comparison
with 8-OMe-tC in 1X PBS buffer at concentrations of 24, 20, 16, 12, 8, and 4 μM or 30,
23, 15, 11, 7, and 3 μM in duplicate and in dioxane at concentrations of 36, 34, 32, 30,
28, and 26 μM or 24, 20, 16, 12, 8, and 4 μM. Emission maxima of 538 ± 3 nm in buffer
490 ± 2 nm in dioxane. Quantum Yield of 0.011 ± 0.000 in buffer 0.277 ± 0.014 in
dioxane.
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7,8,-dinitro-1,3-diaza-2-oxophenoxazine-2’-deoxy-5’triphosphate-β-Dribofuranoside. Emission spectra were obtained with the source changing over set to
occur at 350 nm which is the visible jump in the spectra. Anthracene diluted to
concentrations of 15, 10, 6, 5, 4, 3, 2, 1 and 0.5 μM in ethanol were used in comparison
with 7,8-NO2-tCo in 1X PBS buffer at concentrations of 10, 6, 5, 4, 3, 2, 1 and 0.5 μM.
Emission maxima of 389 nm in buffer. Quantum Yield of 0.03.
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Solvent Sensitivity Experimental:
Mixtures of 10, 30, 50, 70, and 90 dioxane in 1X phosphate buffered saline were
prepared. The analogs were made into samples on 30μM that have less than 0.4 percent
by volume of DMSO from the stock solution. Absorbance and emission spectra were
taken of the nucleosides and Reichardts dye in the above mixtures. Emission spectra were
corrected and the maximum wavelength in combination with data from the quantum
yields studies for the pure solvents and the maximum absorbance wavelength used to
determine a Stokes shift in wavenumbers. These values were the y axis values and the
Et(30) values for Reichardts dye in the corresponding solvent mixtures were the x axis
values for the plots presented below. The slopes of the lines of these graphs were used as
a measure of environmental sensitivity for the compound under study.

8-chloro-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left are
the spectra for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots of
the Stokes shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the
Et(30)value (the shift in absorbance value for Reichardts dye).
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tC 2′-deoxy-β-D-ribonucleoside. On the left are the spectra for the compound obtained in
dioxane and water and mixtures thereof. On the right are the plots of the Stokes shifts in wavenumbers as a
function of the polarity of the solvent. Polarity was defined as the Et(30) value (the shift in absorbance value for
Reichardts dye).

1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left are the spectra
for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots of the Stokes
shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the Et(30) value (the
shift in absorbance value for Reichardts dye).
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1,3-diaza-benzo(h)2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left are
the spectra for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots of
the Stokes shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the Et(30)
value (the shift in absorbance value for Reichardts dye).

7-chloro-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left are
the spectra for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots of
the Stokes shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the Et(30)
value (the shift in absorbance value for Reichardts dye).

7-methoxy-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left
are the spectra for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots
of the Stokes shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the
Et(30) value (the shift in absorbance value for Reichardts dye).
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8-methoxy-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left
are the spectra for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots
of the Stokes shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the
Et(30) value (the shift in absorbance value for Reichardts dye).

8-fluoro-1,3-diaza-2-oxophenoxazine 2’-deoxy-β-D-ribofuranoside. On the left are
the spectra for the compound obtained in dioxane and water and mixtures thereof. On the right are the plots of
the Stokes shifts in wavenumbers as a function of the polarity of the solvent. Polarity was defined as the Et(30)
value (the shift in absorbance value for Reichardts dye).
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7-methoxy-tC 2′-deoxy-β-D-ribonucleoside. On the left are the spectra for the compound
obtained in dioxane and water and mixtures thereof. On the right are the plots of the Stokes shifts in
wavenumbers as a function of the polarity of the solvent. Polarity was defined as the Et(30) value (the shift in
absorbance value for Reichardts dye).

8-methoxy-tC 2′-deoxy-β-D-ribonucleoside. On the left are the spectra for the compound
obtained in dioxane and water and mixtures thereof. On the right are the plots of the Stokes shifts in
wavenumbers as a function of the polarity of the solvent. Polarity was defined as the Et(30) value (the shift in
absorbance value for Reichardts dye).

Reichardts dye On the left are the spectra for the compound obtained in dioxane and water and
mixtures thereof. On the right are the plots of the Et(30) value (the shift in absorbance value for Reichardts dye)
and percent of buffer.
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Stokes shift correlation between substituent Hammett constant and analog absorbance and emission wavelength
separation. No linear relationship is seen with substitution at position 7 of the tricyclic framework and linear
relationship is seen between substitution at position 8 in buffer only. Change refers to the difference in the
photophysical property as compared to the unsubstituted parent compound.
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Chapter 5 Biological Activity of Analogs
Introduction
Fidelity of nucleic acid replication depends on the ability of the enzyme to select
and incorporate the correct nucleotide. Error rates vary between 10-3 and 10-6 errors per
nucleotide incorporated when the enzyme cannot proofread and 10-8 and 10-11 when it
can. There is an intrinsic yet minor natural mechanism to permit purposeful mutations,
through errors in replication, for evolution. Watson and Crick were the first to propose
that this mechanism may rely on the tautomerism of the nucleotides.64 Uridine and
thymidine are likely to be found in the diketo form, while the keto-amino form is
predominant in cytosine and guanine, with adenine alone adopting the amino form as the
major tautomeric configuration.8 The presence of the sugar has been shown to prevent
some tautomerism in nucleobases. Placement of the nucleobase nitrogen in the glycosidic
bond limits its participation in the tautomers that would be accessible by the free base.
Because the tautomeric form of the base can influence photophysics, understanding the
tautomeric equilibrium of a nucleotide can help explain its chromophore capabilities. The
fluorescence decay has been shown to be different between the nucleobase and the
nucleoside which is not entirely unexpected. Even the nucleoside and the nucleotide
have differencing decays which is surprising given they differ only by presence of
phosphate.144 Tautomerism affects more than just the photophysics that were presented in
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Chapter 4, so the positions of nucleobase protons, dictated by tautomeric
equilibria of the analogs, is under investigation.

Figure 5-0-1: Tautomerization of analogs. These are two of the tautomeric forms for the substituted tricyclic
cytosine analogs investigated using incorporation and low temperature NMR.

Experiments by collaborators at the University of Colorado at Boulder have been
published characterizing incorporation of the parent compounds tC and tCo.64 This
chapter presents the characterization of the substituted analogs. These early experiments
reveal that the dinitro substituted tCo analog, the synthesis of which was presented in
Chapter 3, can incorporate more efficiently than the natural nucleotides opposite either G
or A. Other analogs are awaiting analysis for incorporation fidelity by polymerases. The
substitutions will likely have an influence on the tautomeric equilibrium between the
amino and the imino forms of cytosine because of their varying electronic and resonance
contributions. Substituting bromine onto a uracil changes its tautomeric equilibria and its
pairing abilities.145 It is proposed that this substitution increases the occurrence of the
enol form of the compound by an order of magnitude.
Another synthetic nucleotide 2AP has been shown to pair with C or U in the
wobble configuration while finding a partner in T with natural hydrogen bonding.15 X ray structures have shown the presence of wobble base pairs in short duplexes.64
Tautomeric mismatches can resemble the size and the shape of the natural base pairs.
Wobble pairs which result from ionization of a base do not resemble the natural system
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as closely. This decreases the likelihood that wobble pairs are the mechanism for
evolutionary mutations. Tautomer pairs are more likely to make it through the five
polymerase check points than the wobble pairs due to a closer resemblance to the
Watson-Crick pair. These check points are the pre-insertion site, the insertion site, the
catalytic site, the post-insertion site, and the duplex binding region, which all verify that
the correct base has been inserted. Stabilization of these higher energy tautomeric pairs
is achieved by hydrogen bonding with a water molecule that is found in the polymerase
active site. Additional stabilization comes from the electrostatic field. Mismatch as a
result of a tautomerism can also be stabilized by a cofactor that binds to the enzyme and
encourages maintenance of the closed state of the polymerase enzyme. 146 NMR has been
used to study the tautomeric CA pair.64
A change in the metal cofactor from Mg2+ to different metals was shown to be
helpful to the tautomeric base pairs in the polymerase active site. Nickel was shown in a
study of guanine to inhibit tautomerism. Association with nickel prevents formation of
the lowest energy G7 tautomer. Coordination between the metal and the analog occurs at
the 7 position. In the absence of this metal, the authors had been able to use heat to
induce guanine tautomerization from the normal G9 tautomer to the G7(figure 5-0-2).147
Guanine is not only the easiest to oxidize, but it has been suggested to be the nucleobase
that is easiest to tautomerize.148 Computational studies into the C-G tautomeric base pair
revealed that tautomerism, cis-trans isomerism, and sterics all play a role in the stability
of the tautomeric pair. Tautomerism plays interesting roles in the behavior of nucleic
acids in the presence of metals as well as in the formation of triplex structures.149
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Figure 5-0-2: Tautomers of guanine. This tautomeric equilibrium has been investigated computationally and
with other experiments including metal association.

Mutagenesis and carcinogenesis have been observed as a result of O6 alkylation
of G. The G to A mutation may come from the preferred pairing of this alkylated guanine
with T instead of C. There is no difference in the stability of this duo, but it has an effect
on the overall stability of a duplex containing this pair. 150 The decrease in duplex
stability may be a steric problem, because sequence dependent melting temperatures were
not observed. The same steric issue could play a role in the polymerase active site
explaining the observed G to A mutation but it also could be a tautomeric effect.
Tautomeric base pair mismatches have been used as a means to control the
cellular functions of some synthetic nucleotides. A photoinduced change in the hydrogen
bonding face was shown to be a means of controlling recognition and complementarity of
an analog by cellular elements. Site specific irradiation could be used to change the
partner of an analog from guanine to adenine.151 Some applications make the lack of
pairing specificity desirable. An analog that is useful for this purpose is N-alkoxy
cytosine which can tautomerize to pair as either T or C. These are preferable to analogs
that stack but don’t hydrogen bond because of the increased stability.121
Tautomerism remains an understudied phenomenon of nucleosides, because the
availability of sensitive techniques to study the tautomeric forms of nucleotides are
limited. Interconversion of tautomers can occur in less than a millisecond. Through the
use of a combination of techniques, it was recently possible to study tautomeric
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recognition by a riboswitch. Tautomerism is of interest in terms of antivirals because
nucleotides with tautomeric forms can accelerate mutation rates of RNA viruses to
extinction.152
Due to the tunneling effect, quantum jumps of protons can occur, which is a
proposed method for formation of a different tautomer of a nucleobase. If this happens in
one strand it can encourage the nucleobase in the complementary strand to tautomerize to
balance the hydrogen bonding pattern. If ionization due to proton jumping without
tautomerization occurs this would lead to deletions because there is no partner to be
found for replication.153
Compartmentalized self-replication is a polymerase evolution strategy that results
in enzymes with a more tolerable active site. Short patch versions of this replication have
only a small defined sequence of the gene replicated resulting in enzymes with the active
site but not other active domains, i.e. those for proofreading. This has been utilized with
synthetic nucleotides, because it makes possible the enzymatic incorporation of normally
intolerable nucleotides. B family polymerases, evolved with a diversification in the A
mobile and the C mobile regions of the active site, have been used for incorporation of
synthetic nucleotides. “Specialist” polymerases were also found which would select for
dye labeled nucleotides and incorporate them more efficiently than the natural
nucleotides. Polymerases have an error threshold, and those that are too error prone will
not be functional at all, so there are limits to this technique. The minor groove is where
the hydrogen bonding between the nucleic acids and the polymerase enzyme takes place.9
By starving the polymerase enzyme of specific triphosphates, replication can be stalled at
236

specific sites. This has been used to produce fluorescent snapshots with fluorescent
nucleotides of the enzyme DNA complex. 41
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Dinitro Incorporation
Using steady state conditions, it is possible to use polymerization of the analogs
synthesized in Chapter 3 to determine the kinetics and fidelity of the analogs with
biological machinery. Phosphorous labeled template strands make visualization of the
incorporation products possible following denaturing electrophoresis. Tolerance of the
substituted analogs is important in their utility as biophysical probes. Additionally the
ambiguous characterization of the presence of phosphate functional groups on the
deoxyribose of these compounds is verified by the ability to be an enzyme substrate for
synthesis.
Table 7: Kinetic incorporation comparison between 7,8-NO2-tCo-dTP and natural nucleotide partners for
polymerization opposite A and G in the 13th position of a 25 base strand sequence.

dNTP

Template

Vmax KM

Vmax/KM

Discrimination

dTTP

DNAA

2.47

0.32

7.70

1

7,8-NO2-tCo-dTP

DNAA

2.38

0.25

9.48

0.5

dCTP

DNAG

0.69

0.19

3.59

1

7,8-NO2-tCo-dTP

DNAG

2.93

0.38

7.70

0.8

7,8-NO2-tCo-dTP was tested for its incorporation kinetics. Tricyclic cytosine
analogs incorporate across from A and G as was previously established. 64 Therefore, this
substituted analog was tested for incorporation against both of these templating bases. As
discussed in the introduction, it is hypothesized that the ability to pair with both of these
natural bases comes from a tautomeric ratio between the amino and imino forms that is
not as one sided as that for cytidine.
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Figure 5-0-3: Incorporation nucleic acids of DNAA. Template and primer sequence for incorporation kinetic
experiments of 7,8-NO2-tCo-dTP with dTTP.

Incorporation by Klenow fragment polymerase onto the primer opposite adenine
in the template sequence resulted in an observed Vmax of 2.38 (percent/min) for 7,8NO2-tCo and 2.47 (percent/min) for thymidine (figure 5-0-3, table 7). These faster
kinetics for the unnatural base analog were not seen in the experiments with the parent
compounds tC and tCo. Both of these unsubstituted skeletons had Vmax for
incorporation opposite adenine that were higher than that for natural cytosine, but lower
than thymidine. This means that the maximum rate of the incorporation reaction is greater
for this new analog than for the natural nucleotide pair. This measure of the differences
in the catalytic rate constants is complicated because of the multiple steps involved in
polymerase activity.154

Figure 5-0-4: Incorporation nucleic acids DNAG. Template and primer sequence for incorporation kinetic
experiments of 7,8-NO2-tCo-dTP with dCTP.

Faster kinetics were observed not only for the dinitro compound as a substitute for
T in pairing with A, but also in the place of C pairing with G. Using the same primer
sequence and a template with only a single nucleotide difference, the new analog was
tested for polymerization. Incorporation opposite guanosine was seen to have the
greatest Vmax of 2.93 (percent/min) while the natural C was shown to have a 0.69 Vmax
under the conditions tested (figure 5-0-4, table 7). Tricyclic cytosine and tCo have shown
to have faster kinetics than the natural cytosine but not nearly to the extent observed for
7,8-NO2-tCo.64
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As a measure of the dissociation of the polymerase-DNA-nucleotide complex, the
KM is a representation of the affinity in the enzyme substrate complex for the incoming
nucleotide.7, 154 The KM for the enzyme substrate complex where adenine is templating is
0.25 μM with 7,8-NO2-tCo-dTP which is lower than the 0.32 μM seen for the natural
binding partner. A lower concentration of the nucleotide is needed to reach half saturation
of the enzyme that is present which could be evidence of a greater affinity of the enzyme
for the modified base.
The reverse is seen when incorporating opposite guanosine. Cytidine has a KM in
the assay of 0.19 μM and 7,8-NO2-tCo was 0.38 μM. This decrease in enzyme affinity as
compared to the natural nucleotide was seen for the parent compounds in incorporation
opposite both A and G in previous work.64
Combining the two kinetic parameters gives a measure of overall incorporation
efficiency through examining how the polymerase functions at low nucleotide
concentrations for the natural base versus the synthetic base. Vmax/KM of 7,8-NO2-tCo is
9.48 (percent min-1 μM-1) versus 7.70 (percent min-1 μM-1) for thymidine with regards to
incorporation with the templating adenine. Greater efficiency of 7,8-NO2-tCo is observed
across both templates. With guanosine as a partner, Vmax/KM is 7.70 (percent min-1 μM1

) for the substituted tricycle and 3.59 (percent min-1 μM-1) for the natural version of

cytosine. The fidelity of the tC and tCo is reported to be equal to that of the cytosine and
less than that for thymidine with their respective natural partners.
Enzyme discrimination is the ratio of Vmax/KM for the natural nucleotide versus
the analog. Less discrimination (0.5) than that for the natural analog (1) was seen for 7,8240

NO2-tCo, as well as tC (0.6) and tCo (0.6) when incorporating opposite guanosine.
However, the discrimination of (0.8) for the dinitro compound with regards to
incorporation opposite adenosine is thus far unique for the tricyclic cytosine family, the
parent compounds and cytosine have values greater than 1.64
Dinitro Tautomerism
In the NMR spectrum of the substituted tricyclic cytosine analogs there is an
interesting broadness at around 7.7 ppm in the peaks of the nucleobase. An investigation
was made into whether this broadness would resolve into two peaks at low temperature,
perhaps representing the two tautomeric forms of the nucleobase that would explain the
incorporation behavior seen above.

Figure 5-0-3: 7,8-NO2-tCo in DMSO. NMR spectra presented for the proton signals of the nucleoside.

Low temperature NMR studies were not possible in DMSO (which is the best
solvent for obtaining spectra of the nucleosides). To investigate the possible solvents to
use for this study, deuterated acetone and dichloromethane were tried. Limited solubility
in dichloromethane eliminated that solvent immediately. In acetone the solubility was
less than in DMSO, but it was soluble enough for measurements to be attempted. Spectra
were obtained from 30 oC down to -80 oC. Unfortunately, as the temperature decreased
the low solubility became an issue, and the peaks for the nucleoside were difficult to
follow. There was some apparent movement of the aromatic proton signals, but no
discernible resolution of one peak into two.
241

To improve the solubility, spectra were taken in a mixture of 40 percent
deuterated DMSO with 60 percent deuterated chloroform. Spectra were obtained from 30
o

C down to -30 oC. Broadening not seen in the mixture of solvents at room temperature

appears in the aromatic region at lower temperature, but NMR was not able to be
measured at temperatures low enough to resolve the tautomeric forms.
To confirm the assignment of the exchangeable protons, a small amount of
deuterium oxide was added to a sample in the above mixture at 30 oC. This resulted in a
change in two peaks which were suspected to be NH protons (see experimental). Finally,
to ensure the peaks that were assigned in DMSO were the same as those in this mixture a
titration of deuterated chloroform into a sample of the 7,8-NO2-tCo in deuterated DMSO
was performed. Upon addition of the first hundred microliters of chloroform, the
coupling is disturbed and broadening of peaks was observed. After four hundred
microliters the peaks sharpen to those seen in the sample used for the low temperature
measurements (figure 5-0-6).
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Figure 5-0-4: Titration of chloroform into DMSO. 100μL portions of CDCl3 (2-6) were added to a sample of the
7,8-NO2-tCo in DMSO (1) to establish which signals in a mixture of solvents correspond to the proton signals in
DMSO.
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Dinitro Experimental:
Single nucleotide insertion assays were used to determine KM and Vmax.
Experiments were performed with 0.5 nM Klenow fragment polymerase enzyme, 2 μM
primer-template, 2, 5, 10, 20, 40 and 500 μM 7,8-NO2-tCo-dTP, 0.5, 0.75, 1, 2, 4, and 6,
μM dTTP, or 2, 5, 10, 20, 40 and 500 μM dCTP with 5 mM MgCl2, 50 mM Tris-HCl pH
7.5 in a total volume of 10 μL. The DNA primers were 32P labeled on the 5’ terminus
using T4 polynucleotide kinase prior to being annealed to the template strand. Assays
were stopped at 2.5 and 10 minutes by addition of two volumes gel loading buffer (90%
formamide with 50 mM EDTA. Incorporation products were separated by denaturing gel
electrophoresis (20% polyacrylamide, 8 M urea) and analyzed by phosphorous imaging.
Nonlinear curve fitting was used to derive the kinetic parameters presented.
Saturated Samples of 7,8-NO2-tCo were prepared in corresponding deuterated
solvents for variable temperature NMR. Spectra were collected on an INOVA 500 MHz
spectrometer. Titration and proton exchange experiments were collected on a VNMRS
400 MHz spectrometer.
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Variable temperature of 7,8-NO2-tCo in acetone. Measurements were made from 30 degrees (1) down to -80
degrees (-10) but the limited solubility of the nucleoside made determination of the proton signals at lower
temperatures difficult.
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Variable temperature of 7,8-NO2-tCo in 40% DMSO, 60% CDCl3. Measurements were made from 30 degrees
(1) down to -30 degrees (7). Experiments were looking for a resolution of the two amino proton signals for the
tautomeric forms of the nucleoside which were not seen.

Proton exchange of 7,8-NO2-tCo. Deuterium oxide was added to confirm the proton signals for exchangeable
hydrogens of the nucleoside. The 5’ and 3’ hydroxyl signals at around 5 ppm decreased as well as the potential
amino proton signals at around 11.5 ppm and 7.7 ppm.
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Chapter Six: Conclusions and Future Work
The overarching correlation between all experiments in this work is the effect of
substituents; they affect photophysics, synthesis, and incorporation. As discussed in the
fourth chapter of this work, there are some correlations between the photophysical
properties and the substituents that were synthesized into the chromophore framework.
Correlation with quantum yield is not position dependent whereas influence on
absorptivity by substitution is affected by location. Absorbance wavelength changes are
not linearly related to Hammett constant but emission wavelength differences are.
Observed reactivity of compounds in the synthesis presented in chapters two and three
correlates with the Hammett constants of the substituents as well. The most unreactive
compound towards secondary amine formation was the 4-chloro-2-aminophenol, and this
has the greatest Hammett constant (meta to amine formation). Ring closure was difficult
with the secondary amine formed from 5-chloro-2-aminophenol which has the same
Hammett constant (meta to ether formation). Character of the substituent explains the
enzymatic fidelity presented in chapter five as well. The effect of substitution was
effectively examined through a series of closely related compounds, but more remains to
be gleaned from this small library because in general, the trends do not fully explain all
of the results. Sometimes electronic affects are more important and in other cases
resonance substituent character has a greater influence.
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Nucleic acid studies of the compounds may shed some light on the questions of
which analogs are the most and least sensitive to their environment. Conflicting results
obtained from the nucleosides may be resolved by investigations of oligomers containing
these substituted nucleotides. Computational studies are another avenue that may aid in
clarification the phenomena that have been presented. Investigations in different solvents
may provide a better picture of the influence of surroundings on the properties of these
interesting molecules.
The desirable emission wavelengths of the sulfur skeleton could be combined
with the brightness of a chlorine substitution to make a bright analog with a large Stokes
shift. Substituents tested thus far did not result in a large change in Stokes shift but
further elaborations of these analogs or installation of additional functionality may make
a useful pair of analogs for FRET studies with intrinsic nucleic acid probes. Although the
synthetic route to the tricyclic tCc is low yielding, it is possible that modification of the
reaction conditions could provide access to this compound.
Further synthetic modification of compounds discussed in this work would be
desirable. The OH-tC(o) analogs can be investigated on their own, or following further
reaction with other new substituents via activation through the triflate. Buchwald Hartwig
amination of the Cl-tCo analogs are still a potential avenue to new fluorophores.
Synthesis of Et2N-tC analogs appears to have great potential through the thiazole
chemistry. Synthesis of CF3-tC(o) analogs may be the next great fluorescent nucleosides.
Reactions of the substituents that are present will impart new functionality and provide
additional library members to expand the present knowledge on substituent effects.
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High performance liquid chromatography improvements in method development
would likely increase the recovery of compound from the purification of these fluorescent
nucleotides. Purification methods that are effective for the dimethoxytritylated forms of
the nucleosides would also improve the advancement of these compounds towards future
oligomer synthesis. Low reactivity may be circumvented through the use of more reactive
starting materials. Phosphoramidite chemistry works well and purification conditions
have been optimized for this synthetic step which follows the problematic protection of
the 5’ position.
Synthesis from a nucleobase approach would be useful for the production of large
amounts of nucleosides, as these reactants are tolerant to increases in scale. Finding the
right protecting group could make all the difference in the synthesis of tCos by these
means. Similarly, the right protecting groups could make the hydroxy-cytosine a useful
starting material for synthesis of new analogs.
The future of the tC(o) analog library is bright. Fluorescent nucleoside analogs are
very useful in the study of bimolecular processes, and the technology is always
improving. Single molecule studies are now possible, and would be greatly aided by
brighter probes that are incorporated directly at the site of study.155
Cl-tCo nucleoside analogs have been synthesized which are more brilliant than the
bright parent compounds. These bright analogs may have an environmental reporting
ability that is missing from tC. Triphosphate versions of these compounds have been sent
for enzymatic testing which could produce oligonucleotides for nucleic acid studies of
these molecules. Investigations comparing these closely related analogs have provided
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information that suggests relationships between photophysical properties and positions of
substituents. This information will be useful in the design of new fluors with a specific
property in mind. Synthetic routes to new substituents and related molecules have been
presented and the toolbox for biophysical investigation of nucleosides and nucleic acids
will continue to grow.
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